<SEC-DOCUMENT>0001213900-25-042018.txt : 20250512
<SEC-HEADER>0001213900-25-042018.hdr.sgml : 20250512
<ACCEPTANCE-DATETIME>20250512160517
ACCESSION NUMBER:		0001213900-25-042018
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20250506
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250512
DATE AS OF CHANGE:		20250512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OSR Holdings, Inc.
		CENTRAL INDEX KEY:			0001840425
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				845052822
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41390
		FILM NUMBER:		25934692

	BUSINESS ADDRESS:	
		STREET 1:		10900 NE 4TH STREET, SUITE 2300
		CITY:			BELLEVUE
		STATE:			WA
		ZIP:			98004
		BUSINESS PHONE:		425-635-7700

	MAIL ADDRESS:	
		STREET 1:		10900 NE 4TH STREET, SUITE 2300
		CITY:			BELLEVUE
		STATE:			WA
		ZIP:			98004

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Bellevue Life Sciences Acquisition Corp.
		DATE OF NAME CHANGE:	20210113
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0241726-8k_osrhold.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:OSRH="http://bellevuespac.com/20250506">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_OSRH_bellevuespac.com_20250506 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20250506_20250506 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001840425 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-05-06" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-05-06" id="Fact000004" name="dei:EntityCentralIndexKey">0001840425</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="osrh-20250506.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-05-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001840425</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-06</xbrli:startDate>
        <xbrli:endDate>2025-05-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-05-062025-05-06_custom_CommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001840425</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">OSRH:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-06</xbrli:startDate>
        <xbrli:endDate>2025-05-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-05-062025-05-06_custom_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001840425</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">OSRH:RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-06</xbrli:startDate>
        <xbrli:endDate>2025-05-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90A_edei--DocumentType_c20250506__20250506_zP1m7eYKgfU8"><ix:nonNumeric contextRef="AsOf2025-05-06" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 OR 15(d) of The Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span style="text-decoration: underline"><span id="xdx_90E_edei--DocumentPeriodEndDate_c20250506__20250506_zXgGVaVq5EAl"><ix:nonNumeric contextRef="AsOf2025-05-06" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">May 6, 2025</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 100%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityRegistrantName_c20250506__20250506_zoZwIoNLOYxj"><ix:nonNumeric contextRef="AsOf2025-05-06" id="Fact000011" name="dei:EntityRegistrantName">OSR HOLDINGS, INC.</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20250506__20250506_zgxRj2YxSh22"><ix:nonNumeric contextRef="AsOf2025-05-06" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityFileNumber_c20250506__20250506_zjbDFOUrZNue"><ix:nonNumeric contextRef="AsOf2025-05-06" id="Fact000013" name="dei:EntityFileNumber">001-41390</ix:nonNumeric></span></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20250506__20250506_zNmzpO1SiDOh"><ix:nonNumeric contextRef="AsOf2025-05-06" id="Fact000014" name="dei:EntityTaxIdentificationNumber">84-5052822</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or Other Jurisdiction</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityAddressAddressLine1_c20250506__20250506_zTxCemI7Tyd4"><ix:nonNumeric contextRef="AsOf2025-05-06" id="Fact000015" name="dei:EntityAddressAddressLine1">10900 NE 4th Street</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine2_c20250506__20250506_zcw6M6o8vULk"><ix:nonNumeric contextRef="AsOf2025-05-06" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 2300</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressCityOrTown_c20250506__20250506_zSdz5hc1356i"><ix:nonNumeric contextRef="AsOf2025-05-06" id="Fact000017" name="dei:EntityAddressCityOrTown">Bellevue</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressStateOrProvince_c20250506__20250506_zBcaGajCfSy6"><ix:nonNumeric contextRef="AsOf2025-05-06" id="Fact000018" name="dei:EntityAddressStateOrProvince">WA</ix:nonNumeric></span></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--EntityAddressPostalZipCode_c20250506__20250506_zDnT9YxGIts8"><ix:nonNumeric contextRef="AsOf2025-05-06" id="Fact000019" name="dei:EntityAddressPostalZipCode">98004</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of Principal Executive Offices)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code <span style="text-decoration: underline">(<span id="xdx_906_edei--CityAreaCode_c20250506__20250506_z92TYyJYxexj"><ix:nonNumeric contextRef="AsOf2025-05-06" id="Fact000020" name="dei:CityAreaCode">425</ix:nonNumeric></span>) <span id="xdx_90B_edei--LocalPhoneNumber_c20250506__20250506_zjOCiXN4OGl2"><ix:nonNumeric contextRef="AsOf2025-05-06" id="Fact000021" name="dei:LocalPhoneNumber">635-7700</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 100%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not Applicable </span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former Name or Former Address, if Changed Since Last Report)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.15pt">Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--WrittenCommunications_c20250506__20250506_zTyiCqCdNrU6"><ix:nonNumeric contextRef="AsOf2025-05-06" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--SolicitingMaterial_c20250506__20250506_zbQoCFsJoYNg"><ix:nonNumeric contextRef="AsOf2025-05-06" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20250506__20250506_zbyGjyusmbQc"><ix:nonNumeric contextRef="AsOf2025-05-06" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--PreCommencementIssuerTenderOffer_c20250506__20250506_zjuq7hx9spb7"><ix:nonNumeric contextRef="AsOf2025-05-06" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Securities registered pursuant to Section
12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--Security12bTitle_c20250506__20250506__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_z4CM9czrA4eh"><ix:nonNumeric contextRef="From2025-05-062025-05-06_custom_CommonStockParValue0.0001PerShareMember" id="Fact000026" name="dei:Security12bTitle">Common stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--TradingSymbol_c20250506__20250506__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zbgzZpOxppNe"><ix:nonNumeric contextRef="From2025-05-062025-05-06_custom_CommonStockParValue0.0001PerShareMember" id="Fact000027" name="dei:TradingSymbol">OSRH</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_904_edei--SecurityExchangeName_c20250506__20250506__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zzFDArut6FOl"><ix:nonNumeric contextRef="From2025-05-062025-05-06_custom_CommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: bottom; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--Security12bTitle_c20250506__20250506__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember_z7pxikC3rvmf"><ix:nonNumeric contextRef="From2025-05-062025-05-06_custom_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember" id="Fact000029" name="dei:Security12bTitle">Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--TradingSymbol_c20250506__20250506__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember_z4btRJ651K8"><ix:nonNumeric contextRef="From2025-05-062025-05-06_custom_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember" id="Fact000030" name="dei:TradingSymbol">OSRHW</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_90B_edei--SecurityExchangeName_c20250506__20250506__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember_zM1oJGZmdvEb"><ix:nonNumeric contextRef="From2025-05-062025-05-06_custom_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember" format="ixt-sec:exchnameen" id="Fact000031" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20250506__20250506_zjUDCqpxlY05"><ix:nonNumeric contextRef="AsOf2025-05-06" format="ixt:booleantrue" id="Fact000032" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_90D_edei--EntityExTransitionPeriod_c20250506__20250506_z1QrhyDZUp47"><ix:nonNumeric contextRef="AsOf2025-05-06" format="ixt:booleanfalse" id="Fact000033" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01. Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Note Purchase Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 6, 2025, OSR Holdings, Inc. (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;)
entered into a Note Purchase Agreement with White Lion Capital, LLC, dba White Lion GBM Innovation Fund, a Nevada limited liability company
(the &#8220;<span style="text-decoration: underline">Buyer</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Convertible Note</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant and subject to the terms of the Note
Purchase Agreement, the Selling Stockholder has loaned the Company the principal amount of $1,110,000 at an interest rate of 5% per annum
subject to two Convertible Notes maturing on the date occurring Nine (9) months after the closing date of each respective loan. The first
Convertible Note in the principal amount of $400,000 shall close on or before one day after the filing of the Company&#8217;s registration
statement on Form S-1 filed with the SEC on May [&#8226;], 2025. The second Convertible Note shall close one day after this registration
statement becomes effective.&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has agreed to allocate 10% of the
proceeds from each purchase notice under the ELOC and/or warrant exercise toward the repayment of the outstanding Convertible Note(s).&#160;
At any time, the Selling Stockholder may convert one or both Convertible Notes at 95% multiplied by the lowest Volume Weighted Average
Price (&#8220;VWAP&#8221;) fifteen days prior to the conversion notice. The Company and the Investor have agreed that no more than 4.99%
of the shares outstanding will be issued to the Selling Stockholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Warrant Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant and subject to the terms of the Warrant
Agreement, the Selling Stockholder has the right, but not the obligation, to at any time for a period of five years following its execution
date, to subscribe for and purchase from the Company up to $4,000,000 worth, or the Available Share Amount (as defined in the Warrant
Agreement and subject to adjustment thereunder), of Common Stock (the &#8220;Warrant Shares&#8221;). The purchase price of one share of
Common Stock under the Warrant Agreement shall be equal to the Exercise Price, which shall be $1.584 or as otherwise defined therein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Amendment to the Company&#8217;s Equity Line of Credit (&#8220;ELOC&#8221;)
Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the terms of the ELOC Agreement, as
amended May 6, 2025, the Company may elect, in our sole discretion, to issue and sell to White Lion, from time to time, up to $78.9 million
worth of shares of Common Stock from after the effective date of this registration statement under the ELOC Agreement. Any terms in initial
capitals and not otherwise defined herein shall be as defined in the amended Common Stock Purchase Agreement and/or the Registration Rights
Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Common Stock Purchase Agreement,
following the effective date of this resale registration statement registering the shares issuable to White Lion in accordance with the
terms of the Registration Rights Agreement, the Company has the right, but not the obligation, to require White Lion to purchase, from
time to time, up to the lesser of (i) $78,900,000 in aggregate gross purchase price of newly issued shares of Common Stock, par value
$0.0001 per share and (ii) 3,853,467 shares of Common Stock (the &#8220;Exchange Cap&#8221;), in each case, subject to certain limitations
and conditions set forth in the Common Stock Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The number of shares of Common Stock that the
Company may require White Lion to purchase in any single sales notice will depend on a number of factors, including the relevant calculated
purchase price and type of purchase notice that the Company delivers to White Lion. For example: (1) if the Company were to deliver a
Rapid Purchase Notice, the Company can require White Lion to purchase a number of shares equal to $2,000,000 divided by the average of
the three (3) lowest traded prices of the Common Stock on the Rapid Purchase Notice Date; and (2) if the Company were to deliver a VWAP
Purchase Notice, the Company can require White Lion to purchase a number of shares equal to $2,000,000 divided by the product of (i) the
lowest daily VWAP of the Common Stock during the VWAP Purchase Valuation Period and (ii) ninety-seven percent (97%).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">White Lion&#8217;s purchase obligations under
a single Rapid Purchase Notice or a single VWAP Purchase Notice shall not exceed $2,000,000, and the maximum amount of shares of Common
Stock the Company may require White Lion to purchase under a single VWAP Purchase Notice shall be the lesser of (A) 30% of the Average
Daily Trading Volume or (B) $2,000,000 divided by the highest closing price of the Common Stock over the most recent five (5) Business
Days immediately preceding White Lion&#8217;s receipt of the subject VWAP Purchase Notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, in consideration for White Lion&#8217;s
commitments under the Common Stock Purchase Agreement, the Company agreed to issue to White Lion the number of shares of Common Stock
equal to $800,000 divided by the closing price of the Common Stock on the day that is the earlier of (i) the business day prior to effectiveness
of this resale registration statement registering the shares issuable under the Common Stock Purchase Agreement and (ii) the business
day prior to the date that White Lion requests the issuance of such shares (such shares, the &#8220;Commitment Shares&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, the actual number of shares of our
Common Stock issuable will vary depending on the then-current market price of shares of Common Stock sold to the Selling Stockholder under
the ELOC Agreement, but will not exceed the number set forth in the preceding paragraphs unless we file an additional registration statement
under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), with the U.S. Securities and Exchange Commission (the
&#8220;SEC&#8221;). See &#8220;Prospectus Summary&#8212;Post IPO Financing&#8212;Equity Line of Credit Agreement&#8221; and &#8220;ELOC
Financing&#8221; for a description of the ELOC Agreement and &#8220;Selling Stockholder&#8221; for additional information regarding White
Lion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>EXHIBIT INDEX</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea024172601ex10-1_osrhold.htm">Note Purchase Agreement, dated as of May 6, 2025, between OSR Holdings, Inc. and White Lion Capital, LLC.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea024172601ex10-2_osrhold.htm">Senior Secured Convertible Promissory Note, issued May 6, 2025, by OSR Holdings, Inc. to White Lion Capital LLC.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea024172601ex10-3_osrhold.htm">Common Stock Purchase Warrant, issued May 6, 2025, by OSR Holdings, Inc to White Lion Capital, LLC.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea024172601ex10-4_osrhold.htm">Amendment No. 1 to Common Stock Purchase Agreement, between OSR Holdings, Inc. and White Lion Capital LLC.</a></span></td></tr>

<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 9%; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">104</span></td>
    <td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 90%; font-size: 10pt"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: May 12, 2025</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td colspan="3" style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OSR HOLDINGS, INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="width: 4%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="width: 5%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="width: 31%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Kuk Hyoun Hwang</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kuk Hyoun Hwang</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">3</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJyFkN9qgzAUh5+g73CQXopNZO7Cu07aMtauYsu221SPW6gmcpL+e6S95aJWWthgIRCS/L5858TzfG+h57JCgo+nbAlbrJtKWIQMSyRUObpE8vwSg1sz/JTGklC22w5goh2DjnkMWO7Ou+RRGixiYNGEh5MwAs7ihwimK2/U3idalbJAZaWoQKgCUtINSbSCLv0LW3HWSteXzvSGZKRWMfCA9dffEDIewqs+ipOmvYHlMvFGfjdG3oL0oXGp2dmiakmYVVg7nenp2+yqyQ/G6jrOsECsxa7Cd0Ftl2Z2RsqlaY/mmjZfgtCsS9dvrdXG6nw/tdcIpiRzXJecBxFLsc+usN4hOQFnYcjZlA2fM3jgdBX5gDcVlJrAdDLQJeSdDkzrA2Hddw1hhKa1tqFxJ4YGr+Qf7d2VnQp6E9UBWcAY4/+Um9z5fWgEwbFlYdzTv50/5HW5dA== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea024172601ex10-1_osrhold.htm
<DESCRIPTION>NOTE PURCHASE AGREEMENT, DATED AS OF MAY 6, 2025, BETWEEN OSR HOLDINGS, INC. AND WHITE LION CAPITAL, LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.85pt; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.85pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.85pt; text-align: center"><B>NOTE PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt"><B>THIS NOTE PURCHASE AGREEMENT</B>
(this &ldquo;<U>Agreement</U>&rdquo;), dated as of May 6, 2025 (the &ldquo;<U>Execution Date</U>&rdquo;), is entered into by and between
<B>OSR HOLDINGS, INC.</B>, a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and <B>WHITE LION CAPITAL, LLC</B>, <B>dba White
Lion GBM Innovation Fund</B>, a Nevada limited liability company (the &ldquo;<U>Buyer</U>&rdquo;). Each capitalized term used herein shall
have the meaning ascribed thereto in <U>Section 10</U> below, or as otherwise defined herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt"><B>WHEREAS</B>, the Company
and the Buyer are executing and delivering this Agreement in reliance upon an exemption from securities registration afforded by the rules
and regulations as promulgated by the United States Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;) under the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt"><B>WHEREAS</B>, the Buyer
desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement senior secured
convertible promissory notes of the Company, in the form attached hereto as <U>Exhibit A</U>, in an aggregate funded amount of $1,000,000
as set forth on the <U>Issuance Schedule</U> attached hereto (such notes, together with any note(s) issued in replacement thereof or as
a dividend thereon or otherwise with respect thereto in accordance with the terms thereof, the &ldquo;<U>Notes</U>&rdquo;), convertible
into shares (the &ldquo;<U>Conversion Shares</U>&rdquo;) of common stock,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">$0.0001 par value per share, of the Company (the
&ldquo;<U>Common Stock</U>&rdquo;), pursuant to the terms of the Note; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt"><B>WHEREAS</B>, as an inducement
to enter into this Agreement, the Company has agreed to amend that certain Common Stock Purchase Agreement by and between the Company
and Buyer, dated February 25, 2025 (the &ldquo;<U>ELOC Agreement</U>&rdquo;), as pursuant to that amendment in the form attached hereto
as <U>Exhibit B</U> (the &ldquo;<U>ELOC Amendment</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt"><B>NOW THEREFORE</B>, in
consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy
of which are hereby acknowledged, the Company and the Buyer hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">1.</TD><TD STYLE="text-align: justify"><U>PURCHASE AND SALE OF SECURITIES.</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Closings</U>.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">On the First Closing Date (as
defined below), the Company shall sell and issue to the Buyer and the Buyer shall purchase a Note in such principal amount, and for such
funding price, set forth on the <U>Issuance Schedule</U> under &ldquo;First Closing&rdquo; (the &ldquo;<U>First Closing</U>&rdquo;),
which such funding amount shall be $400,000 for the First Closing (the &ldquo;<U>First Funding Amount</U>&rdquo;). The date on which
Buyer funds such Note shall be the &ldquo;<U>First Funding Date</U>.&rdquo;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 144.05pt; text-align: justify; text-indent: -40.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">On the Second Closing Date (as defined below), the Company shall sell and
issue to the Buyer and the Buyer shall purchase a Note in such principal amount, and for such funding price, set forth on the <U>Issuance
Schedule</U> under &ldquo;Second Closing&rdquo; (the &ldquo;<U>Second Closing</U>&rdquo;), which such funding amount shall be $600,000
for the Second Closing (the &ldquo;<U>Second Funding Amount</U>&rdquo;). The date on which Buyer funds such Note shall be the &ldquo;<U>Second
Funding Date</U>.&rdquo; Each of the First Closing and Second Closing shall be referred to herein as a &ldquo;<U>Closing</U>.&rdquo; Each
of the First Funding Date and Second Funding Date shall be referred to herein as a &ldquo;<U>Funding Date</U>.&rdquo; Each of the First
Funding Amount and Second Funding Amount shall be referred to herein as a &ldquo;<U>Funding Amount</U>.&rdquo;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD><FONT STYLE="font-size: 10pt"><U>Closing Dates</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 144.05pt; text-align: justify; text-indent: -40.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Subject to the satisfaction (or written waiver) of the conditions set forth
in <U>Section 7</U> and <U>Section 8</U> below, the date of the purchase, issuance and sale of the Note constituting the First Closing
pursuant to this Agreement (the &ldquo;<U>First Closing Date</U>&rdquo;) shall be within one (1) Trading Day after the date of the Company&rsquo;s
filing of the Registration Statement (as described and defined under <U>Section 5(e)</U> below).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 144.05pt; text-align: justify; text-indent: -40.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Subject to the satisfaction (or written waiver) of the conditions set forth
in <U>Section 7</U> and <U>Section 8</U> below, the date of the purchase, issuance and sale of the Note constituting the Second Closing
pursuant to this Agreement (the &ldquo;<U>Second Closing Date</U>&rdquo;) shall be within one (1) Trading Day after the date that the
Registration Statement is approved as effective by the SEC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Form of Payment</U>. On a Funding Date, the Buyer shall deliver the Funding
Amount by wire transfer of immediately available funds, in accordance with the Company&rsquo;s written wiring instructions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>ELOC Amendment</U>. At the First Closing, the Company shall deliver the
to the Buyer an executed copy of the ELOC Amendment and all of the ancillary documents contemplated by the ELOC Amendment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">2.</TD><TD STYLE="text-align: justify"><U>REPRESENTATIONS AND WARRANTIES OF THE BUYER</U>. The Buyer
represents and warrants to the Company that:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Investment Purpose</U>. As of the Execution Date, the Buyer is purchasing
the Securities for its own account for investment only and not with a view towards the public sale or distribution thereof, except pursuant
to sales registered or exempted from registration under the Securities Act; <U>provided</U>, <U>however</U>, that by making the foregoing
representation and warranty, the Buyer does not agree to hold any of the Securities for any minimum or other specific term and reserves
the right to dispose of all or any portion of the Securities at any time in accordance with or pursuant to a registration statement or
an exemption under the Securities Act.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Reliance on Exemptions</U>. The Buyer understands that the Securities
are being offered and sold to it in reliance upon specific exemptions from the registration requirements of United States federal and
state securities laws </FONT>and that the Company is relying upon the truth and accuracy of, and the Buyer&rsquo;s compliance with, the
representations, warranties, agreements, acknowledgments and understandings of the Buyer set forth herein in order to determine the availability
of such exemptions and the eligibility of the Buyer to acquire the Securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Information</U>. The Buyer and its advisors, if any, have been furnished
with all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of the
Securities which have been requested by the Buyer or its advisors. The Buyer and its advisors, if any, have been afforded the opportunity
to ask questions of the Company. Notwithstanding the foregoing, the Company has not disclosed to the Buyer any material non-public information
and will not disclose such information unless such information is disclosed to the public prior to or promptly following such disclosure
to the Buyer. Neither such inquiries nor any other due diligence investigation conducted by Buyer or any of its advisors or representatives
shall modify, amend or affect Buyer&rsquo;s right to rely on the Company&rsquo;s representations and warranties contained in <U>Section
3</U> below.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Authorization; Enforcement</U>. This Agreement has been duly and validly
authorized by the Buyer. This Agreement has been duly executed and delivered on behalf of the Buyer, and this Agreement constitutes a
valid and binding agreement of the Buyer enforceable in accordance with its terms.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Accredited Investor Status</U>. The Buyer is (i) an &ldquo;accredited
investor&rdquo; as that term is defined in Rule 501 of the General Rules and Regulations under the Securities Act by reason of Rule 501(a)(3)
(an &ldquo;<U>Accredited Investor</U>&rdquo;), (ii) experienced in making investments of the kind described in this Agreement and the
related documents, (iii) able, by reason of the business and financial experience of its officers (if an entity) and professional advisors
(who are not affiliated with or compensated in any way by the Company or any of its Affiliates or selling agents), to protect its own
interests in connection with the transactions described in this Agreement, and the related documents, and </FONT>(iv) able to afford the
entire loss of its investment in the Securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>General Solicitation</U>. The Buyer is not purchasing the Securities
as a result of any advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine
or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation or general advertisement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD><FONT STYLE="font-size: 10pt"><U>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</U>. The Company represents </FONT>and warrants to
the Buyer that as of the Execution Date and as of each Closing Date and as of each Funding Date (or as of such other time expressly specified
below):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD><FONT STYLE="font-size: 10pt"><U>Corporate Governance Compliance</U>:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Issuance of Note and Conversion
Shares</U>. Each Note has been duly authorized and is being validly issued to the Buyer. The Conversion Shares </FONT>have been duly
authorized and fully reserved for issuance and, upon conversion of the Note in accordance with its terms, will be validly issued, fully
paid and non-assessable, and free from all taxes, liens, claims and encumbrances with respect to the issue thereof, with the holders
being entitled to all rights accorded to a holder of Common Stock. The Conversion Shares shall not be subject to pre-emptive rights or
other similar rights of stockholders of the Company (except to the extent already waived) and will not impose personal liability upon
the holder thereof, other than restrictions on transfer provided for in the Transaction Documents and under the Securities Act.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(ii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Organization and Qualification</U>.
The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware, with the
requisite corporate power and authority to own and use its properties and assets and to carry on its business as currently conducted.
Each of the Subsidiaries is an entity duly incorporated or otherwise organized, and, to the extent any Subsidiary is a Material Subsidiary
as defined below, such Subsidiary is validly existing and in good standing under the laws of the jurisdiction of its incorporation or
organization, with the requisite corporate power and authority to own and use its properties and assets and to carry on its business
as currently conducted. Each of the Company and the Material Subsidiaries is not in violation or default of any of the provisions of
its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and
its Material Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each
jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the
failure to be so qualified or in good standing, as the case may be, have or reasonably be expected to result in a Material Adverse Effect
proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such
power and authority or qualification.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(iii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Authorization; Enforcement</U>.
The Company has the requisite corporate power and authority to enter into and perform its obligations under this Agreement and the other
Transaction Documents. The execution and delivery of this Agreement and the other Transaction Documents by the Company and the consummation
by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action, and no further
consent or authorization of the Company or its Board of Directors or stockholders is required. Each of this Agreement and the other Transaction
Documents has been duly executed and delivered by the Company and constitutes a valid and binding obligation of the Company enforceable
against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency,
or similar laws relating to, or affecting generally the enforcement of, creditors&rsquo; rights and remedies or by other equitable principles
of general application.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(iv)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Capitalization</U>. As of the
Execution Date, the authorized capital stock of the Company is as set forth in the SEC Documents (as defined below). The Company has
filed in its SEC Documents true and correct copies of the Company&rsquo;s Certificate of Incorporation as in effect on the Execution
Date, the Company&rsquo;s bylaws, as in effect on the Execution Date, and the terms of all securities convertible into or exercisable
for Common Stock of the Company and the material rights of the holders thereof in respect thereto.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(v)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>No Conflicts</U>. The execution,
delivery and performance of this Agreement and the other Transaction Documents by the Company and the consummation by the Company of
the transactions contemplated hereby and thereby (including, without limitation, the issuance and reservation for issuance of the Conversion
Shares) will not (a) result in a violation of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation,
by- laws or other organizational or charter documents, (b) conflict with, or constitute a material default (or an event that with notice
or lapse of time or both would become a material default) under, result in the creation of any Lien upon any of the properties or assets
of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement,
indenture, instrument or any &ldquo;lock-up&rdquo; or similar provision of any underwriting or similar agreement to which the Company
or any Subsidiary is a party, or (c) result in a violation of any federal, state or local law, rule, regulation, order, judgment or decree
(including federal and state securities laws and regulations) applicable to the Company or any Subsidiary or by which any property or
asset of the Company or any Subsidiary is bound or affected (except for such conflicts, defaults, terminations, amendments, accelerations,
cancellations and violations as would not, individually or in the aggregate, have a Material Adverse Effect), nor is the Company otherwise
in violation of, conflict with or in default under any of the foregoing. The business of the Company is not being conducted in violation
of any law, ordinance or regulation of any governmental entity, except for possible violations that either singly or in the aggregate
do not and will not have a Material Adverse Effect. The Company is not required under federal, state or local law, rule or regulation
to obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental agency in order
for it to issue the Conversion Shares or to execute, deliver or perform any of its obligations under this Agreement or the other Transaction
Documents (other than any SEC, FINRA or state securities filings that may be required to be made by the Company subsequent to Closing).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>SEC and Offering Compliance</U>:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>SEC Documents</U>. The Company
has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act
and the Exchange Act for the Company to be deemed fully &ldquo;fully reporting&rdquo; and &ldquo;current&rdquo; and in compliance with
the periodic and current reporting requirements of Section 13 or 15(d) of the Exchange </FONT>Act, and in compliance with the Rule 144(c)(1)
under the Securities Act (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being
collectively referred to herein as the &ldquo;<U>SEC Documents</U>&rdquo;). The SEC Documents comply in all material respects with the
requirements of the Securities Act and the Exchange Act, as applicable, and other federal laws, rules and regulations applicable to such
SEC Documents, and none of the SEC Documents contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made,
not misleading.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(ii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Financial Statements</U>. The
financial statements of the Company included in its SEC Documents (the &ldquo;<U>Financial Statements</U>&rdquo;) comply as to form and
substance in all material respects with applicable accounting requirements and the published rules and regulations of the SEC as well
as other applicable rules and regulations with respect thereto. Such Financial Statements have been prepared in accordance with generally
accepted accounting principles applied on a consistent basis during the periods involved (except (a) as may be otherwise indicated in
such Financial Statements or the notes thereto or (b) in the case of unaudited interim statements, to the extent they may not include
footnotes or may be condensed or summary statements) and fairly present in all material respects the financial position of the Company
as of the dates thereof and the results of operations and cash flows for the periods then ended (subject, in the case of unaudited statements,
to normal, immaterial, year-end audit adjustments). The Company maintains a system of internal accounting controls appropriate for its
size. There is no transaction, arrangement, or other relationship between the Company and an unconsolidated or other off balance sheet
entity that is not disclosed by the Company in its Financial Statements or otherwise that would be reasonably likely to have a Material
Adverse Effect. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided the Buyer or its agents or counsel with any
information that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that
the Buyer will rely on the foregoing representation in effecting transactions in securities of the Company.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(iii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Acknowledgment Regarding Buyer&rsquo;s
Purchase of Securities</U>. The Company acknowledges and agrees that the Buyer is acting solely in the capacity of an arm&rsquo;s length
purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby and that the Buyer is neither
(i) an officer or director of the Company or any of its Subsidiaries, nor (ii) an &ldquo;affiliate&rdquo; (as defined in Rule 144) of
the Company or any of its Subsidiaries. The Company further acknowledges that the Buyer is not acting as a financial advisor or fiduciary
of the Company or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction Documents and the transactions
contemplated hereby and </FONT>thereby, and any advice given by a Buyer or any of its representatives or agents in connection with the
Transaction Documents and the transactions contemplated hereby and thereby is merely incidental to the Buyer&rsquo;s purchase of the
Securities. The Company further represents to the Buyer that the Company&rsquo;s decision to enter into the Transaction Documents has
been based solely on the independent evaluation by the Company and its representatives.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(iv)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>No Integrated Offering</U>.
Neither the Company, nor any person acting on its or their behalf, has directly or indirectly made any offers or sales in any security
or solicited any offers to buy any security under circumstances that would require registration under the Securities Act of the issuance
of the Securities to the Buyer. The issuance of the Securities to the Buyer will not be integrated with any other issuance of the Company&rsquo;s
securities (past, current or future) for purposes of any stockholder approval provisions applicable to the Company or its securities.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(v)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Brokers</U>. No broker is entitled
to a commission payable by the Company in connection with the transactions contemplated by this transaction and the Company has taken
no action which would give rise to any claim by any person for brokerage commissions, transaction fees or similar payments relating to
this Agreement or the transactions contemplated hereby. Any all fees due to any brokers shall be paid and satisfied by the Company at
the Closing.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(vi)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Disclosure.</U> All information
relating to or concerning the Company or any of its Subsidiaries set forth in this Agreement and provided to the Buyer pursuant in connection
with the transactions contemplated hereby is true and correct in all material respects and the Company has not omitted to state any material
fact necessary in order to make the statements made herein or therein, in light of the circumstances under which they were made, not
misleading. No event or circumstance has occurred or exists with respect to the Company or any of its Subsidiaries or its or their business,
properties, prospects, operations or financial conditions, which, under applicable law, rule or regulation, requires public disclosure
or announcement by the Company but which has not been so publicly announced or disclosed (assuming for this purpose that the Company&rsquo;s
reports filed under the Exchange Act are being incorporated into a qualified filing pursuant to Regulation of the Securities Act, by
the Company under the Securities Act).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(vii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>No Disqualification Events</U>.
With respect to Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act (&ldquo;<U>Regulation D
Securities</U>&rdquo;), none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer
of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting
equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities
Act) connected with the Company </FONT>in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and,
together, &ldquo;<U>Issuer Covered Persons</U>&rdquo;) is subject to any of the &ldquo;bad actor&rdquo; disqualifying events described
in Rule 506(d)(1)(i)(viii) under the Securities Act (each, a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification
Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is
subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e),
and has furnished to the Buyers a copy of any disclosures provided thereunder.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(viii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Other Covered Persons</U>.
The Company is not aware of any Person (other than any Issuer Covered Person) that has been or will be paid (directly or indirectly)
remuneration for solicitation of buyers or potential purchasers in connection with the sale of any Regulation D Securities.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(ix)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>No General Solicitation; Placement
Agent</U>. Neither the Company, nor any of its Subsidiaries or Affiliates, nor any Person acting on its or their behalf, has engaged
in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale
of the Securities. Neither the Company nor any of its Subsidiaries has engaged any placement agent in connection with the sale of the
Securities. In the event that a broker-dealer or other agent or advisory is engaged by the Company subsequent to the Closing, the Company
shall be responsible for the payment of any placement agent&rsquo;s fees, financial advisory fees, or brokers&rsquo; commissions (other
than for persons engaged by any Buyer or its investment advisor) relating to or arising out of the transactions contemplated hereby in
connection with the sale of the Securities. The Company shall pay, and hold the Buyer harmless against, any liability, loss or expense
(including, without limitation, attorney&rsquo;s fees and out-of-pocket expenses) arising in connection with any such claim.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(x)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Investment Company Status</U>.
The Company is not, and upon consummation of the sale of the Securities will not be, an &ldquo;investment company,&rdquo; a company controlled
by an &ldquo;investment company&rdquo; or an &ldquo;affiliated person&rdquo; of, or &ldquo;promoter&rdquo; or &ldquo;principal underwriter&rdquo;
for, an &ldquo;investment company&rdquo; as such terms are defined in the Investment Company Act of 1940, as amended.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(xi)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Transfer Taxes</U>. On the
Closing Date, all stock transfer or other taxes (other than income or similar taxes) which are required to be paid in connection with
the sale and transfer of the Securities to be sold to the Buyer hereunder will be, or will have been, fully paid or provided for by the
Company, and all laws imposing such taxes will be or will have been complied with.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(xii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Compliance with Rule 15c2-11</U>.
On the Closing Date, and at all times that any of the Securities remain outstanding, the Company shall maintain as publicly available
all information required by paragraph (b) of </FONT>Rule 15c2-11 of the Exchange Act (as effective on September 26, 2021), as amended,
such that brokers or dealers attempting to publish any quotation for the Common Stock or, directly or indirectly, to submit any such
quotation for publication, shall be able to comply with Rule 15c2- 11(a).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Operations Related</U>:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Absence of Certain Changes</U>.
No event has occurred that would have a Material Adverse Effect on the Company or any Subsidiary that has not been disclosed in the SEC
Documents.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(ii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Absence of Litigation</U>.
Except as disclosed in the SEC Documents, there are no actions, suits, investigations, inquiries or proceedings pending or, to the Knowledge
of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties, nor has the Company
received any written or oral notice of any such action, suit, proceeding, inquiry or investigation, which would have a Material Adverse
Effect or would require disclosure under the Securities Act or the Exchange Act. No judgment, order, writ, injunction or decree or award
has been issued by or, to the Knowledge of the Company, requested of any court, arbitrator or governmental agency which would have a
Material Adverse Effect. Except as disclosed in the SEC Documents there has not been, and to the Knowledge of the Company, there is not
pending or contemplated, any investigation by the SEC involving the Company, any Subsidiary or any current or former director or officer
of the Company or any Subsidiary.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(iii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Patents, Copyrights, etc</U>.
The Company and the Subsidiaries own or possess adequate rights or licenses to use all material trademarks, trade names, service marks,
service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals, governmental authorizations,
trade secrets and rights necessary to conduct their respective businesses as now conducted (&ldquo;<U>Intellectual Property</U>&rdquo;).
None of the Company&rsquo;s nor any Subsidiary&rsquo;s Intellectual Property rights have expired or terminated, or, by the terms and
conditions thereof, could expire or terminate within two years from the Execution Date other than by default under agreements that grant
such rights. The Company does not have any Knowledge of any infringement by the Company and/or any Subsidiary of any material trademark,
trade name rights, patents, patent rights, copyrights, inventions, licenses, service names, service marks, service mark registrations,
trade secret or other similar rights of others, or of any such development of similar or identical trade secrets or technical information
by others, and there is no claim, action or proceeding being made or brought against, or to the Company&rsquo;s Knowledge, being threatened
against, the Company and/or any Subsidiary regarding trademark, trade name, patents, patent rights, invention, copyright, license, service
names, service marks, service mark registrations, trade secret or other infringement, which could reasonably be expected to have a Material
Adverse Effect.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(iv)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Tax Status</U>. The Company
and each of its Material Subsidiaries has made or filed all federal and material state and foreign income and all other material tax
returns, reports and declarations required by any jurisdiction to which it is subject (unless and only to the extent that the Company
and each of its Material Subsidiaries has set aside on its books provisions reasonably adequate for the payment of all unpaid and unreported
taxes) and has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due
on such returns, reports and declarations, except those being contested in good faith and has set aside on its books provisions reasonably
adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There
are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
know of no basis for any such claim. The Company has not executed a waiver with respect to the statute of limitations relating to the
assessment or collection of any foreign, federal, state or local tax. None of the Company&rsquo;s tax returns is presently being audited
by any taxing authority.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(v)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Certain Transactions</U>. Except
as set forth in the SEC Documents, none of the officers or directors of the Company or any Subsidiary, and to the Knowledge of the Company,
none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other
than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing
of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer,
director or such employee or, to the Knowledge of the Company, any entity in which any officer, director, or any such employee has a
substantial interest or is an officer, director, trustee or partner, in each case in excess of the lesser of (i) $120,000 or (ii) one
percent of the average of the Company&rsquo;s total assets at year end for the last two completed fiscal years, other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company or any Subsidiary
and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(vi)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Permits; Compliance</U>. The
Company and each of its Subsidiaries is in possession of all franchises, grants, authorizations, licenses, permits, easements, variances,
exemptions, consents, certificates, approvals and orders necessary to own, lease and operate its properties and to carry on its business
as it is now being conducted (collectively, the &ldquo;<U>Company Permits</U>&rdquo;), and there is no action pending or, to the Knowledge
of the Company, threatened regarding suspension or cancellation of any of the Company Permits. Neither the Company nor any of its Subsidiaries
is in conflict with, or in default or violation of, any of the Company Permits, except for any such conflicts, defaults or violations
which, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor
any of its Subsidiaries has </FONT>received any notification with respect to possible conflicts, defaults or violations of applicable
laws, except for notices relating to possible conflicts, defaults or violations, which conflicts, defaults or violations would not have
a Material Adverse Effect.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(vii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Environmental Matters</U>.
The Company is in compliance with all applicable Environmental Laws in all respects except where the failure to comply does not have
and could not reasonably be expected to have a Material Adverse Effect. For purposes of the foregoing: &ldquo;<U>Environmental Laws</U>&rdquo;
means, collectively, the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, the Superfund Amendments
and Reauthorization Act of 1986, the Resource Conservation and Recovery Act, the Toxic Substances Control Act, as amended, the Clean
Air Act, as amended, the Clean Water Act, as amended, any other &ldquo;Superfund&rdquo; or &ldquo;Superlien&rdquo; law or any other applicable
federal, state or local statute, law, ordinance, code, rule, regulation, order or decree regulating, relating to, or imposing liability
or standards of conduct concerning, the environment or any Hazardous Material.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(viii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Title to Property</U>. Except
as disclosed in the SEC Documents, the Company and each Subsidiary has good and marketable title in fee simple to all real property owned
by it and good and marketable title in all personal property owned by it that is material to the business of the Company and each Subsidiary,
in each case free and clear of all Liens and, except for Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company or any Subsidiary and Liens for the payment of federal,
state or other taxes, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under
lease by the Company or any Subsidiary is held under valid, subsisting and enforceable leases with which the Company is in compliance
with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings
by the Company or any Subsidiary.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(ix)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Internal Accounting Controls</U>.
Except as disclosed in the SEC Documents the Company and each of its Subsidiaries maintain a system of internal accounting controls sufficient,
in the judgment of the Company&rsquo;s board of directors, to provide reasonable assurance that (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with generally accepted accounting principles and to maintain asset accountability, (iii) access to assets is
permitted only in accordance with management&rsquo;s general or specific authorization and (iv) the recorded accountability for assets
is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company
is in compliance with all provisions of the Sarbanes-Oxley Act of 2002, as amended, which are applicable to it.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(x)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Foreign Corrupt Practices</U>.
Neither the Company, nor any of its Subsidiaries, nor any director, officer, agent, employee or other person acting on behalf of the
Company or any Subsidiary has, in the course of his actions for, or on behalf of, the Company, used any corporate funds for any unlawful
contribution, gift, entertainment or other unlawful expenses relating to political activity; made any direct or indirect unlawful payment
to any foreign or domestic government official or employee from corporate funds; violated or is in violation of any provision of the
U.S. Foreign Corrupt Practices Act of 1977, as amended, or made any bribe, rebate, payoff, influence payment, kickback or other unlawful
payment to any foreign or domestic government official or employee.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(xi)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Insurance</U>. The Company
and each Material Subsidiary is insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as management of the Company believes to be prudent and customary in the businesses in which the Company and each Material Subsidiary
is engaged. Neither the Company, nor any Material Subsidiary has been refused any insurance coverage sought or applied for, and the Company
has no reason to believe that it or any Material Subsidiary will not be able to renew its existing insurance coverage as and when such
coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would
not materially and adversely affect the condition, financial or otherwise, or the earnings, business or operations of the Company, taken
as a whole.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(xii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>No Undisclosed Events, Liabilities,
Developments or Circumstances</U>. Except as set forth in the SEC Documents, the Company and its Subsidiaries have no liabilities or
obligations of any nature (whether accrued, absolute, contingent, unasserted or otherwise and whether due or to become due) other than
those liabilities or obligations that are disclosed in the Financial Statements or which do not exceed, individually in excess of $50,000
and in the aggregate in excess of $200,000. The reserves, if any, established by the Company or the lack of reserves, if applicable,
are reasonable based upon facts and circumstances known by the Company on the Execution Date and there are no loss contingencies that
are required to be accrued by the Statement of Financial Accounting Standard No. 5 of the Financial Accounting Standards Board which
are not provided for in the Financial Statements.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(xiii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Management</U>. During the
past five year period, no current or former officer or director or, to the Knowledge of the Company, stockholder of the Company or any
of its Subsidiaries has been the subject of any matter that would require disclosure under Paragraph (f) of Rule 401 of Regulation S-K
that has not been publicly disclosed.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(xiv)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Assets; Title</U>. Each of
the Company and its Subsidiaries has good and valid title to, or a valid leasehold interest in, as applicable, all of its properties
and assets, free and clear of all Liens except (i) any Lien for taxes not yet due or delinquent or being contested in good faith by </FONT>appropriate
proceedings for which adequate reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in the ordinary
course of business by operation of law with respect to a liability that is not yet due or delinquent, (iii) any Lien created by operation
of law, such as materialmen&rsquo;s liens, mechanics&rsquo; liens and other similar liens, arising in the ordinary course of business
with respect to a liability that is not yet due or delinquent or that are being contested in good faith by appropriate proceedings, and
(iv) such as have been disposed of in the ordinary course of business. To the Company&rsquo;s Knowledge, all tangible personal property
owned by the Company and its Subsidiaries has been maintained in good operating condition and repair, except (x) for ordinary wear and
tear, and (y) where such failure would not have a Material Adverse Effect. To the Company&rsquo;s Knowledge, all assets leased by the
Company or any of its Subsidiaries are in the condition required by the terms of the lease applicable thereto during the term of such
lease and upon the expiration thereof. To the Company&rsquo;s Knowledge, the Company and its Subsidiaries have good and marketable title
in fee simple to all real property and good and marketable title to all personal property owned by them which is material to the business
of the Company and its Subsidiaries, in each case free and clear of all liens, encumbrances and defects. Any real property and facilities
held under lease by the Company or any of its Subsidiaries are held by them under valid, subsisting and enforceable leases with such
exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company
and its Subsidiaries.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(xv)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Subsidiary Rights</U>. The
Company or one of its Subsidiaries has the unrestricted right to vote, and to receive dividends and distributions on, all equity securities
of its Subsidiaries as owned by the Company or such Subsidiary.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(xvi)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Books and Records</U>. To the
Company&rsquo;s Knowledge, the books of account, ledgers, order books, records and documents of the Company and its Subsidiaries accurately
and completely reflect all information relating to the respective businesses of the Company and its Subsidiaries, the nature, acquisition,
maintenance, location and collection of each of their respective assets, and the nature of all transactions giving rise to material obligations
or accounts receivable of the Company or its Subsidiaries, as the case may be, except where the failure to so reflect such information
would not have a Material Adverse Effect. To the Company&rsquo;s Knowledge, the minute books of the Company and its Subsidiaries contain
accurate records in all material respects of all meetings and accurately reflect all other actions taken by the stockholders, boards
of directors and all committees of the boards of directors, and other governing Persons of the Company and its Subsidiaries, respectively.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="text-align: left; width: 0.5in">(xvii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Money Laundering</U>. The Company
and its Subsidiaries are in compliance with, and have not previously violated, the USA PATRIOT ACT of 2001 and all other applicable U.S.
and non-U.S. anti-money </FONT>laundering laws and regulations, including, but not limited to, the laws, regulations and Executive Orders
and sanctions programs administered by the U.S. Office of Foreign Assets Control, including, but not limited, to (i) Executive Order
13224 of September 23, 2001 entitled, &ldquo;Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit,
or Support Terrorism&rdquo; (66 Fed. Reg. 49079 (2001)); and (ii) any regulations contained in 31 CFR, Subtitle B, Chapter V.</TD>
</TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(d)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>General</U></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Acknowledgment of Dilution</U>.
The Company understands and acknowledges the potentially dilutive effect to the Common Stock upon the issuance of the Conversion Shares
upon conversion of the Note. The Company further acknowledges that its obligation to issue Conversion Shares upon conversion of the Note
is absolute and unconditional regardless of the dilutive effect that such issuances may have on the ownership interests of other stockholders
of the Company.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(ii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Breach of Representations and
Warranties by the Company</U>. If the Company breaches any of the representations or warranties set forth in this <U>Section 3</U>, and
in addition to any other remedies available to the Buyer pursuant to this Agreement, it will be considered an &ldquo;Event of Default&rdquo;
as defined under each Note.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(iii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Absence of Schedules</U>. In
the event that at the Closing Date, the Company does not deliver and attach hereto any disclosure schedule contemplated by this Agreement,
the Company hereby acknowledges and agrees that (i) each such undelivered disclosure schedule shall be deemed to read as follows: &ldquo;Nothing
to Disclose&rdquo;, and (ii) the Buyer has not otherwise waived delivery of such disclosure schedule.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD><U>GENERAL COVENANTS.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Best Efforts</U>. The parties shall use their commercially reasonable
best efforts to satisfy timely each of the conditions described in <U>Section 7</U> and <U>8</U> of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Use of Proceeds</U>. The Company shall use the proceeds from the sale
of the Notes for general corporate purposes.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Financial Information</U>.
The Company agrees to send or make available the following reports to the Buyer until the Buyer transfers, assigns, or sells all of the
Securities: (i) within ten (10) days after the filing with the SEC, a copy of its Annual Report on Form 10-K, its Quarterly Reports on
Form 10-Q and any Current Reports on Form 8-K; (ii) within five (5) days after upload or filing, any filings made in the SEC Documents,
(iii) within one (1) day after release, copies of all press releases issued by the Company or any of its Subsidiaries relating to the
transactions contemplated hereby; and (iv) contemporaneously with the making available or giving to the stockholders of the Company,
copies of any notices or other information the Company makes available or gives to such stockholders. For the avoidance of doubt, filing
the documents required in (i) above via EDGAR or releasing any documents set forth in (ii) above via a recognized wire service shall
satisfy the delivery requirements of this <U>Section 4(c)</U>.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Listing</U>. The Company shall work in good faith to secure the listing
of the Conversion Shares upon each national securities exchange or automated quotation system, if any, upon which shares of Common Stock
are then listed (subject to official notice of issuance) and, so long as the Buyer owns any of the Securities, shall maintain, so long
as any other shares of Common Stock shall be so listed, such listing of all Conversion Shares from time to time issuable upon exercise
of the Note. The Company will obtain and, so long as the Buyer owns any of the Securities, maintain the listing and trading of its Common
Stock on the Trading Market and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under the
bylaws or rules of the Financial Industry Regulatory Authority (&ldquo;<U>FINRA</U>&rdquo;) and such exchanges, as applicable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Corporate Existence</U>. So long as the Buyer beneficially owns any of
the Securities, the Company shall maintain its corporate existence and shall not sell all or substantially all of the Company&rsquo;s
assets, except in the event of a merger or consolidation or sale of all or substantially all of the Company&rsquo;s assets, where the
surviving or successor entity in such transaction (i) assumes the Company&rsquo;s obligations hereunder and under the agreements and instruments
entered into in connection herewith and (ii) is a publicly traded corporation whose Common Stock is listed or quoted for trading on the
Trading Market.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>No Integration; Other Investors</U>. The Company shall not make any offers
or sales of any security (other than the Securities) under circumstances that would require registration of the Securities being offered
or sold hereunder under the Securities Act or cause the offering of the Securities to be integrated with any other offering of securities
by the Company for the purpose of any stockholder approval provision applicable to the Company or its securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Failure to Comply with the Exchange Act</U>. So long as the Buyer beneficially
owns any of the Securities, the Company shall comply with the reporting requirements of the Exchange Act; and the Company be subject to
the periodic reporting and other reporting requirements of the Exchange Act.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Breach of Covenants</U>. If the Company breaches any of the covenants
set forth in this <U>Section 4</U>, then in addition to any other remedies available to the Buyer pursuant to this Agreement, each such
breach will be considered an &ldquo;Event of Default&rdquo; as defined under the Note.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Reservation of Shares</U>.
The Company covenants that while the Note remains outstanding, the Company will reserve from its authorized and unissued Common Stock,
five times (5x) the number of shares of Common Stock, free from pre-emptive rights, that would be issuable upon full, unconditioned conversion
of the Note calculated on the basis of the conversion price in effect as the Closing Date, which such reserved amounts shall be increased
by the Company, or upon the written demand of the Buyer, from time to time. In addition to all other rights in this Agreement and the
Notes, in the event that on any date (the &ldquo;<U>Reserve Depletion Date</U>&rdquo;) the Company does not have available enough authorized
shares of Common Stock to satisfy any conversion request regarding the Note, the Company shall first convert as much as would be permitted
based on the number of authorized and available shares of Common Stock and then repay all remaining outstanding amounts owed under the
Note in full within thirty (30) days of the Reserve Depletion Date at the election of the Buyer.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Indemnification</U>. Each party hereto (an &ldquo;<U>Indemnifying Party</U>&rdquo;)
agrees to indemnify and hold harmless the other party along with its officers, directors, employees, and authorized agents, and each Person
or entity, if any, who controls such party within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act or
the rules and regulations thereunder (an &ldquo;<U>Indemnified Party</U>&rdquo;) from and against any Damages, joint or several, and any
action in respect thereof to which the Indemnified Party becomes subject to, resulting from, arising out of or relating to any misrepresentation,
breach of warranty or nonfulfillment of or failure to perform any covenant or agreement on the part of the Indemnifying Party contained
in this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD><U>SPECIAL COVENANTS</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Piggyback Registration Rights</U>. The Company shall include on any registration
and/or offering statement filed with the SEC, including without limitation on any offering statement on Form 1-A, all Conversion Shares
for resale by the Buyer. In addition to all other remedies at law or in equity or otherwise under this Agreement or other Transaction
Documents, failure to do so will result in liquidated damages of $400,000.00 pursuant to this <U>Section 5(a)</U>, being immediately due
and payable to the Buyer at its election in the form of cash payment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Repayment from Proceeds</U>. While any portion of any Note is outstanding,
if the Company receives cash proceeds from the issuance of securities pursuant the ELOC Agreement, or pursuant to the exercise of any
purchase under the Warrant, the Buyer shall have the right in its sole discretion to require the Company to immediately apply up to 10%
of such proceeds to repay all or any portion of the outstanding amounts owed under the Note.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Compliance with Rule 15c2-11</U>. The Company take all actions to maintain
as publicly available all information required by paragraph (b) of Rule 15c2-11 of the Exchange Act (as effective on September 26, 2021),
as amended, such that brokers or dealers attempting to publish any quotation for the Common Stock or, directly or indirectly, to submit
any such quotation for publication, shall be able to comply with Rule 15c2-11(a).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Audit</U>. The Company shall maintain an engagement with a PCAOB registered
accounting firm at all times the Securities are outstanding.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Registration Rights</U>. The Company shall file with the SEC, within
thirty (30) days from the Execution Date, a registration statement on Form S-1 covering the offering and resale of the Securities (the
&ldquo;<U>Registration Statement</U>&rdquo;). The Registration Statement shall relate to the transactions contemplated by, and describing
the material terms and conditions of, this Agreement, and disclosing all information relating to the transactions contemplated hereby
required to be disclosed in the Registration Statement and the related prospectus, including, without limitation, information required
to be disclosed in the section captioned &ldquo;Plan of Distribution&rdquo; in the Registration Statement. The Company shall use its best
efforts to permit the Buyer to review and comment upon the Registration Statement within a reasonable time prior to their filing with
the SEC, and the Company shall give reasonable consideration to all such comments. The Buyer shall also furnish to the Company such information
regarding itself, the Company&rsquo;s securities beneficially owned by the Buyer, and the intended method of distribution thereof, including
any arrangement between the Buyer and any other person or relating to the sale or distribution of the Company&rsquo;s securities, as shall
be reasonably requested by the Company in connection with the preparation and filing of a Current Report and the Registration Statement,
and shall otherwise cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of
a Current Report and the Registration Statement with the SEC. At the time of the filing of the Registration Statement, the Company shall
have no knowledge of any untrue statement (or alleged untrue statement) of a material fact in the Registration Statement (as supplemented
by the Registration Statement) or omission (or alleged omission) of a material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading, and there shall be no such untrue statement
of material fact or omission in any effective registration statement filed or any post-effective amendment or prospectus which is a part
of the foregoing. The Company shall promptly give the Buyer notice of any event (including the passage of time) which makes the aforementioned
prospectus not to be in compliance with Section 5(b) or 10 of the Securities Act and shall use its best efforts thereafter to file with
the SEC any post-effective amendment to the Registration Statement, or amended prospectus in order to comply with Section 5(b) or 10 of
the Securities Act.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(f)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Stockholder Approval</U>. The
Company will take all actions necessary, including without limitation the filing of a proposal in a proxy statement, to obtain Stockholder
Approval, which shall expressly allow for issuances of all Securities hereunder and under the ELOC Agreement and Warrant. In the event
that such Stockholder Approval is not obtained by the June 30, 2025, such failure will result in liquidated damages of $400,000.00 being
immediately due and payable to the Buyer at its election in the form of cash payment. &ldquo;<U>Stockholder Approval</U>&rdquo; means
the approval of the holders of a majority of the Company&rsquo;s outstanding voting Common Stock that are present or represented by proxy
at a meeting, to effectuate the transactions contemplated by this Agreement, the issuance of all of the Securities in excess the Exchange
Cap, subject to appropriate adjustment for any stock dividend, stock split, stock combination, rights offerings, reclassification or
similar transaction that proportionately decreases or increases the Common Stock. &ldquo;<U>Exchange Cap</U>&rdquo; means that threshold
amount of shares that the Company cannot issue to the Buyer related to this Agreement, and any other agreements with the Buyer, without
first obtaining the approval of the Company&rsquo;s stockholders in compliance with the rules of the Trading Market. For the avoidance
of doubt, the Company shall obtain Stockholder Approval regarding the issuance to the Buyer of 20% or more of its outstanding shares
of Common Stock as required by the NASDAQ stock market rules regarding the shares of Common Stock issuable under the Note, ELOC Agreement
and the Warrant.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Variable Rate Right of First Refusal</U>. Until the first anniversary
of the Execution Date, prior to entering into any definitive documents regarding a Variable Rate Transaction with any third-parties, the
Company shall present the terms of such contemplated Variable Rate Transaction to the Buyer as a right of first refusal, and the Buyer
shall have the option, in its sole discretion, to fund the complete, or any portion, of the contemplated Variable Rate Transaction to
the exclusion of any third-parties. The Buyer shall notify the Company of its election to proceed with the Variable Rate Transaction within
thirty (30) Trading Days of receiving notice thereof from the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Breach of Covenants</U>. If the Company breaches any of the covenants
set forth in this <U>Section 5</U>, then in addition to any other remedies available to the Buyer pursuant to this Agreement, each such
breach will be considered an &ldquo;Event of Default&rdquo; as defined under the Note.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">6.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>TRANSFER AGENT INSTRUCTIONS</U>. Prior to registration of the Conversion
Shares under the Securities Act or the date on which the Conversion Shares may be sold pursuant to Rule 144 without any restriction as
to the number of Securities as of a particular date that can then be immediately sold, all such certificates shall bear the restrictive
legend specified in the Note or Warrants as applicable. The Company warrants that: (i) no stop transfer instructions will be given by
the Company to its Transfer Agent and that the Securities shall otherwise be freely transferable on the books and records of the Company
as and to the extent provided in this Agreement and the Note; (ii) it will not direct its Transfer Agent not to transfer or delay, impair,
and/or hinder its Transfer Agent in transferring (or issuing) (electronically or in certificated form) any certificate for Conversion
Shares to be issued to the Buyer upon conversion of or otherwise pursuant to the Note, as and when required by the Note or this Agreement;
and (iii) it will not fail to remove (or direct its Transfer Agent not to remove or impairs, delays, and/or hinders its Transfer Agent
from removing) any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any certificate for any Conversion
Shares as contemplated by the terms of this Agreement and the Note, as applicable. Nothing in this Section shall affect in any way the
Buyer&rsquo;s obligations and agreement to comply with all applicable prospectus delivery requirements, if any, upon re-sale of the Securities.
If the Buyer provides the Company (which shall be at the cost of the Company), with (i) an opinion of counsel in form, substance and scope
customary for opinions in comparable transactions, to </FONT>the effect that a public sale or transfer of any Securities may be made without
registration under the Securities Act and such sale or transfer is effected or (ii) the Buyer provides reasonable assurances that the
Securities can be sold pursuant to Rule 144, the Company shall permit the transfer, and, in the case of the Conversion Shares, promptly
instruct its Transfer Agent to issue one or more certificates, free from restrictive legend, in such name and in such denominations as
specified by the Buyer or, in the sole discretion of the Buyer, the Company shall take all action necessary to ensure that such Common
Stock is transferred electronically as DWAC (as defined in the Note) shares. The Company acknowledges that a breach by it of its obligations
hereunder will cause irreparable harm to the Buyer, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly,
the Company acknowledges that the remedy at law for a breach of its obligations under this Section may be inadequate and agrees, in the
event of a breach or threatened breach by the Company of the provisions of this Section, that the Buyer shall be entitled, in addition
to all other available remedies, to an injunction restraining any breach and requiring immediate transfer, without the necessity of showing
economic loss and without any bond or other security being required.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">7.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>CONDITIONS PRECEDENT TO THE COMPANY&rsquo;S OBLIGATIONS TO SELL</U>.
The </FONT>obligation of the Company hereunder to issue and sell any Note to the Buyer at the Closing is subject to the satisfaction,
at or before the Closing Date of each of the following conditions thereto, provided that these conditions are for the Company&rsquo;s
sole benefit and may be waived by the Company at any time in its sole discretion:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Buyer shall have executed this Agreement and delivered the same to the
Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Buyer shall have delivered the Funding Amount in accordance with <U>Section
1</U> above.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The representations and warranties of the Buyer shall be true and correct
in all material respects as of the date when made and as of the First Closing Date as though made at that time (except for representations
and warranties that speak as of a specific date), and the Buyer shall have performed, satisfied and complied in all material respects
with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Buyer at or
prior to the First Closing Date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">No litigation, statute, rule, regulation, executive order, decree, ruling
or injunction shall have been enacted, entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction
or any self- regulatory organization having authority over the matters contemplated hereby which prohibits the consummation of any of
the transactions contemplated by this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">8.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>CONDITIONS PRECEDENT TO THE
BUYER&rsquo;S OBLIGATION TO PURCHASE</U>. The </FONT>obligation of the Buyer hereunder to purchase any Note and fund any such Note at
any Closing is subject to the satisfaction, at or before the applicable Closing Date of each of the following conditions, provided that
these conditions are for the Buyer&rsquo;s sole benefit and may be waived by the Buyer at any time in its sole discretion:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company shall have executed this Agreement and delivered the same to
the Buyer on the First Closing Date.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company shall have executed the ELOC Agreement and delivered the same
to the Buyer on the First Closing Date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company shall have delivered to the Buyer the duly executed Note in
accordance with <U>Section 1</U> above on the applicable Closing Date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company shall have delivered to the Buyer the duly executed Transfer
Agent Instruction Letter on the First Closing Date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company shall have delivered a copy of its Directors&rsquo; resolutions
relating to the transactions contemplated hereby, the form of which is reasonably acceptable to the Buyer, on the Closing Date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">No litigation, statute, rule, regulation, executive order, decree, ruling
or injunction shall have been enacted, entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction
or any self- regulatory organization having authority over the matters contemplated hereby which prohibits the consummation of any of
the transactions contemplated by this Agreement, as of each Closing Date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">No event shall have occurred which could reasonably be expected to have
a Material Adverse Effect on the Company including but not limited to a change in the Exchange Act reporting status of the Company or
the failure of the Company to be timely in its Exchange Act reporting obligations, as of the subject Closing Date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company shall have delivered to the Buyer a copy of its certificate
of good standing with the State of Delaware dated within five (5) days of the subject Closing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company shall have delivered a legal opinion to the Transfer Agent regarding
the issuance of the Conversion Shares in form and substance acceptable to the Buyer.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The representations and warranties of the Company shall be true and correct
in all material respects as of the date when made and as of the Execution Date and the subject Closing Date as though made at such time
(except for representations and warranties that speak as of a specific date, which shall be true and correct in all material respects
as of such specific date) and the Company shall have performed, satisfied and complied in all material respects with the covenants, agreements
and conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the subject Closing
Date. The Buyer shall have received a certificate or certificates, executed by the chief executive officer of the Company, dated as of
the subject Closing Date, to the foregoing effect and </FONT>as to such other matters as may be reasonably requested by the Buyer, in
the form prescribed by the Buyer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">9.</TD><TD STYLE="text-align: justify"><U>GOVERNING LAW; MISCELLANEOUS</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Governing Law</U>. This Agreement
shall be governed by and construed in accordance with the laws of the State of New York without regard to principles of conflicts of
laws. Any dispute, controversy, difference or claim that may arise between the Company and the Buyer in connection with these Transaction
Documents, shall be submitted to binding arbitration governed by the rules of the American Arbitration Association. The seat of the arbitration
shall be in the State and County of New York. There shall be only one arbitrator selected in accordance with the rules of the American
Arbitration Association. The arbitration shall be conducted in English and may be conducted in a virtual setting. The arbitrator&rsquo;s
decision shall be final and binding and judgment may be entered thereon.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><B>(b)</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>JURY TRIAL WAIVER</U>. THE COMPANY AND THE BUYER HEREBY WAIVE A TRIAL
BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM BROUGHT BY EITHER OF THE PARTIES HERETO AGAINST THE OTHER IN RESPECT OF ANY MATTER ARISING
OUT OF OR IN CONNECTION WITH THE TRANSACTION DOCUMENTS.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Counterparts; Signatures by Electronic Mail</U>. This Agreement may be
executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party. This Agreement, once executed
by a party, may be delivered to the other party hereto by electronic mail transmission of a copy of this Agreement bearing the signature
of the party so delivering this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Headings</U>. The headings of this Agreement are for convenience of reference
only and shall not form part of, or affect the interpretation of, this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Severability</U>. In the event that any provision of this Agreement or
of any of the Transaction Documents is invalid or unenforceable under any applicable statute or rule of law, then such provision shall
be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of
law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any
other provision hereof.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Entire Agreement; Amendments</U>. This Agreement and the instruments
referenced herein contain the entire understanding of the parties with respect to the matters covered herein and therein and, except as
specifically set forth herein or therein, neither the Company nor the Buyer makes any representation, warranty, covenant or undertaking
with respect to such </FONT>matters. No provision of this Agreement may be waived or amended other than by an instrument in writing signed
by the Buyer and the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Notices</U>. All notices, demands, requests, consents, approvals, and
other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (a) personally
served, (b) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (c) delivered by reputable air
courier service with charges prepaid, or (d) transmitted by hand delivery, or e-mail, addressed as set forth below or to such other address
as such party shall have specified most recently by written notice given in accordance herewith. Any notice or other communication required
or permitted to be given hereunder shall be deemed effective (i) upon hand delivery or delivery by e-mail at the address designated below
(if delivered on a business day during normal business hours where such notice is to be received), or the first business day following
such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (ii) on
the second business day following the date of mailing by express courier service or on the fifth business day after deposited in the mail,
in each case, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">If to the Company, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 107.65pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><B>OSR HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">10900 NE 4th Street, Suite 2300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Bellevue, WA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attn: Kuk Hyoun Hwang, CEO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">E-mail: peter.hwang@osr-holdings.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">If to the Buyer, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><B>WHITE LION CAPITAL, LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">21031 Ventura Blvd #920</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Woodland Hills, CA 91364</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attn: Yash Thukral, Managing Director</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">E-mail: team@whitelioncapital.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Either party hereto may from
time to time change its address or e-mail for notices under this <U>Section 9(g)</U> by giving prior written notice of such changed address
to the other party hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Successors and Assigns</U>. This Agreement shall be binding upon and
inure to the benefit of the parties and their successors and assigns. Neither the Company nor the Buyer shall assign this Agreement or
any rights or obligations hereunder without the prior written consent of the other. Notwithstanding the foregoing, subject to <U>Section
4(c)</U>, the Buyer may assign its rights hereunder to any person that purchases Securities in a private transaction from the Buyer or
to any of its &ldquo;affiliates,&rdquo; as that term is defined under the Exchange Act, without the consent of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Third Party Beneficiaries</U>. This Agreement is intended for the benefit
of the parties hereto and their respective permitted successors and assigns and is not for the benefit of, nor may any provision hereof
be enforced by, any other person.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Survival</U>. The representations and warranties of the Company and the
agreements and covenants set forth in this Agreement shall survive the Closings hereunder as well as the termination/satisfaction of the
Note for the longest period allowable under applicable law. The Company agrees to indemnify and hold harmless the Buyer and all their
officers, directors, employees and agents for loss or damage arising as a result of or related to any breach by the Company of any of
its representations, warranties and covenants set forth in this Agreement or any of its covenants and obligations under this Agreement,
including advancement of expenses as they are incurred. The Buyer agrees to indemnify and hold harmless the Company and all its officers,
directors, employees and agents for loss or damage arising as a result of or related to any breach by the Buyer of any of its representations,
warranties and covenants set forth in this Agreement or any of its covenants and obligations under this Agreement, including advancement
of expenses as they are incurred.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Further Assurances</U>. Each party shall do and perform, or cause to
be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments
and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement
and the consummation of the transactions contemplated hereby.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>No Strict Construction</U>. The language used in this Agreement will
be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied
against any party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(m)</TD><TD><FONT STYLE="font-size: 10pt"><U>Remedies</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Company acknowledges that
a breach by it of its obligations hereunder will cause irreparable harm to the Buyer by vitiating the intent and purpose of the transaction
contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under this Agreement
will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of this Agreement, that
the Buyer shall be entitled, in addition to all other available remedies at law or in equity, and in addition to the penalties assessable
herein, to an injunction or injunctions restraining, preventing or curing any breach of this Agreement and to enforce specifically the
terms and provisions hereof, without the necessity of showing economic loss and without any bond or other security being required.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 126.05pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(ii)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">In addition to any other remedy
provided herein or in any document executed in connection herewith, the Company shall pay the Buyer for all </FONT> costs, fees and expenses
in connection with any arbitration, litigation, contest, dispute, suit or any other action to enforce any rights of the Buyer against
the Company in connection herewith, including, but not limited to, costs and expenses and attorneys&rsquo; fees, and costs and time charges
of counsel to the Buyer.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(n)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Publicity</U>. The Company
and the Buyer shall have the right to review a reasonable period of time before issuance of any press releases, SEC, Trading Market,
or FINRA filings, or any other public statements with respect to the transactions contemplated hereby; <U>provided</U>, <U>however</U>,
that the Company shall be entitled, without the prior approval of the Buyer, to make any press release or SEC, Trading Market or FINRA
filings with respect to such transactions as is required by applicable law and regulations (although the Buyer shall be consulted by
the Company in connection with any such press release prior to its release and shall be provided with a copy thereof).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">10.</TD><TD STYLE="text-align: justify"><U>DEFINED TERMS</U>. As used in this Agreement, the following
terms shall have the following meanings specified or indicated (such meanings to be equally applicable to both the singular and plural
forms of the terms defined):</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls, or is controlled
by, or is under common control with, such Person, and the term &ldquo;control&rdquo; (including the terms &ldquo;controlled by&rdquo;
and &ldquo;under common control with&rdquo;) means the possession, directly or indirectly, of the power to direct or cause the direction
of the management policies of such Person, whether through ownership of voting securities, by contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
shall mean any securities of the Company entitling the holder thereof to acquire at any time shares of Common Stock, including, without
limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Damages</U>&rdquo;
shall mean any loss, claim, damage, liability, cost and expense (including, without limitation, reasonable attorneys&rsquo; fees and disbursements
and costs and expenses of expert witnesses and investigation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;
shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Hazardous Material</U>&rdquo;
means and includes any hazardous, toxic or dangerous waste, substance or material, the generation, handling, storage, disposal, treatment
or emission of which is subject to any Environmental Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Knowledge</U>&rdquo;
including the phrase &ldquo;<U>to the Company&rsquo;s Knowledge</U>&rdquo; shall mean the actual knowledge after reasonable investigation
of the Company&rsquo;s officers and directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lien</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, pre- emptive right or any other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Adverse
Effect</U>&rdquo; means any effect on the business, operations, properties, or financial condition of the Company and/or the Subsidiaries
that is material and adverse to the Company and/or the Subsidiaries and/or any condition, circumstance, or situation that prohibits or
otherwise materially interferes with the ability of the Company and/or the Subsidiaries to enter into and/or perform its obligations under
any Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Subsidiary</U>&rdquo;
means any Subsidiary with assets, liabilities or operations that is material to the business, operations, properties or financial condition
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual, a corporation, a partnership, an association, a trust or other entity or organization, including a government or
political subdivision or an agency or instrumentality thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means, collectively, the Note, the Conversion Shares, and any other securities of the Company issued in connection with or in exchange
for any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
or &ldquo;<U>Subsidiaries</U>&rdquo; means any Person the Company wholly-owns or controls, or in which the Company, directly or indirectly,
owns a majority of the voting stock or similar voting interest, in each case that would be disclosable pursuant to Item 601(b)(21) of
Regulation S-K promulgated under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo;
shall mean a day on which the NASDAQ stock market shall be open for business.</P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; margin: 0pt 0 0pt 0.5in; text-align: left">&ldquo;<U>Trading Market</U>&rdquo; means
the NASDAQ stock market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction Documents</U>&rdquo;
shall mean this Agreement, the Note, the Transfer Agent Instruction Letter and all schedules and exhibits hereto and thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo;
shall mean the current transfer agent of the Company, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer Agent
Instruction Letter</U>&rdquo; means the letter from the Company to the Transfer Agent in the form of <U>Exhibit C</U> attached hereto,
or in such other form approved by the Buyer. .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable Rate
Transaction</U>&rdquo; means a transaction in which the Company (i) issues or sells any equity or debt securities that are convertible
into, exchangeable or exercisable for, or include the right to receive additional shares of Common Stock or Common Stock Equivalents either
(A) at a conversion price, exercise price, exchange rate or other price that is based upon and/or varies with the trading prices of or
quotations for the Common Stock at any time after the initial issuance of such equity or debt securities, or (B) with a conversion, exercise
or exchange price that is subject to being reset at some future date after the initial issuance of such equity or debt security or upon
the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common
Stock (including, without limitation, any &ldquo;full ratchet&rdquo; or &ldquo;weighted average&rdquo; anti-dilution provisions, but not
including any standard anti-dilution protection for any reorganization, recapitalization, non-cash dividend, stock split or other similar
transaction), (ii) issues or sells any equity or debt securities, including without limitation, Common Stock or Common Stock Equivalents,
either (A) at a price that is subject to being reset at some future date after the initial issuance of such debt or equity security or
upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for
the Common Stock (other than standard anti- dilution protection for any reorganization, recapitalization, non-cash dividend, stock split
or other similar transaction), or (B) that are subject to or contain any put, call, redemption, buy-back, price- reset or other similar
provision or mechanism (including, without limitation, a &ldquo;Black-Scholes&rdquo; put or call right) that provides for the issuance
of additional equity securities of the Company or the payment of cash by the Company, or (iii) enters into any agreement, including, but
not limited to, an &ldquo;equity line of credit&rdquo; or &ldquo;at the market offering&rdquo; or other continuous offering or similar
offering of Common Stock or Common Stock Equivalents, whereby the Company may sell Common Stock or Common Stock Equivalents at a future
determined price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant</U>&rdquo;
means any warrants to purchase Common Stock issued by the Company to the Buyer under the ELOC Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>** signature page follows **</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B>
the Buyer and the Company have caused their respective signature page to this Note Purchase Agreement to be duly executed as of the Execution
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 35.95pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-size: 10pt"><B><U>COMPANY</U>:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"><B>OSR HOLDINGS, INC.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: left">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: left">/s/ Kuk Hyoun Hwang</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Name:</TD>
    <TD STYLE="text-align: left">Kuk Hyoun Hwang</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Title:</TD>
    <TD STYLE="text-align: left">CEO</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 221.45pt; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-size: 10pt"><B><U>BUYER</U>:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>WHITE LION CAPITAL, LLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">dba WHITE LION GBM INNOVATION FUND</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: left">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: left">/s/ Yash Thukral</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Name:</TD>
    <TD STYLE="text-align: left">Yash Thukral</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Title:</TD>
    <TD STYLE="text-align: left">Managing Director</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">** Signature Page to Note Purchase
Agreement **</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B><U>ISSUANCE SCHEDULE</U></B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B><U>FIRST CLOSING</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 70%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border: black 1pt solid; padding: 6pt 3pt 3pt; width: 43%; text-align: center"><FONT STYLE="font-size: 10pt"><B>(1)</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 6pt 3pt 3pt; width: 30%; text-align: center"><FONT STYLE="font-size: 10pt"><B>(2)</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 6pt 3pt 3pt; width: 27%; text-align: center"><FONT STYLE="font-size: 10pt"><B>(3)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; padding: 6pt 3pt 3pt; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Buyer</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 6pt 0pt 3pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Face Value of Note</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 6pt 0pt 3pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Funding Amount</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; padding: 3pt; border-bottom: black 1pt solid; border-left: black 1pt solid"><FONT STYLE="font-size: 10pt">White Lion Capital, LLC, dba White Lion GBM Innovation Fund</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 3pt 0pt; text-align: center"><FONT STYLE="font-size: 10pt">$445,000.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; padding: 3pt 0pt; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$400,000.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><B><U>SECOND CLOSING</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 70%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border: black 1pt solid; padding: 6pt 3pt 3pt; width: 43%; text-align: center"><FONT STYLE="font-size: 10pt"><B>(1)</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 6pt 3pt 3pt; width: 30%; text-align: center"><FONT STYLE="font-size: 10pt"><B>(2)</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 6pt 3pt 3pt; width: 27%; text-align: center"><FONT STYLE="font-size: 10pt"><B>(3)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; padding: 6pt 3pt 3pt; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Buyer</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center; border-bottom: black 1pt solid; padding: 6pt 0pt 3pt"><FONT STYLE="font-size: 10pt"><B>Face Value of Note</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 6pt 0pt 3pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Funding Amount</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 3pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"><FONT STYLE="font-size: 10pt">White Lion Capital, LLC, dba White Lion GBM Innovation Fund</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; text-align: center; padding: 3pt 0pt; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">$665,000.00</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 3pt 0pt; text-align: center"><FONT STYLE="font-size: 10pt">$600,000.00</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>EXHIBITS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><U>A &ndash; FORM OF NOTE</U></B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><U>B &ndash; FORM OF ELOC AMENDMENT</U></B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B><U>C - TRANSFER AGENT INSTRUCTIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea024172601ex10-2_osrhold.htm
<DESCRIPTION>SENIOR SECURED CONVERTIBLE PROMISSORY NOTE, ISSUED MAY 6, 2025, BY OSR HOLDINGS, INC. TO WHITE LION CAPITAL LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">NEITHER THE ISSUANCE NOR
SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED
OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES FILED PURSUANT TO THE SECURITIES ACT OF 1933,
AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION
IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE
SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Principal Amount: $445,000.00</B></FONT></TD>
    <TD STYLE="text-align: right; width: 50%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Issue Date: May 6, 2025 </B></FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B><U>SENIOR SECURED CONVERTIBLE
PROMISSORY NOTE</U></B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><B>FOR VALUE RECEIVED</B>,
as of <B>May 6, 2025</B> (the &ldquo;<U>Issue Date</U>&rdquo;), <B>OSR HOLDINGS, INC.</B>, a Delaware corporation (hereinafter called
the &ldquo;<U>Borrower</U>&rdquo; or &ldquo;<U>Company</U>&rdquo;), hereby promises to pay to the order of <B>WHITE LION CAPITAL, LLC</B>,
<B>dba White Lion GBM Innovation Fund</B>, a Nevada limited liability company, or its registered assigns (the &ldquo;<U>Holder</U>&rdquo;),
the principal amount of <B>$445,000.00</B>, payable upon the earlier of maturity or upon prepayment of this Note as set forth herein.
The term &ldquo;<U>Note</U>&rdquo; and all references thereto, as used throughout this instrument, shall mean this instrument as originally
executed, or if later amended or supplemented, then as so amended or supplemented. This Note shall accrue interest at the rate of 5%
on the principal amount of this Note. <B>The maturity date of this Note shall be the nine (9) month anniversary of the Issue Date (the
&ldquo;<U>Maturity Date</U>&rdquo;), and is the date upon which the principal amount, as well as any accrued and unpaid interest and
other fees, shall be due and payable. </B>This Note may be prepaid in whole or in part as explicitly set forth herein. All payments due
hereunder (to the extent not converted into common stock of the Company, $0.0001 par value per share (the &ldquo;<U>Common Stock</U>&rdquo;)
in accordance with the terms hereof) shall be made in lawful money of the United States of America. All payments shall be made at such
address as the Holder shall hereafter give to the Borrower by written notice made in accordance with the provisions of this Note. Whenever
any amount expressed to be due by the terms of this Note is due on any day which is not a business day, the same shall instead be due
on the next succeeding day which is a business day and, in the case of any interest payment date which is not the date on which this
Note is paid in full, the extension of the due date thereof shall not be taken into account for purposes of determining the amount of
interest due on such date. As used in this Note, the term &ldquo;business day&rdquo; shall mean any day other than a Saturday, Sunday
or a day on which commercial banks in the city of Los Angeles, California are authorized or required by law or executive order to remain
closed. Each capitalized term used herein, and not otherwise defined, shall have the meaning ascribed thereto in that certain Note Purchase
Agreement dated <B>May 6, 2025</B> between the parties, pursuant to which this Note was originally issued (as amended and/or restated
from time to time, the &ldquo;<U>Purchase Agreement</U>&rdquo;). The consideration delivered to the Borrower at the closing for the issuance
of this Note is the delivery of $400,000 of cash, as contemplated by the Purchase Agreement.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">This Note
is free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights
or other similar rights of shareholders of the Borrower and will not impose personal liability upon the holder thereof.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company hereby
affirms all of its obligations to the Holder under all of the Transaction Documents and agrees and affirms as follows: (i) that as
of the Issue Date, the Company has performed, satisfied and complied in all material respects with all the covenants, agreements and
conditions under each of the Transaction Documents to be performed, satisfied or complied with by the Company; (ii) that the Company
shall continue to perform each and every covenant, agreement and condition set forth in each of the Transaction Documents and this
Note, and continue to be bound by each and all of the terms and provisions thereof and hereof; (iii) that as of the Issue Date, no
default or Event of Default has occurred or is continuing under the Purchase Agreement, the Note or any other Transaction Documents,
and no event has occurred that, with the passage of time, the giving of notice, or both, would constitute a default or an Event of
Default under the Purchase Agreement, the Note or any other Transaction Documents; and (iv) that as of the Issue Date, no event,
fact, or other set of circumstances has occurred which could reasonably be expected to have, cause, or result in a Material Adverse
Effect. &ldquo;<U>Material Adverse Effect</U>&rdquo; means any effect on the business, operations, properties, or financial
condition of the Company and/or its Subsidiaries that is material and adverse to the Company and/or such Subsidiaries and/or any
condition, circumstance, or situation that prohibits or otherwise materially interferes with the ability of the Company and/or its
subsidiaries to enter into and/or perform its obligations under any Transaction Document.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company
hereby acknowledges, represents, warrants and confirms to the Holder that: (i) each of the Transaction Documents executed by the Company
are valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms; and (ii)
no oral representations, statements, or inducements have been made by Holder, or any agent or representative of Holder, with respect to
this Note, any other Note, the Purchase Agreement, and all other Transaction Documents.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">This
Note shall be a first senior secured obligation of the Borrower, with priority over all existing and future Indebtedness (as defined
below) of the Borrower as provided for herein. The obligations of the Borrower under this Note are secured by all of the assets,
personal property of every kind, intellectually property, claims and products and proceeds of the foregoing, of the Borrower (the
&ldquo;<U>Collateral</U>&rdquo;). So long as the Borrower shall have any obligation under this Note, the Borrower shall not
(directly or indirectly through any subsidiary or affiliate) incur or suffer to exist or guarantee any Indebtedness that is senior
to or pari passu with (in priority of payment and performance) the Borrower&rsquo;s obligations hereunder. For purposes of this
paragraph, the term &ldquo;<U>Borrower</U>&rdquo; shall include any subsidiary of the Borrower in addition to the Borrower. As used
herein, the term &ldquo;<U>Indebtedness</U>&rdquo; means (a) all indebtedness of the Borrower for borrowed money or for the deferred
purchase price of property or services, including any type of letters of credit, but not including deferred purchase price
obligations in place as of the Issue Date and as disclosed in the Company&rsquo;s SEC filings or obligations to trade creditors
incurred in the ordinary course of business, (b) all obligations of the Borrower evidenced by notes, bonds, debentures or other
similar instruments, (c) purchase money indebtedness hereafter incurred by the Borrower to finance the purchase of fixed or capital
assets, including all capital lease obligations of the Borrower which do not exceed the purchase price of the assets funded, (d) all
guarantee obligations of the Borrower in respect of obligations of the kind referred to in clauses (a) through (c) above that the
Borrower would not be permitted to incur or enter into, and (e) all obligations of the kind referred to in clauses (a) through (d)
above that the Borrower is not permitted to incur or enter into that are secured and/or unsecured by (or for which the holder of
such obligation has an existing right, contingent or otherwise, to be secured and/or unsecured by) any lien or encumbrance on
property (including accounts and contract rights) owned by the Borrower, whether or not the Borrower has assumed or become liable
for the payment of such obligation. The Borrower shall take all actions required to perfect the security interest of the Holder in
the Collateral, including, without limitation, with respect to all Collateral over which control may be obtained within the meaning
of sections 8-106, 9-104, 9-105, 9- 106 and 9-107 of the UCC. The Borrower shall immediately take all actions as may be requested
from time to time by the Holder so that control of such Collateral is obtained and at all times held by the Holder. All of the
foregoing shall be at the sole cost and expense of the Borrower. The Borrower hereby irrevocably authorizes the Holder at any time
and from time to time to file in any relevant jurisdiction any financing statements, or file any documents with the United States
Patent and Trademark Office and the United States Copyright Office, for the purpose of perfecting, confirming, continuing, enforcing
or protecting the security interest granted by the Borrower hereunder, without the signature of the Borrower where permitted by
law.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">The following additional terms shall
also apply to this Note:</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLE I CONVERSION RIGHTS</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">1.1&nbsp;<U>Conversion
Right</U>. The Holder shall have the right at any time, and from time to time, on or after the Issue Date until the complete satisfaction
by the Borrower of all amounts owed under this Note to convert all or any part of the outstanding and unpaid principal, interest, fees,
or any other obligation owed pursuant to this Note into fully paid and non-assessable shares of Common Stock, as such Common Stock exists
on the Issue Date, or any shares of capital stock or other securities of the Borrower into which such Common Stock shall hereafter be
changed or reclassified, at the Conversion Price (as defined below) selected by the Holder for any particular conversion, determined as
provided herein (a &ldquo;<U>Conversion</U>&rdquo;); <U>provided</U>, <U>however</U>, that in no event shall the Holder be entitled to
convert any portion of this Note in excess of that portion of this Note upon conversion of which the sum of (1) the number of shares of
Common Stock beneficially owned by the Holder and its affiliates (other than shares of Common Stock which may be deemed beneficially owned
through the ownership of the unconverted portion of this Note or the unexercised or unconverted portion of any other security of the Borrower
subject to a limitation on conversion or exercise analogous to the limitations contained herein) and (2) the number of shares of Common
Stock issuable upon the Conversion of the portion of this Note with respect to which the determination of this proviso is being made,
would result in beneficial ownership by the Holder and its affiliates of more than 4.99% of the outstanding shares of Common Stock (the
&ldquo;<U>Ownership Limitation</U>&rdquo;), provided that, the Holder may increase the Ownership Limitation up to 9.99% at its sole discretion
upon sixty-one (61) days prior written notice to the Company. For purposes of the proviso to the immediately preceding sentence, beneficial
ownership shall be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the &ldquo;<U>1934
Act</U>&rdquo;), and Regulations 13D-G thereunder, except as otherwise provided in clause (1) of such proviso. The number of shares of
Common Stock to be issued upon each Conversion of this Note shall be determined by dividing the Conversion Amount (as defined below) (the
numerator) by the applicable Conversion Price then in effect on the date specified in the notice of conversion (the denominator), in the
form attached hereto as <U>Exhibit A</U> (the &ldquo;<U>Notice of Conversion</U>&rdquo;), delivered to the Company by the Holder in accordance
with <U>Section 1.4</U> below; provided that the Notice of Conversion is submitted by facsimile or e-mail (or by other means resulting
in, or reasonably expected to result in, notice) to the Borrower before 8:00 p.m., New York, New York time on such conversion date (the
&ldquo;<U>Conversion Date</U>&rdquo;). The term &ldquo;<U>Conversion Amount</U>&rdquo; means, with respect to any Conversion of this Note,
the sum of (1) the principal amount of this Note to be converted in such Conversion <U>plus</U> (2) at the Holder&rsquo;s option, accrued
and unpaid interest, if any, on such principal amount at the interest rates provided in this Note to the Conversion Date.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">1.2&nbsp;<U>Conversion
Price</U>. Subject to the adjustments described herein, this Note shall be convertible into shares of Common Stock at any time, and from
time to time, in any portion at the Conversion Price. The Conversion Price shall be automatically adjusted equitably for stock splits,
stock dividends or rights offerings by the Borrower relating to the Borrower&rsquo;s securities or the securities of any subsidiary of
the Borrower, as well as combinations, recapitalization, reclassifications, extraordinary distributions and similar events:</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(a)&nbsp;<U>Variable
Conversion Price</U>. At any time, and from time to time, the Holder may utilize the Variable Conversion Price for conversions of
this Note into Common Stock. The Variable Conversion Price shall be a rate per share equal to 95% multiplied by the Market Price (as
defined herein) (representing a discount rate of 5%) (the &ldquo;<U>Variable Conversion Price</U>&rdquo;). &ldquo;<U>Market
Price</U>&rdquo; means the lowest daily VWAP of the Common Stock during the fifteen (15) Trading Day period ending on the latest
complete Trading Day prior to the Conversion Date. &ldquo;<U>Trading Price</U>&rdquo; means the lowest volume-weighted average daily
price as reported on the principal securities exchange or trading market where such security is quoted, listed or traded or, if no
trading price of such security is available in any of the foregoing manners, the average of the trading prices of any market makers
for such security that are listed in the &ldquo;pink sheets&rdquo; by the National Quotation Bureau, Inc. &ldquo;<U>Trading
Day</U>&rdquo; shall mean any day on which the Common Stock is tradable for any period on the NASDAQ stock market or on the
principal securities exchange or other securities market on which the Common Stock is then being quoted or traded.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(b)&nbsp;<U>Additional
Conversion Considerations</U>. To the extent the Conversion Price of the Borrower&rsquo;s Common Stock closes below the par value per
share, the Borrower will take all steps necessary to solicit the consent of the stockholders to reduce the par value of the Common Stock
to the lowest value possible under law. The Borrower agrees to honor all conversions submitted pending this adjustment. If the shares
of the Borrower&rsquo;s Common Stock have not been delivered within two (2) business days to the Holder after its transmittal of the Notice
of Conversion, the Notice of Conversion may be rescinded by the Holder in its sole discretion. If the Trading Price cannot be calculated
for such security on such date in the manner provided above, the Trading Price shall be the fair market value as mutually determined by
the Borrower and the Holder for which the calculation of the Trading Price is required in order to determine the Conversion Price of such
Notes. If at any time the Conversion Price as determined hereunder for any conversion would be less than the par value of the Common Stock,
then at the sole discretion of the Holder, the Conversion Price hereunder may equal such par value for such conversion and the Conversion
Amount for such conversion may be increased to include Additional Principal, where &ldquo;<U>Additional Principal</U>&rdquo; means such
additional amount to be added to the Conversion Amount to the extent necessary to cause the number of conversion shares issuable upon
such conversion to equal the same number of conversion shares as would have been issued had the Conversion Price not been adjusted by
the Holder to the par value price. The Note is convertible into shares of Common Stock at any time, and from time to time either of the
Variable Conversion Price or the Default Conversion Price then in effect. &ldquo;<U>Conversion Price</U>&rdquo; means the then applicable
Variable Conversion Price or Default Conversion Price or other conversion price as determined in accordance with this Note.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(c)&nbsp;<U>Pro
Rata Conversion; Disputes</U>. In the event of a dispute as to the number of shares of Common Stock issuable to the Holder in connection
with a conversion of this Note, the Borrower shall issue to the Holder the number of shares of Common Stock not in dispute and resolve
such dispute in accordance with this Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">1.3&nbsp;<U>Authorized
Shares</U>. The Borrower covenants that during the period the Conversion right exists, the Borrower will reserve from its authorized
and unissued Common Stock a sufficient number of shares, free from preemptive rights, to provide for the issuance of Common Stock
upon the full conversion of this Note issued pursuant to the Purchase Agreement. The Borrower is required at all times to have
authorized and reserved five times (5x) the number of shares that is actually issuable upon full conversion of the Note (based on
the Conversion Price of the Note in effect from time to time) (the &ldquo;<U>Reserved Amount</U>&rdquo;). The Borrower represents
that upon issuance, such shares of Common Stock will be duly and validly issued, fully paid and non-assessable. In addition, if the
Borrower shall issue any securities or make any change to its capital structure which would change the number of shares of Common
Stock into which this Note shall be convertible at the then current Conversion Price, the Borrower shall at the same time make
proper provision so that thereafter there shall be a sufficient number of shares of Common Stock authorized and reserved, free from
preemptive rights, for conversion of the outstanding Note. The Borrower (i) represents that it has irrevocably instructed its
transfer agent to issue certificates for the Common Stock issuable upon conversion of this Note, and (ii) agrees that its issuance
of this Note shall constitute full authority to its officers and agents who are charged with the duty of executing stock
certificates to execute and issue the necessary certificates for shares of Common Stock in accordance with the terms and conditions
of this Note.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Borrower&rsquo;s
failure to maintain or to replenish the Reserved Amount within two (2) business days of a request of the Holder, shall be an Event of
Default under this Note.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> 1.4 <U>Method of Conversion</U>.</P>



<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(a)&nbsp;<U>Mechanics
of Conversion</U>. Subject to <U>Section 1.1</U>, this Note may be converted by the Holder in whole or in part at any time from time to
time on or after the Issue Date, by (i) submitting to the Borrower a Notice of Conversion (by facsimile, e-mail or other reasonable means
of communication dispatched on the Conversion Date prior to 8:00 p.m., New York, New York time) and (ii) subject to <U>Section 1.4(b)</U>,
surrendering this Note at the principal office of the Borrower.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(b)&nbsp;<U>Surrender
of Note Upon Conversion</U>. Notwithstanding anything to the contrary set forth herein, upon conversion of this Note in accordance with
the terms hereof, the Holder shall not be required to physically surrender this Note to the Borrower unless the entire unpaid principal
amount of this Note is so converted. The Holder and the Borrower shall maintain records showing the principal amount so converted and
the dates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Borrower, so as not to require
physical surrender of this Note upon each such conversion. In the event of any dispute or discrepancy, such records of the Holder shall,
<I>prima facie,</I> be controlling and determinative in the absence of manifest error. The Holder and any assignee, by acceptance of this
Note, acknowledge and agree that, by reason of the provisions of this paragraph, following conversion of a portion of this Note, the unpaid
and unconverted principal amount of this Note represented by this Note may be less than the amount stated on the face hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(c)&nbsp;<U>Delivery
of Common Stock Upon Conversion</U>. Upon receipt by the Borrower from the Holder of a facsimile transmission or e-mail (or other reasonable
means of communication) of a Notice of Conversion meeting the requirements for conversion as provided in this <U>Section 1.4</U>, the
Borrower shall issue and deliver or cause to be issued and delivered to or upon the order of the Holder certificates (or electronic shares
via DWAC transfer, at the option of Holder) for the Common Stock issuable upon such conversion within one (1) business day after such
receipt (the &ldquo;<U>Deadline</U>&rdquo;) (and, solely in the case of conversion of the entire unpaid principal amount hereof, surrender
of this Note) in accordance with the terms hereof.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(d)&nbsp;<U>Obligation
of Borrower to Deliver Common Stock</U>. Upon receipt by the Borrower of a Notice of Conversion, the Holder shall be deemed to be
the holder of record of the Common Stock issuable upon such conversion, the outstanding principal amount and the amount of accrued
and unpaid interest on this Note shall be reduced to reflect such conversion, and, unless the Borrower defaults on its obligations
under this <U>Article I</U>, all rights with respect to the portion of this Note being so converted shall forthwith terminate except
the right to receive the Common Stock or other securities, cash or other assets, as herein provided, on such conversion. If the
Holder shall have given a Notice of Conversion as provided herein, the Borrower&rsquo;s obligation to issue and deliver the
certificates for Common Stock shall be absolute and unconditional, irrespective of the absence of any action by the Holder to
enforce the same, any waiver or consent with respect to any provision thereof, the recovery of any judgment against any person or
any action to enforce the same, any failure or delay in the enforcement of any other obligation of the Borrower to the holder of
record, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder of any
obligation to the Borrower, and irrespective of any other circumstance which might otherwise limit such obligation of the Borrower
to the Holder in connection with such conversion. The Conversion Date specified in the Notice of Conversion shall be the Conversion
Date so long as the Notice of Conversion is received by the Borrower before 8:00 p.m., New York, New York time, on such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(e)&nbsp;<U>Delivery
of Common Stock by Electronic Transfer</U>. In lieu of delivering physical certificates representing the Common Stock issuable upon conversion,
provided the Borrower is participating in the Depository Trust Company (&ldquo;<U>DTC</U>&rdquo;) Fast Automated Securities Transfer (&ldquo;<U>FAST</U>&rdquo;)
program, upon request of the Holder and its compliance with the provisions contained in <U>Section 1.1</U> and in this <U>Section 1.4</U>,
the Borrower shall cause its transfer agent to electronically transmit the Common Stock issuable upon conversion to the Holder by crediting
the account of Holder&rsquo;s Prime Broker with DTC (as designated by the Holder in a Notice of Conversion) through its Deposit Withdrawal
At Custodian (&ldquo;<U>DWAC</U>&rdquo;) system.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(f)&nbsp;<U>Failure
to Deliver Common Stock Prior to Delivery Deadline</U>. Without in any way limiting the Holder&rsquo;s right to pursue other remedies,
including actual damages and/or equitable relief, the parties agree that if delivery of the Common Stock issuable upon conversion of this
Note is not delivered by the Deadline the Borrower shall pay to the Holder $2,000.00 per day in cash, for each day beyond the Deadline
that the Borrower fails to deliver such Common Stock until the Borrower issues and delivers a certificate to the Holder or credit the
Holder&rsquo;s balance account with DTC for the number of shares of Common Stock to which the Holder is entitled upon such Holder&rsquo;s
conversion of any Conversion Amount (under Holder&rsquo;s and Borrower&rsquo;s expectation that any damages will tack back to the Issue
Date). Such cash amount shall be paid to Holder by the fifth day of the month following the month in which it has accrued or, at the option
of the Holder (by written notice to the Borrower by the first day of the month following the month in which it has accrued), shall be
added to the principal amount of this Note, in which event interest shall accrue thereon in accordance with the terms of this Note and
such additional principal amount shall be convertible into Common Stock in accordance with the terms of this Note. The Borrower agrees
that the right to convert is a valuable right to the Holder. The damages resulting from a failure, attempt to frustrate, interference
with such conversion right are difficult if not impossible to qualify. Accordingly, the parties acknowledge that the liquidated damages
provision contained in this <U>Section 1.4(f)</U> are justified.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(g)&nbsp;<U>Rescindment
of a Notice of Conversion</U>. If (i) the Borrower fails to respond to Holder within one (1) business day from the Conversion Date
confirming the details of Notice of Conversion, (ii) the Borrower fails to provide any of the shares of the Borrower&rsquo;s Common
Stock requested in the Notice of Conversion within one (1) business day from the date of receipt of the Note of Conversion, (iii)
the Holder is unable to procure a legal opinion required to have the shares of the Borrower&rsquo;s Common Stock issued unrestricted
and/or deposited to sell for any reason related to the Borrower&rsquo;s standing, (iv) the Holder is unable to deposit the shares of
the Borrower&rsquo;s Common Stock requested in the Notice of Conversion for any reason related to the Borrower&rsquo;s standing, (v)
at any time after a missed Deadline, at the Holder&rsquo;s sole discretion, or (vi) if there is a trading restriction on the Common
Stock on the day of or any day after the Conversion Date, the Holder maintains the option and sole discretion to rescind the Notice
of Conversion with a &ldquo;Notice of Rescindment.&rdquo;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">1.5&nbsp;<U>Concerning
the Shares</U>. Until such time as the shares of Common Stock issuable upon conversion of this Note have been registered under the 1933
Act or otherwise may be sold pursuant to Rule 144 without any restriction as to the number of securities as of a particular date that
can then be immediately sold, each certificate for shares of Common Stock issuable upon conversion of this Note that has not been so included
in an effective registration statement or that has not been sold pursuant to an effective registration statement or an exemption that
permits removal of the legend, shall bear a legend substantially in the following form, as appropriate:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><B>&ldquo;NEITHER
THE ISSUANCE OR SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE
ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN
OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT
REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE
SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE
SECURITIES.&rdquo;</B></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The legend
set forth above shall be removed and the Borrower shall issue to the Holder a new certificate therefore free of any transfer legend if
(i) the Borrower or its transfer agent shall have received an opinion of counsel, in form, substance and scope customary for opinions
of counsel in comparable transactions, to the effect that a public sale or transfer of such Common Stock may be made without registration
under the 1933 Act, which opinion shall be reasonably accepted by the Company so that the sale or transfer is effected or (ii) in the
case of the Common Stock issuable upon conversion of this Note, such security is registered for sale by the Holder under an effective
registration statement filed under the 1933 Act or otherwise may be sold pursuant to Rule 144 without any restriction as to the number
of securities as of a particular date that can then be immediately sold. In the event that the Company does not accept the opinion of
counsel provided by the Holder with respect to the transfer of securities pursuant to an exemption from registration, such as Rule 144
or Regulation S, at the Deadline, and the does not provide a suitable replacement opinion to the Holder within two (2) business days,
it will be considered an Event of Default pursuant to <U>Section 3.2</U> of the Note.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> 1.6 <U>Effect of Certain Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(a)&nbsp;<U>Effect
of Merger, Consolidation, Etc</U>. At the option of the Holder, the sale, conveyance or disposition of all or substantially all of the
assets of the Borrower, the effectuation by the Borrower of a transaction or series of related transactions in which more than 50% of
the voting power of the Borrower is disposed of, or the consolidation, merger or other business combination of the Borrower with or into
any other Person (as defined below) or Persons when the Borrower is not the survivor shall either: (i) be deemed to be an Event of Default
(as defined in <U>Article III</U>) pursuant to which the Borrower shall be required to pay to the Holder upon the consummation of and
as a condition to such transaction an amount equal to the Default Amount (as defined in <U>Article III</U>) or (ii) be treated pursuant
to <U>Section 1.6(b)</U> hereof. &ldquo;<U>Person</U>&rdquo; shall mean any individual, corporation, limited liability company, partnership,
association, trust or other entity or organization.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(b)&nbsp;<U>Adjustment
Due to Merger, Consolidation, Etc</U>. If, at any time when this Note is issued and outstanding and prior to conversion of all of
the Notes, there shall be any merger, consolidation, exchange of shares, recapitalization, reorganization, or other similar event,
as a result of which shares of Common Stock of the Borrower shall be changed into the same or a different number of shares of
another class or classes of stock or securities of the Borrower or another entity, or in case of any sale or conveyance of all or
substantially all of the assets of the Borrower other than in connection with a plan of complete liquidation of the Borrower, then
the Holder of this Note shall thereafter have the right to receive upon conversion of this Note, upon the basis and upon the terms
and conditions specified herein and in lieu of the shares of Common Stock immediately theretofore issuable upon conversion, such
stock, securities or assets which the Holder would have been entitled to receive in such transaction had this Note been converted in
full immediately prior to such transaction (without regard to any limitations on conversion set forth herein), and in any such case
appropriate provisions shall be made with respect to the rights and interests of the Holder of this Note to the end that the
provisions hereof (including, without limitation, provisions for adjustment of the Conversion Price and of the number of shares
issuable upon conversion of the Note) shall thereafter be applicable, as nearly as may be practicable in relation to any securities
or assets thereafter deliverable upon the conversion hereof. The Borrower shall not affect any transaction described in this <U>Section
1.6(b)</U> unless (a) it first gives, to the extent practicable, thirty (30) days prior written notice (but in any event at least
fifteen (15) days prior written notice) of the record date of the special meeting of shareholders to approve, or if there is no such
record date, the consummation of, such merger, consolidation, exchange of shares, recapitalization, reorganization or other similar
event or sale of assets (during which time the Holder shall be entitled to convert this Note) and (b) the resulting successor or
acquiring entity (if not the Borrower) assumes by written instrument the obligations of this <U>Section 1.6(b)</U>. The above
provisions shall similarly apply to successive consolidations, mergers, sales, transfers or share exchanges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(c)&nbsp;<U>Adjustment
Due to Distribution</U>. If the Borrower shall declare or make any distribution of its assets (or rights to acquire its assets) to holders
of Common Stock as a dividend, stock repurchase, by way of return of capital or otherwise (including any dividend or distribution to the
Borrower&rsquo;s shareholders in cash or shares (or rights to acquire shares) of capital stock of a subsidiary (i.e., a spin-off)) (a
&ldquo;<U>Distribution</U>&rdquo;), then the Holder of this Note shall be entitled, upon any conversion of this Note after the date of
record for determining shareholders entitled to such Distribution, to receive the amount of such assets which would have been payable
to the Holder with respect to the shares of Common Stock issuable upon such conversion had such Holder been the holder of such shares
of Common Stock on the record date for the determination of shareholders entitled to such Distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(d)&nbsp;<U>Adjustment
Due to Dilutive Issuance</U>. If, at any time when this Note is issued and outstanding, the Borrower issues or sells, or in accordance
with this <U>Section 1.6(d)</U> hereof is deemed to have issued or sold, any shares of Common Stock for no consideration or for a consideration
per share less than the Conversion Price in effect on the date of such issuance (or deemed issuance) of such shares of Common Stock (a
&ldquo;<U>Dilutive Issuance</U>&rdquo;), then immediately upon the Dilutive Issuance, the Conversion Price will be reduced to the amount
of the consideration per share received by the Borrower in such Dilutive Issuance, subject to the Holder&rsquo;s other rights under <U>Section
1.2</U> to select its Conversion Price.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Borrower
shall be deemed to have issued or sold shares of Common Stock if the Borrower in any manner issues or grants any warrants, rights or options
(not including employee stock option plans), whether or not immediately exercisable, to subscribe for or to purchase Common Stock or other
securities convertible into or exchangeable for Common Stock (&ldquo;<U>Convertible Securities</U>&rdquo;) (such warrants, rights and
options to purchase Common Stock or Convertible Securities are hereinafter referred to as &ldquo;<U>Options</U>&rdquo;) and the price
per share for which Common Stock is issuable upon the exercise of such Options is less than the Conversion Price then in effect, then
the Conversion Price shall be equal to such price per share. For purposes of the preceding sentence, the &ldquo;price per share for which
Common Stock is issuable upon the exercise of such Options&rdquo; is determined by dividing (i) the total amount, if any, received or
receivable by the Borrower as consideration for the issuance or granting of all such Options, plus the minimum aggregate amount of additional
consideration, if any, payable to the Borrower upon the exercise of all such Options, plus, in the case of Convertible Securities issuable
upon the exercise of such Options, the minimum aggregate amount of additional consideration payable upon the conversion or exchange thereof
at the time such Convertible Securities first become convertible or exchangeable, by (ii) the maximum total number of shares of Common
Stock issuable upon the exercise of all such Options (assuming full conversion of Convertible Securities, if applicable). No further adjustment
to the Conversion Price will be made upon the actual issuance of such Common Stock upon the exercise of such Options or upon the conversion
or exchange of Convertible Securities issuable upon exercise of such Options.</P>




<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Additionally,
the Borrower shall be deemed to have issued or sold shares of Common Stock if the Borrower in any manner issues or sells any Convertible
Securities, whether or not immediately convertible (other than where the same are issuable upon the exercise of Options), and the price
per share for which Common Stock is issuable upon such conversion or exchange is less than the Conversion Price then in effect, then the
Conversion Price shall be equal to such price per share. For the purposes of the preceding sentence, the &ldquo;price per share for which
Common Stock is issuable upon such conversion or exchange&rdquo; is determined by dividing (i) the total amount, if any, received or receivable
by the Borrower as consideration for the issuance or sale of all such Convertible Securities, plus the minimum aggregate amount of additional
consideration, if any, payable to the Borrower upon the conversion or exchange thereof at the time such Convertible Securities first become
convertible or exchangeable, by (ii) the maximum total number of shares of Common Stock issuable upon the conversion or exchange of all
such Convertible Securities. No further adjustment to the Conversion Price will be made upon the actual issuance of such Common Stock
upon conversion or exchange of such Convertible Securities.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">For the avoidance
of doubt, notwithstanding any other terms of this Note, if, at any time when this Note is issued and outstanding, the Borrower issues
or sells any shares of Common Stock under an &ldquo;equity line&rdquo; common stock purchase agreement, or other agreement similar in
function thereto, with the Borrower or other investor, for a purchase price per share less than the Conversion Price in effect on the
date of such issuance of such shares of Common Stock, then such issuance shall constitute a Dilutive Issuance and the Conversion Price
will be reduced to the amount of the purchase price per share received by the Borrower in such Dilutive Issuance, subject to the Holder&rsquo;s
other rights under <U>Section 1.2</U> to select its Conversion Price.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(e)&nbsp;<U>Purchase
Rights</U>. If, at any time when any Notes are issued and outstanding, the Borrower issues any Convertible Securities or rights to purchase
stock, warrants, securities or other property (the &ldquo;<U>Purchase Rights</U>&rdquo;) pro rata to the record holders of any class of
Common Stock, then the Holder of this Note will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate
Purchase Rights which such Holder could have acquired if such Holder had held the number of shares of Common Stock acquirable upon complete
conversion of this Note (without regard to any limitations on conversion contained herein) immediately before the date on which a record
is taken for the grant, issuance or sale of such Purchase Rights or, if no such record is taken, the date as of which the record holders
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(f)&nbsp;<U>Notice
of Adjustments</U>. Upon the occurrence of each adjustment or readjustment of the Conversion Price as a result of the events described
in this <U>Section 1.6</U>, or under <U>Section 1.2</U> (regarding stock splits, combinations, etc.), the Borrower, at its expense, shall
promptly compute such adjustment or readjustment and prepare and furnish to the Holder a certificate setting forth such adjustment or
readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Borrower shall, upon the written
request at any time of the Holder, furnish to such Holder a like certificate setting forth (i) such adjustment or readjustment, (ii) the
Conversion Price at the time in effect and (iii) the number of shares of Common Stock and the amount, if any, of other securities or property
which at the time would be received upon conversion of the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">1.7&nbsp;<U>Trading
Market Limitations</U>. Unless permitted by the applicable rules and regulations of the principal securities market on which the
Common Stock is then quoted, listed or traded, in no event shall the Borrower issue upon conversion of or otherwise pursuant to this
Note more than the maximum number of shares of Common Stock that the Borrower can issue pursuant to any rule of the principal United
States securities market on which the Common Stock is then traded (the &ldquo;<U>Maximum Share Amount</U>&rdquo;), subject to
equitable adjustment from time to time for stock splits, stock dividends, combinations, capital reorganizations and similar events
relating to the Common Stock occurring after the Issue Date. Once the Maximum Share Amount has been issued, if the Borrower fails to
eliminate any prohibitions under applicable law or the rules or regulations of any stock exchange, interdealer quotation system or
other self- regulatory organization with jurisdiction over the Borrower or any of its securities on the Borrower&rsquo;s ability to
issue shares of Common Stock in excess of the Maximum Share Amount, in lieu of any further right to convert this Note, this will be
considered an Event of Default under <U>Section 3.2</U> of the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">1.8&nbsp;<U>Status
as Shareholder</U>. Upon submission of a Notice of Conversion by a Holder, (i) the shares covered thereby (other than the shares, if any,
which cannot be issued because their issuance would exceed such Holder&rsquo;s allocated portion of the Reserved Amount or Maximum Share
Amount) shall be deemed converted into shares of Common Stock and (ii) the Holder&rsquo;s rights as a Holder of such converted portion
of this Note shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies
provided herein or otherwise available at law or in equity to such Holder because of a failure by the Borrower to comply with the terms
of this Note. Notwithstanding the foregoing, if a Holder has not received certificates or transmission of such shares pursuant to <U>Section
1.4(e)</U> for all shares of Common Stock prior to the tenth (10th) business day after the expiration of the Deadline with respect to
a conversion of any portion of this Note for any reason, then (unless the Holder otherwise elects to retain its status as a holder of
Common Stock by so notifying the Borrower) the Holder shall regain the rights of a Holder of this Note with respect to such unconverted
portions of this Note and the Borrower shall, as soon as practicable, return such unconverted Note to the Holder or, if this Note has
not been surrendered, adjust its records to reflect that such portion of this Note has not been converted. In all cases, the Holder shall
retain all of its rights and remedies (including, without limitation, (i) the right to receive Conversion default payments pursuant to
<U>Section 1.3</U> to the extent required thereby for such Conversion default and any subsequent Conversion default and (ii) the right
to have the Conversion Price with respect to subsequent conversions determined in accordance with <U>Section 1.2</U>) for the Borrower&rsquo;s
failure to convert this Note.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">1.9&nbsp;<U>Prepayment</U>.
Notwithstanding anything to the contrary contained in this Note, the Borrower may not prepay the amounts outstanding hereunder without
first obtaining the written consent of the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">ARTICLE II</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">CERTAIN COVENANTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">2.1&nbsp;<U>Section
3(a)(9) or 3(a)(10) Transaction</U>. So long as this Note is outstanding, the Borrower shall not enter into any transaction or arrangement
structured in accordance with, based upon, or related or pursuant to, in whole or in part, either Section 3(a)(9) of the 1933 Act (a &ldquo;<U>3(a)(9)
Transaction</U>&rdquo;) or Section 3(a)(10) of the 1933 Act (a &ldquo;<U>3(a)(10) Transaction</U>&rdquo;). In the event that the Borrower
does enter into, or makes any issuance of Common Stock related to a 3(a)(9) Transaction or a 3(a)(10) Transaction while this Note is outstanding,
a liquidated damages charge of 25% of the outstanding principal balance of this Note, but not less than Fifteen Thousand Dollars ($15,000.00),
will be assessed and will become immediately due and payable to the Holder at its election in the form of cash payment or addition to
the balance of this Note.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">2.2&nbsp;<U>Preservation
of Existence, etc.</U> The Borrower shall maintain and preserve, and cause each of its subsidiaries to maintain and preserve, its existence,
rights and privileges, and become or remain, and cause each of its subsidiaries to become or remain, duly qualified and in good standing
in each jurisdiction in which the character of the properties owned or leased by it or in which the transaction of its business makes
such qualification necessary.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">2.3&nbsp;<U>Non-circumvention</U>.
The Borrower hereby covenants and agrees that the Borrower will not, by amendment of its Certificate of Incorporation or Bylaws, or
through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of
securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Note,
and will at all times in good faith carry out all the provisions of this Note and take all action as may be required to protect the
rights of the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">2.4&nbsp;<U>Piggyback
Registration Rights</U>. The Company shall include on any registration statement or offering statement filed with the SEC, all shares
of Common Stock issuable and issued pursuant to the exercise of this Note. In addition to all other remedies at law or in equity or otherwise
in connection with any breaches under this Note or the other Transaction Documents, failure to do so in compliance with this <U>Section
2.4</U> will result in liquidated damages of $400,000, being immediately due and payable to the Holder at its election in the form of
cash payment.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">2.5&nbsp;<U>Legal
Opinions</U>. If the Holder provides the Company (which shall be at the cost of the Company), with (i) an opinion of counsel in form,
substance and scope customary for opinions in comparable transactions, to the effect that a public sale or transfer of the shares may
be made without registration under the 1933 Act and such sale or transfer is effected or (ii) the Holder provides reasonable assurances
that the Shares can be sold pursuant to Rule 144, the Company shall permit the transfer, and, in the case of the Shares, promptly instruct
its transfer agent to issue one or more certificates, free from restrictive legend, in such name and in such denominations as specified
by the Holder or, in the sole discretion of the Holder, the Company shall take all action necessary to ensure that such Shares are transferred
electronically as DWAC shares. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to
the Holder, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly, the Company acknowledges that the
remedy at law for a breach of its obligations under this Section may be inadequate and agrees, in the event of a breach or threatened
breach by the Company of the provisions of this Section, that the Holder shall be entitled, in addition to all other available remedies
(including without limitation consequential damages), to an injunction restraining any breach and requiring immediate transfer, without
the necessity of showing economic loss and without any bond or other security being required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">ARTICLE III</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">EVENTS OF
DEFAULT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">The occurrence
of any of the following shall each constitute an &ldquo;<U>Event of Default</U>&rdquo; with no right to notice or the right to cure except
as specifically stated:</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.1&nbsp;<U>Failure
to Pay Principal or Interest</U>. The Borrower fails to pay the principal hereof or interest thereon when due on this Note, whether at
the Maturity Date, or upon any granted optional prepayment date, upon acceleration or otherwise.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.2&nbsp;<U>Conversion
and the Shares</U>. The Borrower fails to issue shares of Common Stock to the Holder (or announces or threatens in writing that it
will not honor its obligation to do so) upon exercise by the Holder of the Conversion rights of the Holder in accordance with the
terms of this Note, fails to transfer or cause its transfer agent to transfer (issue) (electronically or in certificated form) any
certificate for shares of Common Stock issued to the Holder upon conversion of or otherwise pursuant to this Note as and when
required by this Note, the Borrower directs its transfer agent not to transfer or delays, impairs, and/or hinders its transfer agent
in transferring (or issuing) (electronically or in certificated form) any certificate for shares of Common Stock to be issued to the
Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note, or fails to remove (or directs its
transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from removing) any restrictive legend (or to
withdraw any stop transfer instructions in respect thereof) on any certificate for any shares of Common Stock issued to the Holder
upon conversion of or otherwise pursuant to this Note as and when required by this Note (or makes any written announcement,
statement or threat that it does not intend to honor the obligations described in this paragraph) and any such failure shall
continue uncured (or any written announcement, statement or threat not to honor its obligations shall not be rescinded in writing)
for two (2) business days after the Holder shall have delivered a Notice of Conversion. It is an obligation of the Borrower to
remain current in its obligations to its transfer agent. It shall be an &ldquo;Event of Default&rdquo; of this Note, if a conversion
of this Note is delayed, hindered or frustrated due to a balance owed by the Borrower to its transfer agent. If at the option of the
Holder, the Holder advances any funds to the Borrower&rsquo;s transfer agent in order to process a conversion, such advanced funds
shall be paid by the Borrower to the Holder within forty-eight (48) hours of a demand from the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.3&nbsp;<U>Breach
of Agreement</U>. The Borrower breaches any covenant or other term or condition contained in this Note or in any of the Transaction Documents,
including but not limited to the Purchase Agreement.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.4&nbsp;<U>Breach
of Representations and Warranties</U>. Any representation or warranty of the Borrower made herein or in any agreement, statement or certificate
given in writing pursuant hereto or in connection herewith (including, without limitation, the Purchase Agreement), shall be false or
misleading in any material respect when made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.5&nbsp;R<U>eceiver
or Trustee</U>. The Company or any subsidiary of the Company shall make an assignment for the benefit of creditors, or apply for or consent
to the appointment of a receiver or trustee for it or for a substantial part of its property or business, or such a receiver or trustee
shall otherwise be appointed.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.6&nbsp;<U>Judgments</U>.
Except with respect to the $500,000 claim filed by Benjamin Securities, Inc. prior to the Issue Date, if any money judgment, writ or similar
process shall be entered or filed against the Borrower or any subsidiary of the Borrower or any of its property or other assets for more
than $50,000.00, and shall remain unvacated, unbonded or unstayed for a period of twenty (20) days unless otherwise consented to by the
Holder, which consent will not be unreasonably withheld.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.7&nbsp;<U>Bankruptcy;
Liquidation</U>. (i) Bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings, voluntary or involuntary,
for relief under any bankruptcy law or any law for the relief of debtors shall be instituted by or against the Company or any subsidiary
of the Company or the Borrower admits in writing its inability to pay its debts generally as they mature, or have filed against it an
involuntary petition for bankruptcy; or (ii) any dissolution, liquidation, or winding up of Borrower or any substantial portion of its
business occurs.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.8&nbsp;<U>Delisting
of Common Stock</U>. The Borrower shall fail to maintain the listing of the Common Stock on the NASDAQ stock market.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.9&nbsp;<U>Failure
to Comply with the Exchange Act</U>. The Borrower shall fail to timely comply with the reporting requirements of the 1934 Act (including
but not limited to becoming delinquent in its filings); and/or the Borrower shall cease to be subject to the reporting requirements of
the Exchange Act; and/or the Borrower shall not have publicly available all information required by paragraph (b) of Rule 15c2-11 of the
Exchange Act (as effective on September 26, 2021), as amended, such that brokers or dealers attempting to publish any quotation for the
Common Stock or, directly or indirectly, to submit any such quotation for publication, shall be able to comply with Rule 15c2-11(a).</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.10&nbsp;<U>DTC</U>.
In the event that the Company (i) loses its ability to deliver shares via &ldquo;DWAC/FAST&rdquo; electronic transfer, or (ii) loses its
stats as &ldquo;DTC Eligible.&rdquo;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.11&nbsp;<U>Cessation
of Operations</U>. Any cessation of operations by Borrower or Borrower admits it is otherwise generally unable to pay its debts as
such debts become due, provided, however, that any disclosure of the Borrower&rsquo;s ability to continue as a &ldquo;going
concern&rdquo; shall not be an admission that the Borrower cannot pay its debts as they become due.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.12&nbsp;<U>Maintenance
of Assets</U>. The failure by Borrower to maintain any material intellectual property rights, personal, real property or other assets
which are necessary to conduct its business (whether now or in the future) or any disposition or conveyance of any material asset of the
Borrower.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.13&nbsp;<U>Financial
Statement Restatement</U>. The restatement of any financial statements filed by the Borrower with the SEC for any date or period from
two years prior to the Issue Date of this Note and until this Note is no longer outstanding, if the result of such restatement would,
by comparison to the unrestated financial statement, have constituted a material adverse effect on the rights of the Holder with respect
to this Note or the Purchase Agreement.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> 3.14 <U>Reverse Splits</U>. The Borrower effectuates a reverse split of its Common Stock.</P>



<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.15&nbsp;<U>Replacement
of Transfer Agent</U>. In the event that the Borrower proposes to replace its transfer agent, the Borrower fails to provide, prior to
the effective date of such replacement, a fully executed Transfer Agent Instruction Letter in a form as initially delivered pursuant to
the Purchase Agreement (including but not limited to the provision to irrevocably reserve shares of Common Stock in the Reserved Amount)
signed by the successor transfer agent to Borrower and the Borrower.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.16&nbsp;<U>Cessation
of Trading</U>. Any cessation of trading of the Common Stock on the NASDAQ stock market, and such cessation of trading shall continue
for a period of five consecutive (5) Trading Days.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.17&nbsp;<U>Cross-Default</U>.
Notwithstanding anything to the contrary contained in this Note or the other related or companion documents, a breach, non-compliance,
or default by the Borrower of any covenant or other term or condition contained in any of the Other Agreements, shall, at the option of
the Holder, be considered a default under this Note and the Other Agreements, in which event the Holder shall be entitled (but in no event
required) to apply all rights and remedies of the Holder under the terms of this Note and the Other Agreements by reason of a default
under said Other Agreement or hereunder. &ldquo;<U>Other Agreements</U>&rdquo; means, collectively, all agreements and instruments between,
among or by: (1) the Borrower, and, or for the benefit of, (2) the Holder and any affiliate of the Holder. For the avoidance of doubt,
Other Agreements shall include, without limitation, the Purchase Agreement, that certain Common Stock Purchase Agreement &ldquo;equity
line&rdquo;, as amended, between the Holder and Borrower (&ldquo;<U>ELOC Agreement</U>&rdquo;), that certain Warrant to be issued pursuant
to the ELOC Agreement, and that certain Registration Rights Agreement between the Holder and the Borrower. Any loan transactions will
be cross-defaulted with each other loan transaction and with all other existing and future debt of Borrower to the Holder.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.18&nbsp;<U>Inside
Information</U>. Any attempt by the Borrower or its officers, directors, and/or affiliates to transmit, convey, disclose, or any actual
transmittal, conveyance, or disclosure by the Borrower or its officers, directors, and/or affiliates of, material non-public information
concerning the Borrower, to the Holder or its successors and assigns, which is not immediately cured by Borrower&rsquo;s filing of a Form
8-K pursuant to Regulation FD on that same date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">3.19&nbsp;<U>Unavailability
of Rule 144</U>. If, at any time on or after the Issue Date, the Holder is unable to (i) obtain a standard &ldquo;144 legal opinion letter&rdquo;
from an attorney reasonably acceptable to the Holder, the Holder&rsquo;s brokerage firm (and respective clearing firm), and the Borrower&rsquo;s
transfer agent in order to facilitate the Holder&rsquo;s conversion of any portion of the Note into free trading shares of the Borrower&rsquo;s
Common Stock pursuant to Rule 144, and (ii) thereupon deposit such shares into the Holder&rsquo;s brokerage account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>




<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Upon the occurrence
of any Event of Default specified above, exercisable through the delivery of written notice to the Borrower by such Holders (the &ldquo;<U>Default
Notice</U>&rdquo;) the Note shall become immediately due and payable and the Borrower shall pay to the Holder, in full satisfaction of
its obligations hereunder, an amount equal to (x) the then outstanding principal amount of this Note <U>plus</U> (y) accrued and unpaid
interest on the unpaid principal amount of this Note to the date of payment on the amounts referred to in clauses (x) and/or (y) <U>plus</U>
(z) any amounts owed to the Holder pursuant to <U>Sections 1.3</U> and <U>1.4(f)</U> hereof (the then outstanding principal amount of
this Note to the date of payment <U>plus</U> the amounts referred to in clauses (x), (y) and (z) shall collectively be known as the &ldquo;<U>Default
Amount</U>&rdquo;). Notwithstanding anything herein to the contrary, upon delivery by the Holder to the Borrower of a Default Notice (as
defined herein) setting forth the Event of Default under the Note, at the sole option of the Holder the Default Conversion Price (as defined
below) can be used by the Holder as the Conversion Price, at any time, and from time to time, thereafter while the Note remains outstanding.
The &ldquo;<U>Default Conversion Price</U>&rdquo; shall mean $0.01 per share.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Holder
shall have the right at any time, to require the Borrower to immediately issue, in lieu of the Default Amount, the number of shares of
Common Stock of the Borrower equal to the Default Amount divided by the Conversion Price then in effect, subject to the terms of this
Note. This requirement by the Borrower shall automatically apply upon the occurrence of an Event of Default without the need for any party
to give any notice or take any other action.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">If the Holder
shall commence an action or proceeding to enforce any provisions of this Note, including, without limitation, engaging an attorney, then
if the Holder prevails in such action, the Holder shall be reimbursed by the Borrower for its attorneys&rsquo; fees and other costs and
expenses incurred in the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ARTICLE
IV</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">4.1&nbsp;<U>Failure
or Indulgence Not Waiver</U>. No failure or delay on the part of the Holder in the exercise of any power, right or privilege hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further
exercise thereof or of any other right, power or privileges. All rights and remedies existing hereunder are cumulative to, and not exclusive
of, any rights or remedies otherwise available.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">4.2&nbsp;<U>Notices</U>.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be delivered as contemplated
by the notice provisions under <U>Section 9(g)</U> of the Purchase Agreement.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">4.3&nbsp;<U>Amendments</U>.
This Note and any provision hereof may only be amended by an instrument in writing signed by the Borrower and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">4.4&nbsp;<U>Assignability</U>.
This Note shall be binding upon the Borrower and its successors and assigns, and shall inure to the benefit of the Holder and its successors
and assigns. The Borrower shall not assign this Note or any rights or obligations hereunder without the prior written consent of the Holder.
Notwithstanding anything in this Note to the contrary, (i) this Note may be pledged as collateral in connection with a bonafide margin
account or other lending arrangement, and (ii) the Holder may assign this Note and any rights hereunder without the prior written consent
of the Borrower. The Holder and any assignee, by acceptance of this Note, acknowledge and agree that following conversion of a portion
of this Note, the unpaid and unconverted principal amount of this Note represented by this Note may be less than the amount stated on
the face hereof.</P>




<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">4.5&nbsp;<U>Cost
of Collection</U>. If default is made in the payment of this Note, the Borrower shall pay the Holder hereof reasonable costs of collection,
including reasonable attorneys&rsquo; fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">4.6&nbsp;<U>Governing
Law; Dispute Resolution</U>. This Note shall be governed by and interpreted in accordance with the laws of the State of New York
without regard to the principles of conflicts of law. THE COMPANY AND THE HOLDER HEREBY WAIVE A TRIAL BY JURY IN ANY ACTION,
PROCEEDING OR COUNTERCLAIM BROUGHT BY EITHER OF THE PARTIES HERETO AGAINST THE OTHER IN RESPECT OF ANY MATTER ARISING OUT OF OR IN
CONNECTION WITH THIS NOTE. Any dispute, controversy, difference or claim that may arise between the Company and the Holder in
connection with this Note; and all claims arising out of or relating to the validity, construction, interpretation, enforceability,
breach, performance, application or termination of this Note, shall be submitted to binding arbitration governed by the rules of the
American Arbitration Association. The seat of the arbitration shall be in the State and County of New York. There shall be only one
arbitrator selected in accordance with the rules of the American Arbitration Association. The arbitration shall be conducted in
English and may be conducted in a virtual setting. The arbitrator&rsquo;s decision shall be final and binding and judgment may be
entered thereon. Provided a party has made a sufficient showing under applicable law, the arbitrator shall have the freedom to
invoke, and the parties agree to abide by, injunctive measures that either party submits in writing for arbitration claims requiring
immediate relief. Additionally, nothing in this Section shall preclude either party from seeking equitable relief or interim or
provisional relief from a court of competent jurisdiction, including a temporary restraining order, preliminary injunction or other
equitable relief, concerning a dispute either prior to or during arbitration if necessary to protect the interests of such party or
to preserve the status quo pending the arbitration proceeding. Each side must bear its own costs and legal fees during the pendency
of the arbitration. A party&rsquo;s failure to pay any costs or fees required to proceed in the arbitration, as they timely come
due, shall result in an immediate default against that party. The prevailing party in the arbitration shall be entitled to recoup
all its reasonable attorneys&rsquo; fees and costs from the nonprevailing, including, without limitation, all of its costs relating
to the arbitration. The arbitrator&rsquo;s final award shall include this assessment of costs and fees.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">4.7&nbsp;<U>Certain
Amounts</U>. Whenever pursuant to this Note the Borrower is required to pay an amount in excess of the outstanding principal amount (or
the portion thereof required to be paid at that time) plus accrued and unpaid interest, the Borrower and the Holder agree that the actual
damages to the Holder from the receipt of cash payment on this Note may be difficult to determine and the amount to be so paid by the
Borrower represents stipulated damages and not a penalty.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">4.8&nbsp;<U>Purchase
Agreement</U>. By its acceptance of this Note, each party agrees to be bound by the applicable terms of the Purchase Agreement.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">4.9&nbsp;<U>Notice
of Corporate Events</U>. Except as otherwise provided in this Note, the Holder of this Note shall have no rights as a Holder of
Common Stock unless and only to the extent that it converts this Note into Common Stock. The Borrower shall provide the Holder with
prior notification of any meeting of the Borrower&rsquo;s shareholders (and copies of proxy materials and other information sent to
shareholders). In the event of any taking by the Borrower of a record of its shareholders for the purpose of determining
shareholders who are entitled to receive payment of any dividend or other distribution, any right to subscribe for, purchase or
otherwise acquire (including by way of merger, consolidation, reclassification or recapitalization) any share of any class or any
other securities or property, or to receive any other right, or for the purpose of determining shareholders who are entitled to vote
in connection with any proposed sale, lease or conveyance of all or substantially all of the assets of the Borrower or any proposed
liquidation, dissolution or winding up of the Borrower, the Borrower shall mail a notice to the Holder, at least twenty (20) days
prior to the record date specified therein (or thirty (30) days prior to the consummation of the transaction or event, whichever is
earlier), of the date on which any such record is to be taken for the purpose of such dividend, distribution, right or other event,
and a brief statement regarding the amount and character of such dividend, distribution, right or other event to the extent known at
such time. The Borrower shall make a public announcement of any event requiring notification to the Holder hereunder substantially
simultaneously with the notification to the Holder in accordance with the terms of this <U>Section 4.9</U> including, but not
limited to, name changes, recapitalizations, etc. as soon as possible under law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">4.10&nbsp;<U>Usury</U>.
If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the
applicable provision shall automatically be revised to equal the maximum rate of interest or other amount deemed interest permitted under
applicable law. The Borrower covenants (to the extent that it may lawfully do so) that it will not seek to claim or take advantage of
any usury law that would prohibit or forgive the Borrower from paying all or a portion of the principal or interest on this Note.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">4.11&nbsp;<U>Remedies</U>.
The Borrower acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder, by vitiating the
intent and purpose of the transaction contemplated hereby. Accordingly, the Borrower acknowledges that the remedy at law for a breach
of its obligations under this Note will be inadequate and agrees, in the event of a breach or threatened breach by the Borrower of the
provisions of this Note, that the Holder shall be entitled, in addition to all other available remedies at law or in equity, and in addition
to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach of this Note and to enforce
specifically the terms and provisions thereof, without the necessity of showing economic loss and without any bond or other security being
required. No provision of this Note shall alter or impair the obligation of the Borrower, which is absolute and unconditional, to pay
the principal of, and interest on, this Note at the time, place, and rate, and in the form, herein prescribed.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">4.12&nbsp;<U>Severability</U>.
In the event that any provision of this Note is invalid or unenforceable under any applicable statute or rule of law, then such provision
shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or
rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect the validity or enforceability
of any other provision hereof.</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">4.13&nbsp;<U>Terms
of Future Financings.</U> So long as this Note is outstanding, upon any issuance by the Borrower or any of its Subsidiaries of any security
with any term more favorable to the holder of such security or with a term (including without limitation any Conversion Price) in favor
of the holder of such security that was not similarly provided to the Holder in this Note (other than a future financing with the Holder),
then the Borrower shall notify the Holder of such additional or more favorable term and such term, at Holder&rsquo;s option, shall become
a part of the Transaction Documents with the Holder. The types of terms contained in another security that may be more favorable to the
holder of such security include, but are not limited to, terms addressing conversion discounts, prepayment rate, conversion lookback periods,
interest rates, original issue discounts, stock sale price, private placement price per share, and warrant coverage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>*** signature page follows
***</I></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">IN WITNESS
WHEREOF, Borrower has caused this Note to be signed in its name by its duly authorized officer as of the Issue Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>




<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>COMPANY:</U></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OSR Holdings,
    Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Kuk Hyoun
    Hwang</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kuk Hyoun Hwang</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Acknowledged and Accepted by:</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>HOLDER:</U></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>White Lion
    Capital, LLC, dba White Lion GBM Innovation Fund</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Yash Thukral</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yash Thukral</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>EXHIBIT A</U></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">NOTICE OF CONVERSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The
undersigned hereby elects to convert $<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
principal amount of the Note (defined below) together with $<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> of accrued and unpaid interest thereto, totaling
$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </U> into that number of shares of Common
Stock to be issued pursuant to the conversion of the Note (&ldquo;Common Stock&rdquo;) as set forth below, of OSR Holdings, Inc., a
Delaware corporation (the &ldquo;Borrower&rdquo;), according to the conditions of the senior secured convertible note of the
Borrower dated as of <B>May 6, 2025 </B>(the &ldquo;Note&rdquo;), as of the date written below. No fee will be charged to the Holder
for any conversion, except for transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Box Checked as to applicable instructions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify">The Borrower shall electronically transmit the Common Stock
issuable pursuant to this Notice of Conversion to the account of the undersigned or its nominee with DTC through its Deposit Withdrawal
At Custodian system (&ldquo;DWAC Transfer&rdquo;).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Name of DTC Prime Broker: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Account
Number: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify">The undersigned hereby requests that the Borrower issue
a certificate or certificates for the number of shares of Common Stock set forth below (which numbers are based on the Holder&rsquo;s
calculation attached hereto) in the name(s) specified immediately below or, if additional space is necessary, on an attachment hereto:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Name: <U>[NAME]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Address: <U>[ADDRESS]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Date of Conversion: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Applicable Conversion Price: $<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Number of Shares of Common Stock to be Issued</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Pursuant
to Conversion of the Notes: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Amount of Principal Balance Due remaining</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Under the Note after this conversion:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Accrued and unpaid interest remaining: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">[HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">By: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Name: <U>[NAME]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Title: <U>[TITLE]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Date: <U>[DATE]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ea024172601ex10-3_osrhold.htm
<DESCRIPTION>COMMON STOCK PURCHASE WARRANT, ISSUED MAY 6, 2025, BY OSR HOLDINGS, INC TO WHITE LION CAPITAL, LLC
<TEXT>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><b>Exhibit 10.3</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES
FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF
ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 177.5pt; text-indent: -53.05pt">COMMON STOCK PURCHASE
WARRANT OSR HOLDINGS, INC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 50%; text-align: left">Warrant Shares: $4,000,000</td><td style="text-align: right; width: 50%">Initial Exercise Date: May 6,
2025</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 35.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; text-indent: 35.95pt">THIS COMMON STOCK PURCHASE WARRANT
(the &ldquo;<u>Warrant</u>&rdquo;) certifies that, for value received, <b>WHITE LION CAPITAL, LLC, DBA WHITE LION GBM INNOVATION
FUND</b> or its assigns (the &ldquo;<u>Holder</u>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and
the conditions hereinafter set forth, at any time on or after the date hereof (the &ldquo;<u>Initial Exercise Date</u>&rdquo;) and
until the earlier of the fifth (5<sup>th</sup>) anniversary of the Initial Exercise Date or until this Warrant is exercised in full
(the &ldquo;<u>Termination Date</u>&rdquo;) but not thereafter, to subscribe for and purchase from <b>OSR HOLDINGS, INC.</b>, a
Delaware corporation (the &ldquo;<u>Company</u>&rdquo;), up to the Available Share Amount (as subject to adjustment hereunder, the
&ldquo;<u>Warrant Shares</u>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in <u>Section 2(b)</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><font style="font-size: 10pt"><u>Section
1.</u></font><u> Definitions</u>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this <u>Section 1</u>:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&ldquo;<u>Affiliate</u>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&ldquo;<u>Available
Share Amount</u>&rdquo; means up to $4,000,000 of shares of Common Stock, meaning that this Warrant shall be exercisable for up to
such number of shares of Common Stock equal to $4,000,000 in the aggregate with Warrant Shares valued upon each exercise hereunder
(as such amount of shares may be adjusted from time to time in accordance with the provisions of this Warrant, and as with respect
to changes in the Exercise Price). By way of example, the Holder shall have the right to purchase up to 800,000 shares of Common
Stock if the Exercise Price is $5.00 per share on any given day and no exercises have been executed, but if the Exercise Price is
$4.00 per share on the following day, the Holder would have the right to purchase up to 1,000,000 shares of Common Stock as of such
day if no exercise had been previously executed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&ldquo;<u>Bid
Price</u>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common
Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a
Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the
fees and expenses of which shall be paid by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&ldquo;<u>Business
Day</u>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of Los Angeles, California
are authorized or required by law to remain closed&#894; <u>provided</u>, <u>however</u>, for clarification, commercial banks shall not
be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential
employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental
authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York
generally are open for use by customers on such day.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 22.1pt; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&ldquo;<u>Commission</u>&rdquo;
means the United States Securities and Exchange Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&ldquo;<u>Common
Stock</u>&rdquo; means the Common Stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&ldquo;<u>Common
Stock Equivalents</u>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&ldquo;<u>Exchange
Act</u>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&ldquo;<u>Person</u>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&ldquo;<u>Securities
Act</u>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&ldquo;<u>Subsidiary</u>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in">&ldquo;<u>Trading Day</u>&rdquo; means a day on which the Common
Stock is traded on a Trading Market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&ldquo;<u>Trading
Market</u>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock
Exchange (or any successors to any of the foregoing).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&ldquo;<u>Transfer
Agent</u>&rdquo; means the transfer agent of the Company as of the Initial Exercise Date, or such other Person who is then serving as
the transfer agent for the Company in respect of the Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&ldquo;<u>VWAP</u>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the
reasonable and documented fees and expenses of which shall be paid by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in">&ldquo;<u>Warrant</u>&rdquo; means this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><u>Section 2.</u>&#9;<u>Exercise.</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(a)&nbsp;
Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the
Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed copy submitted by e-mail
(or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<u>Notice of Exercise</u>&rdquo;). Within
the earlier of (i) one (1) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in <u>Section
2(d)(i)</u> herein) following the date of exercise as aforesaid, the Holder shall deliver to the Company the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a
United States bank unless the cashless exercise procedure specified in <u>Section 2(c)</u> below is specified in the applicable
Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of
guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall
not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares
available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the
Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the
Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available
hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the
applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. With respect to any Notice(s) of Exercise delivered on or prior to 8:00 p.m. (New
York City time) on the business day prior to the Initial Exercise Date the Company agrees to deliver the Warrant Shares subject to
such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant
Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a
cashless exercise) is received by such Warrant Share Delivery Date. <b>The Holder and any assignee, by acceptance of this Warrant,
acknowledge and agree that, by reason of the provisions of this <u>Section 2(a)</u>, following the purchase of a portion of the
Warrant Shares hereunder, the Available Share Amount of Warrant Shares available for purchase hereunder at any given time may be
less than the Available Share Amount stated set forth above.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt"><b>&nbsp;</b></p>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(b) <u>Exercise
Price</u>. The exercise price per Warrant Share under this Warrant shall be $1.584<sup>1</sup>, subject to adjustment hereunder (the
&ldquo;<u>Exercise Price</u>&rdquo;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(c)&nbsp;<u>Cashless
Exercise</u>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B)*(X)] by (A), where:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(A) = the highest
traded price of the common stock the thirty days prior to the applicable Notice of Exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in">(B) = the Exercise Price of this Warrant, as adjusted hereunder;
and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(X) = the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">If Warrant Shares are issued in such
a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares
shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position contrary to
this <u>Section 2(c)</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-indent: -0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(d)
<u>Mechanics of Exercise</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">(i)&nbsp;<u>Delivery
of Warrant Shares Upon Exercise</u>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system if the Company&rsquo;s transfer agent is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered
in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<u>Warrant Share Delivery Date</u>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the
number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, $1,000 per Trading Day for each Trading Day after such
Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain
a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein,
&ldquo;<u>Standard Settlement Period</u>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the
Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><sup>&nbsp;</sup></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><sup></sup></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><sup>1</sup></td><td style="text-align: justify">Equal to 120% of the closing price on the Initial Exercise Date.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">(ii)&nbsp;<u>Delivery
of New Warrants Upon Exercise</u>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">(iii)&nbsp;<u>Rescission
Rights</u>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <u>Section 2(d)(i)</u>
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering written notice to the Company
at any time prior to the delivery of such Warrant Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">(iv)&nbsp;<u>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</u>. In addition to any other rights available to the Holder,
if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of <u>Section
2(d)(i)</u> above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely
due to any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases for the
Holder shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated
receiving upon such exercise (a &ldquo;<u>Buy-In</u>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if
any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock
so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to
deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such
purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent
number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver
to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and
delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover
a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase
obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder
$1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In
and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the
Warrant as required pursuant to the terms hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">(v)&nbsp;<u>No
Fractional Shares or Scrip</u>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">(vi)&nbsp;<u>Charges,
Taxes and Expenses</u>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder&#894; <u>provided</u>,
<u>however</u>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 107.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt"></p>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 107.95pt">(vii)&nbsp;<u>Closing
of Books</u>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 107.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(e)&nbsp;<u>Holder&rsquo;s
Exercise Limitations</u>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to <u>Section 2</u> or otherwise, to the extent that after giving effect to such issuance after
exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons
acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<u>Attribution Parties</u>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this <u>Section 2(e)</u>, beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this <u>Section 2(e)</u> applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination and shall have no liability for exercises
of this Warrant that are not in compliance with the Beneficial Ownership Limitation, provided this limitation of liability shall not apply
if the Holder has detrimentally relied on outstanding share information provided by the Company or the Transfer Agent. In addition, a
determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and
the rules and regulations promulgated thereunder, and the Company shall have no obligation to verify or confirm the accuracy of such determination
and shall have no liability for exercises of the Warrant that are not in compliance with the Beneficial Ownership Limitation, except to
the extent the Holder relies on the number of outstanding shares of Common Stock that was provided by the Company. For purposes of this
<u>Section 2(e)</u>, in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares
of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may
be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting
forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within two Trading Days confirm
orally and in writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In any case, the number
of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company,
including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares
of Common Stock was reported. The &ldquo;<u>Beneficial Ownership Limitation</u>&rdquo; shall be 4.99% of the number of shares of the Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The
Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this <u>Section 2(e)</u>,
provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this
<u>Section 2(e)</u> shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st
day after such notice is delivered to the Company. The provisions of this <u>Section 2(e)</u> shall be construed and implemented in a
manner otherwise than in strict conformity with the terms of this <u>Section 2(e)</u> to correct this paragraph (or any portion hereof)
which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor
holder of this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><font style="font-size: 10pt"><u>Section 3.</u></font><u>
Certain Adjustments</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(a)&nbsp;<u>Stock
Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this <u>Section 3(a)</u> shall become effective immediately after the record date
for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(b)&nbsp;<u>Subsequent
Equity Sales</u>. If, at any time while this Warrant is outstanding, the Company sells or grants any option to purchase or sells or
grants any right to reprice, or otherwise disposes of, or issues (or announces any sale, grant or any option to purchase or other
disposition), any Common Stock, or Common Stock Equivalents entitling any Person to acquire shares of Common Stock, at an effective
price per share that is lower than the then Exercise Price (such lower price, the &ldquo;<u>Base Exercise Price</u>&rdquo; and such
issuances, collectively, a &ldquo;<u>Dilutive Issuance</u>&rdquo;) (if the holder of the Common Stock or Common Stock Equivalents so
issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or
exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be
entitled to receive shares of Common Stock at an effective price per share that is lower than the then Exercise Price, such issuance
shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance), then the Exercise Price
shall be reduced to equal the Base Exercise Price. Such adjustment shall be made whenever such Common Stock or Common Stock
Equivalents are issued. The Company shall notify the Holder in writing, no later than the Trading
Day following the issuance of any Common Stock or Common Stock Equivalents subject to this <u>Section 3(b)</u>, indicating therein the
applicable issuance price, or applicable reset price, exchange price, exercise price, conversion price and other pricing terms (such notice,
the &ldquo;<u>Dilutive Issuance Notice</u>&rdquo;). For purposes of clarification, whether or not the Company provides a Dilutive Issuance
Notice pursuant to this <u>Section 3(b)</u>, upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number
of Warrant Shares based upon the Base Exercise Price on or after the date of such Dilutive Issuance, regardless of whether the Holder
accurately refers to the Base Exercise Price in the Notice of Exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(c)&nbsp;<u>Subsequent
Rights Offerings</u>. In addition to any adjustments pursuant to <u>Section 3(a)</u> above, if at any time the Company grants, issues
or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders
of any class of shares of Common Stock (the &ldquo;<u>Purchase Rights</u>&rdquo;), then the Holder will be entitled to acquire, upon the
terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the
number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof,
including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant,
issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common
Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(d)&nbsp;<u>Pro
Rata Distributions</u>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<u>Distribution</u>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, upon the exercise of this Warrant, the Holder shall be entitled to participate
in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of
Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without
limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if
no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation
in such Distribution (provided, however, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would
result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution
to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the
portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would
not result in the Holder exceeding the Beneficial Ownership Limitation).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt"></p>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(e)&nbsp;<u>Fundamental
Transaction</u>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of its Subsidiaries, taken as
a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common
Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders
of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other
Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the
other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or
share purchase agreement or other business combination)(each a &ldquo;<u>Fundamental Transaction</u>&rdquo;), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in
<u>Section 2(e)</u> on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or
of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<u>Alternate Consideration</u>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such Fundamental Transaction (without regard to any limitation in <u>Section 2(e)</u> on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<u>Successor Entity</u>&rdquo;) to assume in writing all
of the obligations of the Company under this Warrant in accordance with the provisions of this <u>Section 3(e)</u> pursuant to written
agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to
such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of
the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and
be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(f)&nbsp;<u>Failure
to Approve Issuances</u>. In the event that the Company fails to obtain stockholder approval of this Warrant, or stockholder approval
of any other of the agreements or instruments entered into between the Company and the Holder, by June 30, 2025, for the issuance of
Common Stock in excess of 20% of the voting power and number of shares (as contemplated by NASDAQ rule 5635 and otherwise) of the Company
under the Warrant and such agreements and instruments, the same will constitute a breach and default under this Warrant, and the Exercise
Price shall be immediately adjusted to $0.01 at the sole election of the Holder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt"></p>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(g)&nbsp;<u>Calculations</u>.
All calculations under this <u>Section 3</u> shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
For purposes of this <u>Section 3</u>, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall
be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-indent: -0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(h)
<u>Notice to Holder</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">(i)&nbsp;<u>Adjustment
to Exercise Price</u>. Whenever the Exercise Price is adjusted pursuant to any provision of this <u>Section 3</u>, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">(ii)&nbsp;If
(A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare
a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders
of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the
approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation
or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory
share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary
or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be
delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 10 calendar
days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be
taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of
which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to
be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become
effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their
shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale,
transfer or share exchange; provided that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect
the validity of the corporate action required to be specified in such notice. To the extent that any notice required by this Warrant constitutes,
or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file
the material terms of such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise
this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except
as may otherwise be expressly set forth herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">(iii)&nbsp;Notwithstanding
the provisions of <u>Section 3(a)</u> through <u>3(g)</u> above, whenever any event requiring an adjustment to the Exercise Price or the
number of shares issuable upon exercise of this Warrant shall occur prior to the date on which the Exercise Price or the number of shares
issuable upon exercise of this Warrant shall be determined pursuant to the terms of this Warrant, such adjustment shall be effected upon
the determination of the Exercise Price or number of shares, as the case may be, and any notice thereof to the Holder required by <u>Section
3(g)</u> shall thereafter be promptly provided to the Holder pursuant to <u>Section 3(g)</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">&nbsp;</p>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-size: 10pt"><u>Section 4.</u>&#9;</font><u>Transfer
of Warrant</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(a)&nbsp;<u>Transferability</u>.
Subject to compliance with any applicable securities laws, and the conditions set forth in <u>Section 4(d)</u> hereof, this Warrant and
all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its
designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder
or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees,
as applicable, and in the denomination or denominations specified in such instrument of assignment and shall issue to the assignor a new
Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned
this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date
on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance
herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(b)&nbsp;<u>New
Warrants</u>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with <u>Section 4(a)</u>, as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(c)&nbsp;<u>Warrant
Register</u>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<u>Warrant
Register</u>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(d)&nbsp;<u>Transfer
Restrictions</u>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, make usual and customary representations as to investment intent to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(e)&nbsp;<u>Representation
by the Holder</u>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-size: 10pt"><u>Section 5.</u>&#9;</font><u>Miscellaneous</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 71.95pt">&nbsp;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 71.95pt">(a)&nbsp;<u>No
Rights as Stockholder Until Exercise; No Settlement in Cash</u>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set
forth in <u>Section 2(d)(i)</u>, except as expressly set forth in <u>Section 3</u>. Without limiting any rights of a Holder to receive
Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to <u>Section 2(c)</u> or to receive cash payments pursuant to <u>Section
2(d)(i)</u>, <u>Section 2(d)(iv)</u> and <u>Section 2(d)(v)</u> herein, in no event shall the Company be required to net cash settle an
exercise of this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 71.95pt">&nbsp;</p>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(b)&nbsp;<u>Loss,
Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(c)&nbsp;<u>Saturdays,
Sundays, Holidays, etc</u>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-indent: -0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(d)
<u>Authorized Shares</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">(i)&nbsp;The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock five
times (5x) the amount of shares issuable under this Warrant to provide for the issuance of the Warrant Shares upon the exercise of any
purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to
its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this
Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided
herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock
may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company
in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">(ii)&nbsp;Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant, and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">(iii)&nbsp;Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions
thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 107.95pt">&nbsp;</p>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(e)&nbsp;<u>Jurisdiction</u>.
This Warrant shall be governed by and interpreted in accordance with the laws of the State of New York without regard to the
principles of conflicts of law. THE COMPANY AND THE HOLDER HEREBY WAIVE A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM
BROUGHT BY EITHER OF THE PARTIES HERETO AGAINST THE OTHER IN RESPECT OF ANY MATTER ARISING OUT OF OR IN CONNECTION WITH THIS
WARRANT. Any dispute, controversy, difference or claim that may arise between the Company and the Holder in connection with this
Warrant; and all claims arising out of or relating to the validity, construction, interpretation, enforceability, breach,
performance, application or termination of this Warrant, shall be submitted to binding arbitration governed by the rules of the
American Arbitration Association. The seat of the arbitration shall be in the State and County of New York. There shall be only one
arbitrator selected in accordance with the rules of the American Arbitration Association. The arbitration shall be conducted in
English and may be conducted in a virtual setting. The arbitrator&rsquo;s decision shall be final and binding and judgment may be
entered thereon. Provided a party has made a sufficient showing under applicable law, the arbitrator shall have the freedom to
invoke, and the parties agree to abide by, injunctive measures that either party submits in writing for arbitration claims requiring
immediate relief. Additionally, nothing in this Section shall preclude either party from seeking equitable relief or interim or
provisional relief from a court of competent jurisdiction, including a temporary restraining order, preliminary injunction or other
equitable relief, concerning a dispute either prior to or during arbitration if necessary to protect the interests of such party or
to preserve the status quo pending the arbitration proceeding. Each side must bear its own costs and legal fees during the pendency
of the arbitration. A party&rsquo;s failure to pay any costs or fees required to proceed in the arbitration, as they timely come
due, shall result in an immediate default against that party. The prevailing party in the arbitration shall be entitled to recoup
all its reasonable attorneys&rsquo; fees and costs from the nonprevailing, including, without limitation, all of its costs relating
to the arbitration. The arbitrator&rsquo;s final award shall include this assessment of costs and fees..</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(f)&nbsp;<u>Restrictions</u>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and if the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(g)&nbsp;<u>Nonwaiver
and Expenses</u>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that all rights
hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(h)&nbsp;<u>Remedies</u>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt"></p>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(i)&nbsp;<u>Notices</u>.
Any notice, request or other document required or permitted to be given or delivered to the either party to the other shall be delivered
in by recognized overnight courier, facsimile or email as follows:</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in">If to the Holder:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in">White Lion Capital, LLC, dba White Lion GBM Innovation
Fund <br>
21031 Ventura Blvd #920</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in">Woodland Hills, CA 91364</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1.5in"></td><td style="width: 0.75in; text-align: left">Attn:</td><td style="text-align: justify">Yash Thukral, Managing Director</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1.5in"></td><td style="width: 0.75in; text-align: left">E-mail:</td><td style="text-align: justify">team@whitelioncapital.com</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in">With a copy to (which shall not constitute notice
or service of process):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in">Greenberg Traurig, P.A.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in">333 S.E. 2nd Avenue, Suite 4400</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in">Miami, Florida 33131</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1.5in"></td><td style="width: 0.75in; text-align: left">Attention:</td><td style="text-align: justify">John D. Owens, III, Esq.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1.5in"></td><td style="width: 0.75in; text-align: left">E-mail:</td><td style="text-align: justify">jo@gtlaw.com</td>
</tr></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.55pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in">If to the Company:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in">OSR Holdings, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in">10900 NE 4th Street, Suite 2300</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in">Bellevue, WA</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1.5in"></td><td style="width: 0.75in; text-align: left">Attn:</td><td style="text-align: justify">Kuk Hyoun Hwang, CEO</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 1.5in">&nbsp;</td>
  <td style="width: 0.75in">E-mail:</td>
  <td>peter.hwang@osr-holdings.com</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(j)&nbsp;<u>Limitation
of Liability</u>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(k)&nbsp;<u>Successors
and Assigns</u>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(l)&nbsp;<u>Amendment</u>.
No provision of this Warrant may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an
amendment, by the Company and the Holder. No waiver of any default with respect to any provision, condition or requirement of this Warrant
shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition
or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise
of any such right.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">(m)&nbsp;<u>Severability</u>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 71.95pt">&nbsp;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 71.95pt">(n)&nbsp;<u>Headings</u>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 71.95pt">&nbsp;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 71.95pt">(o)&#9;<u>Electronic Signatures</u>.&#9;Electronically
scanned and transmitted signatures, including by email attachment, shall be deemed originals for all purposes of this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.25pt; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.25pt; text-align: center">********************</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.25pt; text-align: center"><i>&nbsp;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.25pt; text-align: center"><i>(Signature Page Follows)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.25pt; text-align: center"><i>&nbsp;</i></p>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 35.95pt">&nbsp;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 35.95pt">IN WITNESS WHEREOF, the Company has caused this
Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 35.95pt">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 60%; font-size: 10pt">&nbsp;</td>
    <td style="width: 40%; font-size: 10pt"><b>OSR HOLDINGS, INC.</b></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 35.95pt">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 60%">&nbsp;</td>
    <td style="width: 5%">By:</td>
    <td style="width: 35%; border-bottom: black 1.5pt solid">/s/ Kuk Hyoun Hwang</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>Name:&nbsp;</td>
    <td>Kuk Hyoun Hwang</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>Title:</td>
    <td>Chief Executive Officer</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 35.95pt">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="3"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>Acknowledged and accepted by the Holder:</u></b></font></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2">&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="3"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHITE LION CAPITAL, LLC, DBA WHITE LION GBM <br>
INNOVATION FUND</b></font></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2">&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 5%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
    <td style="border-bottom: Black 1.5pt solid; width: 35%">/s/ <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yash Thukral</font></td>
    <td style="width: 60%">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yash Thukral</font></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing Director</font></td>
    <td>&nbsp;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.25pt; text-align: center"></p>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.25pt; text-align: center">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.25pt; text-align: center">NOTICE OF EXERCISE</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">TO: OSR HOLDINGS, INC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">(1)
The undersigned hereby elects to purchase <u>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>Warrant Shares of the Company (constituting <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</u> of the Available Share Amount)
pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full,
together with all applicable transfer taxes, if any.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.9pt; text-align: justify; text-indent: -35.9pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">(2)
Payment shall take the form of (check applicable box):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 192.6pt; text-indent: -12.55pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 2.5in; text-align: justify">&#9744;&nbsp;in
lawful money of the United States&#894; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 180.05pt">&nbsp;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 180.05pt">&#9744;&nbsp;if permitted the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant
with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection
2(c).</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 180.05pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">(3)
(Optional) If the exercise is being done cashlessly, the net number of shares to be received is <u>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 99.1pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">(4)&#9;Please issue said Warrant Shares in the name of
the undersigned or in such other name as is specified: <u>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">(5)&#9;The Warrant Shares shall be delivered to the undersigned&rsquo;s
account with the following transfer agent: <u>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.25pt; text-align: center">[SIGNATURE OF HOLDER]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">Name of Investing Entity: <u>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><i>&nbsp;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><i>Signature of Authorized</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><i>Signatory of Investing Entity: <u>&#9;&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Name of Authorized Signatory: <u>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Title of Authorized Signatory: <u>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Date: <u>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><u></u></p>


<!-- Field: Page; Sequence: 16 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.25pt; text-align: center">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.25pt; text-align: center">ASSIGNMENT FORM</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">(<i>To assign the foregoing Warrant, execute this form
and supply required information. Do not use this form to purchase shares</i>.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced
thereby are hereby assigned to</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="width: 60%">Name:</td>
    <td style="border-bottom: Black 1.5pt solid; width: 40%">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>(Please Print)</td></tr>
  <tr style="vertical-align: bottom">
    <td>Address:</td>
    <td style="border-bottom: Black 1.5pt solid">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>(Please Print)</td></tr>
  <tr style="vertical-align: bottom">
    <td>Phone Number:</td>
    <td style="border-bottom: Black 1.5pt solid">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Email Address:</td>
    <td style="border-bottom: Black 1.5pt solid">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Dated:</td>
    <td>&nbsp;</td></tr>
</table>

<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="width: 15%">Holder&rsquo;s Signature:</td>
    <td style="border-bottom: Black 1.5pt solid; width: 25%">&nbsp;</td>
    <td style="width: 60%">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Holder&rsquo;s Address:</td>
    <td style="border-bottom: Black 1.5pt solid">&nbsp;</td>
    <td>&nbsp;</td></tr>
  </table>


<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>
<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ea024172601ex10-4_osrhold.htm
<DESCRIPTION>AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENT, BETWEEN OSR HOLDINGS, INC. AND WHITE LION CAPITAL LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font-family: Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit 10.4</B></FONT></P>

<P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AMENDMENT
NO. 1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>COMMON
STOCK PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>BETWEEN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>OSR
HOLDINGS INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AND</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WHITE
LION CAPITAL, LLC,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DBA
WHITE LION GBM INNOVATION FUND</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">THIS
AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENT (this &ldquo;<B><I><U>Amendment</U></I></B>&rdquo;), effective May 6, 2025 (the &ldquo;<B><I><U>Amendment
Effective Date</U></I></B>&rdquo;), is by and between OSR Holdings, Inc., a Delaware corporation (the &ldquo;<B><I><U>Company</U></I></B>&rdquo;),
and White Lion Capital, LLC, dba White Lion GBM Innovation Fund, a Nevada limited liability company (the &ldquo;<B><I><U>Investor</U></I></B>&rdquo;),
and amends the Common Stock Purchase Agreement, dated February 25, 2025, by and between the Company and the Investor (the &ldquo;<B><I><U>Agreement</U></I></B><U>&rdquo;</U>).
All capitalized terms used but not defined herein shall have the respective meanings ascribed to them in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">NOW,
THEREFORE, in consideration of the premises, the mutual covenants contained herein, and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.
<U>Amendments to Article VI</U><FONT STYLE="font-weight: normal">.</FONT></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sections
6.3 and 6.4 of Article VI of the Agreement are hereby amended and restated in their entirety as follows as of the Amendment Effective
Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Section
6.3 <U>FILING OF REGISTRATION STATEMENT</U>.</B> The Company shall file with the SEC, within thirty (30) days after the closing of the
Business Combination, a new Registration Statement on Form S-1 (the &ldquo;Registration Statement&rdquo;) in compliance with the terms
of the Registration Rights Agreement, covering only the resale of the Resale Securities by the Investor. The Registration Statement shall
relate to the transactions contemplated by, and describing the material terms and conditions of, this Agreement and disclosing all information
relating to the transactions contemplated hereby required to be disclosed in the Registration Statement and the prospectus supplement
as of the date of the Registration Statement, including, without limitation, information required to be disclosed in the section captioned
&ldquo;Plan of Distribution&rdquo; in the Registration Statement. The Company shall permit the Investor to review and comment upon the
Registration Statement within a reasonable time prior to its filing with the SEC, the Company shall give reasonable consideration to
all such comments, and the Company shall not file the Current Report or the Registration Statement with the SEC in a form to which the
Investor reasonably objects. The Investor shall furnish to the Company such information regarding itself, the Company&rsquo;s securities
beneficially owned by the Investor and the intended method of distribution thereof, including any arrangement between the Investor and
any other person or relating to the sale or distribution of the Company&rsquo;s securities, as shall be reasonably requested by the Company
in connection with the preparation and filing of the Current Report and the Registration Statement, and shall otherwise cooperate with
the Company as reasonably requested by the Company in connection with the preparation and filing of the Current Report and the Registration
Statement with the SEC. The Company shall have no knowledge of any untrue statement (or alleged untrue statement) of a material fact
or omission (or alleged omission) of a material fact required to be stated therein or necessary to make the statements therein, in light
of the circumstances under which they were made, not misleading, in any pre-existing registration statement filed or any new registration
statement or prospectus which is a part of the foregoing. The Company shall promptly give the Investor notice of any event (including
the passage of time) which makes the final prospectus not to be in compliance with Section 5(b) or 10 of the Securities Act and shall
use its best efforts thereafter to file with the SEC any post-effective amendment to the Registration Statement, amended prospectus or
prospectus supplement in order to comply with Section 5(b) or 10 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Section
6.4 <U>COMMITMENT SHARES</U>. </B>In consideration for the Investor&rsquo;s execution and delivery of, and agreement to perform under
this Agreement, the Company shall (i) cause the Transfer Agent to issue an amount of shares of Common Stock equal to $800,000 divided
by the closing price of the Common Stock on the Commitment Shares Determination Date (the &ldquo;<B><U>Initial Commitment Shares</U></B>&rdquo;)
and (ii) issue to the Investor the Warrant to purchase $4,000,000 of shares of Common Stock, to the Investor as a commitment fee. The
Initial Commitment Shares and the Warrant Shares issuable upon the exercise of the Warrant are collectively referred to herein as the
&ldquo;<B><U>Commitment Shares</U></B>&rdquo;. For the avoidance of doubt, all of the Initial Commitment Shares and the Warrant shall
be fully earned as of the Execution Date, and the issuance of the Initial Commitment Shares and the Warrant is not contingent upon any
other event or condition, including, without limitation, the Company&rsquo;s submission of a Purchase Notice to the Investor, the filing
of a Registration Statement, and irrespective of any termination of this Agreement. The Company shall include on the Registration Statement
filed with the SEC, all Commitment Shares. In the event that the Company does not promptly issue the Initial Commitment Shares to the
Investor within at least two (2) Business Days after the Commitment Shares Determination Date, or the Warrant to the Investor on May
6, 2025, or if the Company fails to include all of the Commitment Shares on the initial Registration Statement filed with the SEC, in
addition to all other remedies at law or in equity or otherwise under this Agreement, the Company shall be obligated to pay to the Investor
liquidated damages of $800,000, being immediately due and payable to the Investor at its election in the form of cash payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.
<U>Amendments to Article I</U><FONT STYLE="font-weight: normal">.</FONT></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following terms shall be added to Article I of the Agreement as of the Amendment Effective Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Resale
Securities</U></B>&rdquo; shall mean the Purchase Notice Shares issued to the Investor by the Company pursuant to this Agreement, the
Warrant Shares and the Commitment Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Warrant</U></B>&rdquo;
shall mean that Common Stock Purchase Warrant issued by the Company to the Investor on May 6, 2025, the form of which is attached here
to as <B><U>Exhibit E</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Warrant
Shares</U></B>&rdquo; shall mean those shares of Common Stock issuable upon exercise of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following terms in Article I of the Agreement shall be amended and restated as follows as of the Amendment Effective Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Securities</U></B>&rdquo;
mean the Purchase Notice Shares issued to the Investor by the Company pursuant to this Agreement, the Commitment Shares, the Warrant
Shares and the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Transaction
Documents</U></B>&rdquo; shall mean this Agreement, the Registration Rights Agreement, the Warrant and all schedules and exhibits hereto
and thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.
<U>Amendment to Section 10.14.</U></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Section
10.14 of the Agreement is hereby amended and restated in its entirety as follows as of the Amendment Effective Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Section
10.14 <U>AMENDMENTS; WAIVERS</U></B>. (i) No provision of this Agreement may be amended other than by a written instrument signed by
both parties hereto and (ii) no provision of this Agreement may be waived other than in a written instrument signed by the party against
whom enforcement of such waiver is sought. No failure or delay in the exercise of any power, right or privilege hereunder shall operate
as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise
thereof or of any other right, power or privilege.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.
<U>Amendment to Exhibits</U><FONT STYLE="font-weight: normal">.</FONT></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exhibit
A attached hereto shall be added as Exhibit E to the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.&nbsp;<U>Representations
and Warranties</U></B>. Each of the Investor and the Company represents and warrants that it has the authority and legal right to execute,
deliver and carry out the terms of this Amendment, that such actions were duly authorized by all necessary entity action and that the
officers executing this Amendment on its behalf were similarly authorized and empowered and that this Amendment does not contravene any
provisions of its articles of incorporation, bylaws, certificate of formation, limited liability company agreement or other formation
documents, as applicable, or of any contract or agreement to which it is a party or by which any of its properties are bound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.
<U>Miscellaneous</U><FONT STYLE="font-weight: normal">.</FONT></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;Except as modified by this Amendment, the Agreement continues in full force and effect in accordance with its terms.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;This
Amendment shall be governed by and construed in accordance with the laws of the State of New York as set forth in Section 10.1 of the
Agreement and the dispute resolution provisions set forth in Section 10.16 of the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;This
Amendment may be executed in any number of counterparts and by electronic transmission (which shall bind the parties hereto), each of
which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>**
signature page follows **</I></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">IN
WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their respective authorized officer as of the Amendment
Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>OSR HOLDINGS INC.</B></FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ <FONT STYLE="font-size: 10pt">Kuk
    Hyoun Hwang</FONT></FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kuk Hyoun Hwang</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHITE LION CAPITAL, LLC</B></FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DBA/ WHITE LION GBM INNOVATION FUND</B></FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ <FONT STYLE="font-size: 10pt">Yash
    Thukral</FONT></FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yash Thukral</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing Director</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: right"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I><U>Exhibit
A</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>EXHIBIT
E</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FORM
OF WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>osrh-20250506.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +K4ps7xRiXgOn8uBan0sSaKB+cP9wZ1ySZkxvW9wbanqPyAjVw8nhCQgEniWQU8F -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:OSRH="http://bellevuespac.com/20250506" elementFormDefault="qualified" targetNamespace="http://bellevuespac.com/20250506">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://bellevuespac.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="osrh-20250506_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="osrh-20250506_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="osrh-20250506_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="OSRH_CommonStockParValue0.0001PerShareMember" name="CommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="OSRH_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember" name="RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>osrh-20250506_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bellevuespac.com/role/Cover" xlink:href="osrh-20250506.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bellevuespac.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="osrh-20250506.xsd#OSRH_CommonStockParValue0.0001PerShareMember" xlink:label="loc_OSRHCommonStockParValue0.0001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_OSRHCommonStockParValue0.0001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="osrh-20250506.xsd#OSRH_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:label="loc_OSRHRedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_OSRHRedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>osrh-20250506_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="osrh-20250506.xsd#OSRH_CommonStockParValue0.0001PerShareMember" xlink:label="OSRH_CommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OSRH_CommonStockParValue0.0001PerShareMember" xlink:to="OSRH_CommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="OSRH_CommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Common stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="osrh-20250506.xsd#OSRH_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:label="OSRH_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OSRH_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:to="OSRH_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="OSRH_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember_lbl" xml:lang="en-US">Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>osrh-20250506_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bellevuespac.com/role/Cover" xlink:href="osrh-20250506.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://bellevuespac.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="osrh-20250506.xsd#OSRH_CommonStockParValue0.0001PerShareMember" xlink:label="loc_OSRHCommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_OSRHCommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="osrh-20250506.xsd#OSRH_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:label="loc_OSRHRedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_OSRHRedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 06, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  06,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">OSR HOLDINGS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001840425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-5052822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10900 NE 4th Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 2300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bellevue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">98004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">635-7700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=OSRH_CommonStockParValue0.0001PerShareMember', window );">Common stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">OSRH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=OSRH_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember', window );">Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">OSRHW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=OSRH_CommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=OSRH_CommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=OSRH_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=OSRH_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *> K%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( *> K%J,8S9C[P   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL].PS ,AU\%Y=XZ[2B'J,ME$R>0D)@$XA8E
MWA:M^:/$J-W;TY:M$X('X!C[E\^?);<Z"AT2OJ00,9'%?#>XSF>AXYH=B:(
MR/J(3N5R3/BQN0_)*1J?Z0!1Z9,Z(-2</X!#4D:1@@E8Q(7(9&NTT D5A73!
M&[W@XV?J9IC1@!TZ])2A*BM@<IH8ST/7P@TPP0B3R]\%- MQKOZ)G3O +LDA
MVR75]WW9K^;<N$,%[\]/K_.ZA?69E-<X_LI6T#GBFETGOZTVV]TCDS6OFX(W
M157O:BYX(ZK[C\GUA]]-V 5C]_8?&U\%90N_[D)^ 5!+ P04    " "G@*Q:
MF5R<(Q &  "<)P  $P   'AL+W1H96UE+W1H96UE,2YX;6SM6EMSVC@4?N^O
MT'AG]FT+QC:!MK03<VEVV[29A.U.'X416(UL>621A'^_1S80RY8-[9)-NIL\
M!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,
M7K5::0##.'W)$Q+#W(*+"$MX%,O67.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH
M0-!445IO7R"TY1\S^!7+5(UEHP$35T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;
M6"!_SF^GY$Y:B.%4PL3 :F<_5FO'T=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV
M?/;$[9^,RMIT-&T:X./Q>#BVR]*+<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJN
MD::JC5-/T_=]W^N;:)P*C5M/TVMWW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G
M_:YKI.D6:$)&X^MZ$A6UY4#3( !8<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)
M$?[&Q036:=(9EC1&<IV0!0X -\313%!\KT&VBN#"DM)<D-;/*;50&@B:R('U
M1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)
M\?LC6V&')VX[$W(Z'&="?,_V]I&E)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=
M]EA]]D]';B/7J<"S(M>41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&
M^+3&K!'@$WVWO@C(WXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\
MW*.76!4!EQC?-*HU+,76>)7 \:V</!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:
M_IS30/"4+R3Z2I&/:;,CIW0FS>@S&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;
MLT8AA&F[\!ZO)(Z:K<(1*T(^8ADV&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63
M/F#([,V1=<[6D0X1DEXW0CYBSHN0$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX
M?H;5,VPLCO='U!=*Y \FIS_I,C0'HYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z
M> HWEL:\4*Z">P'_T=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;
MQ/NN,=K7-"XH8U=RS<C'5*^3*=@YG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!
M)+C\B\KP*L0)Z&1;)0G+5--E-XH2GD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XL
MS_D\7^>TS0LS0[=R2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9==N0C
MI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[
MY\%1L*/O/)8=QXCRHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4
MX&1@+: '@Z]1 O)256 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM
M(E(YPFF8$V>KRMYEL<%5'<]56_*POFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*
MHO,94[[G*TG$53B_13.V$I<8O./FQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,
M"2Q;B%D2XDU=[=7GFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[
M2$R<><41 71% B.5' 86%S+D4.Z2D 83 <V4R43P H)DIAR F/H+O?(,N2D5
MSJT^.7]%+(.&3E[2)1(4BK ,!2$7<N/O[Y-J=XS7^BR!;814,F35%\I#B<$]
M,W)#V%0E\Z[:)@N%V^)4S;L:OB9@2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=S
MFWJXPD6L_UC6'ODRWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ
M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
M6/,,H68XWX=%FAHSU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS<
M_N\-L,+$CN'MB[\!4$L#!!0    ( *> K%J<D-( [ 0  .L4   8    >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&ULO9AO4^HX%,:_2H:]L[,[HY*6/Z*KS"#J
ME;F*K'C7F7T7V@-D;MOT)JG(M]^3@JVZY93UQ;Z!MC0/OYR3/"?)V4KI'V8)
M8-E+'"7FO+&T-CUM-DVPA%B8(Y5"@K_,E8Z%Q5N]:)I4@PCS1G'4]#GO-F,A
MDT;_+'\VT?TSE=E()C#1S&1Q+/3Z B*U.F]XC=<'#W*QM.Y!LW^6B@5,P7Y/
M)QKOFH5**&-(C%0)TS _;PR\TXL6=PWR-_Z2L#)OKIGKRDRI'^YF%)XWN"."
M" +K) 1^/<,0HL@I(<?/K6BC^$_7\.WUJ_IUWGGLS$P8&*KH289V>=[H-5@(
M<Y%%]D&M;F#;H8[3"U1D\D^VVK[+&RS(C%7QMC$2Q#+9?(N7;2#V:>!O&_@Y
M]^:/<LI+847_3*L5T^YM5',7>5?SU@@G$Y>5J=7XJ\1VMC]4SZ#/FA:EW(-F
ML&UVL6GF[VAV)]:,=P^8S_W.^]9-!"@H_(+"S^5:.^0N59!AJBU[7*=014,W
M[QU^(R!:!42+5!D@09A37$=B445!MY^+R #!T2XXVOL%8P):JI!=)2'#W%;&
MA59R6<K35)>G3H'6(06O$BOMFEW+"-@XBV?50X?6X-P[;'NM$T[P= N>[CX\
M#["0QFJ!,1N+N#)0M,[]]('=W-]>CL9?IP=L-!X>$7#'!=SQ/G!#3*46$1LE
M(;RP;["NPJ.5.,:LU^9M,H>] JNW#]:C>&&C$-GD7 8B=\C=&:45>^W##N_X
M/=\G\$X*O)-]\$9)H'2J=$YVP*86)P!3F@U5AN'$J*JP,L^T^.450>CQTC/Y
M/HR#,-1@S,'K!;O%]]A]4@E6(^GQ$\[9^(JU[1)[J]'/*=0W]NY]'O5QI2I1
M:<EI)C$7?HM3,]@KK=^CS?LCX=#=8:8?U2JII*/E<*$1P7-&&;%75@2/MO2/
M;,4PG&CU+).@.M.TYM. 0BN+A$=[^T>TB3(67>9OF>Z<&S6*)SW.VQ1;624\
MVN+S% YPD;@;A1:@G<XKRX-'^_JM"C FDZ5*J'I5(])M=0Z/C^G17M8$C[;R
M)RVMA00#$\=9LG5>4TE%"]6M-KRR'GBT?4]5) -I9;)@=SB\M111)0^M4LM3
M%@"/-NF)AL, PP,XOS:+0ER7@6;W\_F._-%Z=61^Z?L^;=+_(AL9DR%9'6"-
M;"U@Z?;^7FY_%8->N'Q^106L)SC84I%4+CQJ!*TFG=1_L\"O<7FW#8.0C17F
M4['O!IA= KMZL2YV(7O$U9N1^3)DL^RMA*7_HS:.I>_[M$>[V8DDN/L*?ARP
M5&CV+*(,V!=^Y-9B+,5LFZ70U7L54MMMLT]-*@(X;^ ^VH!^AD;_UU^\+O^#
M8B\+@T_;^*.TN#I7<^;YO\U^9U,(,O2<ZN332I^,PGONLFCXM.?C" C=F)VN
MXYFJ=* : 5S$WU D9=7P:<-_#1F.SF ID@7LW%74"(T'T\O!GQ1363=\VNX?
M( 2(Q0Q3NQ+:;76PYL,+Z$":_.E<;9-A7.Z#-ZECPC*1O+X,+-4RR ?(%\\[
MZO":P4QB?78PE[7)IZO*?QG,M-+_'\#W72[+GT^7JSWF 2W@YL$3=1Y2UKL6
M79CVGP@U0KLG0O/-T94[!KP3KG(9%L$<E?C1,<YYO3E9V]Q8E>:G63-EK8KS
MRR4(++_N!?Q]KI1]O7$'9,7Y9O\?4$L#!!0    ( *> K%K@]#J)J@(  # ,
M   -    >&PO<W1Y;&5S+GAM;.U7VXK;,!#]%:$/J).X-7%) FT@4&C+PNY#
M7Y58=@2ZN+*<.OOUU5BV<UG-]O)8ZI!X9HYFYHQF9)-5X\Z2/QXY=Z134C=K
M>G2N?I\DS>'(%6O>F)IKCY3&*N:\:JNDJ2UG10-.2B:+V2Q+%!.:;E:Z53OE
M&G(PK79K.J/)9E4:?;&D-!C\4J8X.3&YIELFQ=Z*?BU30IZ#>0&&@Y'&$N>I
M\#6=@Z5Y#O \:,!RB*.$-A:,2<@0?O?#\CM@U!JO"BDG@@L:#)M5S9SC5N^\
MTB_NC2\@,LA/Y]HSK"P[SQ?OZ,6AO_DD>V,+;J<T<SJ:-BO)2Z!C176$NS-U
M J!S1GFA$*PRFO4<1H]!\&$/7,I':.&W\B9V5Y+0BT\%M(% J:/H"0UB"!,4
MB'\=+<2^"OOVK\*26IR,^]CZ:G2O?V^-XP^6EZ+K]:Z<\F/1YWAT5M?R_$&*
M2BL>:O_MA)L5&_W(T5CQ[+/!I!R\@5M*3MPZ<;BV_+"L?N*=&Z>I*W'.B_^<
M?\&YXII;)J])^]&/,TZ&6;P:^)MQGZP$'BMK^A6>5O+"@>Q;(9W0@W841<'U
MBZGWX1W;^\?A37R_ON E:Z5[FL UO<A?>"%:E4^K'F!?AE47^3.<[GDV/=-\
M+J$+WO%B.ZBVVO<B\8+/.ES@<(_L^BN.8#X!BR. 87DP!IA/\,+R_$OU+-%Z
M H9Q6T:1)>JS1'V"5PS9]A\L3]PG]U>\TCQ/TRS#=G2[C3+88ON69?"-1\.X
M@0>6!S+]V5[CW<8GY/4YP'KZVH1@E>*3B%6*[S4@\7T#CSR/=QO+ QY8%[#9
M@?SQ/#!3<9\TA:YBW+ 3C"-YCB$PB_$9S3)D=S+XQ/N#G9(TS?,X EB<09IB
M")Q&',$8  <,2=/^/7CW/DK&]U1R^8^P^0E02P,$%     @ IX"L6I>*NQS
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M4$L! A0#%     @ IX"L6D;'34B5    S0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "G@*Q:C&,V8^\    K @
M$0              @ '#    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" "G@*Q:F5R<(Q &  "<)P  $P              @ 'A 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( *> K%J<D-( [ 0  .L4   8
M      " @2((  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" "G@*Q:X/0ZB:H"   P#   #0              @ %$#0  >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( *> K%J7BKL<P    !,"   +              "
M 1D0  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *> K%JJQ"(6,P$  "("   /
M              "  0(1  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "G
M@*Q:)!Z;HJT   #X 0  &@              @ %B$@  >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "G@*Q:99!YDAD!  #/ P  $P
M            @ %'$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 )
+ #X"  "1%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0241726-8k_osrhold.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bellevuespac.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0241726-8k_osrhold.htm">ea0241726-8k_osrhold.htm</File>
    <File>osrh-20250506.xsd</File>
    <File>osrh-20250506_def.xml</File>
    <File>osrh-20250506_lab.xml</File>
    <File>osrh-20250506_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0241726-8k_osrhold.htm": {
   "nsprefix": "OSRH",
   "nsuri": "http://bellevuespac.com/20250506",
   "dts": {
    "inline": {
     "local": [
      "ea0241726-8k_osrhold.htm"
     ]
    },
    "schema": {
     "local": [
      "osrh-20250506.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "osrh-20250506_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "osrh-20250506_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "osrh-20250506_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 27
   },
   "report": {
    "R1": {
     "role": "http://bellevuespac.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-05-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0241726-8k_osrhold.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-05-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0241726-8k_osrhold.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "auth_ref": []
    },
    "OSRH_CommonStockParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bellevuespac.com/20250506",
     "localname": "CommonStockParValue0.0001PerShareMember",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "OSRH_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bellevuespac.com/20250506",
     "localname": "RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://bellevuespac.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001213900-25-042018-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-042018-xbrl.zip
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M'=8C-(]'U;(]=+:.FD\?&EJ9T,SN)D?G%;>17-Z),U%A*B7!$W*5_E@@640
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M$) .C(9"RKI=EWX95ZI7[&+?0E4N0E*,PDU1!\29#"",*5(F*??!KPU BJ+
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M+JH8X7K]\&-]_I*%S8&<63Z!/1-*I0#^G$+1C2/=6N)H&1AP33-NV#CAM?.
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M<)@PF_OAT=]77?\E'KE*!NCI-YX!>OH=9X VUL<MK8^+=1%OFGX6*H]OR^K
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MRKS+-V%_.BG$20G)2V$[PN _[%^$ . 3:1I+<0[UZ# G*6MZAE<)JU<\T;_
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M]3QC]D55UM&LF;S)9&!M<00?Q9;S,,\_E9J<0IT3UI;O0ONE"'BQ1?)UQC-
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MA@ Q.[K;BA@S681-9(,MVQMF/"YJ2N.-P+NCK!IO1#9;ZPP]^T(,)(<(%KW
MX>4Z%CTPBJE\"3[85E!4A$MCC8L_.J\5C"VY:47%7MMM>^(",KEIM2<Q78S^
MXCMX$"D/L/NW9X3.Y;.NB9QJ7/IXEZ[E0Q*!X\4%RGY"$PB6;XEI$6Y.TP[\
M,DP7C;5IX[>N,PY7Q*A "?>>)PYC[%8HY4A>@T$L7&EUGA>>I48%N\/>2>$-
MT7C;51TG4N-DAN$1JXH\6"H0,^GX/FXM5(#S1!*CP6'^*'AFU.25EY;!2PHG
MTAJ:\J#*IU&]8ODWBO:>*]IU:=IWU@QDC?FJ+H20!AT?, FFB- @E#S7J854
MU=\BHQ%?7!>EK%:,H+MJ=^+:";/:"8DDZX]*PB3;YF@;*M:+S2[F+:*D]XY"
M=4H4JM+H;:_1:.)DYY]4D=)@5+.,K5:GWL>-<V\ BH^_]>CIXP<>/=TH\Z^A
MS-=5:CB@!!$(*8))Q #FE*;?\7:)?:MP+@0C$%"*8+8B^9#P ]3DQ-9\8>OF
MJ/3Z$E)E_;11)L&6(:>QPBM!)X(WP<0F#A@_9- &U36C^EV /2]&L8)>8%G>
ME57>(]N+4Z7*J%>SY22<6LO7D5Z)D:EHX[6%VI$O_'TP>"_Y4JZ?0C0==L:A
M5U$-6:BBD]!U&!!QD6;K(2.WCO&0J>8YNFRG\AR0SL*#EDZ2S82:B1U3!<C$
M>Q(=N@3]8T9#!S>:(;!04J"(,H25G,7(*9B,;9N?U""'&J1$<OV2UP_:;R_I
MZMN^*CL+D6XH?85@Z.2I$HB0J; HD6LFP\D!'/P,92%$P'7O _[.M8Q&3!N0
MG5%Q10L*!@MCL& K;6D:I,F,J[>6E992I,3FJS%7GQ06\;7U>9LVA'VG2]RK
M-"$5_(O#:%N+;4$IT_P8F+)?S7$5WGBU29'\-RF@2;,'A"+X;,T#KKY-Y9B7
MU0P>E64]LW6G5/"ELM3X>MCXU9K'W"584$L&K67;Y'#B?I[(OJV8/&V5-UTM
M$+$40TAHD^L@B5>C$.4G5Z 088PS!X%;!D1LD5%VO4ZC KC[4!"] ;94/1L5
M[*PSV0?*SPK NGY/8>2N M8M$Q_ZN7GSVT#M6$J^)H2N\<82IFF\[-+"JHV=
M^-7MQ'69B2IO<4Q\=AWUNY37CI<6(Y(X9FC\%0D5E1 #'LKB16[ZI% *A(H5
M XH8QICX9JZ&TJ:Z0>-FK-U;K=R[_?ZH##H/0,.$L &$/A1I7E<$ZR7Q,YD2
MG6)BQ#GW[(-E1RVS.^$YPS%4+/:&+YDP$]4\71 *?$\$V")(5SC@\,8UHB'2
MA2G08EZ)%(^L*19&!>TF/QZ7T1**V95.5[R"\Q%(P@E[K.1<7;]'1F$L53U8
M]&-M0)\KR:!BJR;;K7'D3"95TAZ&^4K#1,\2HKDN,*U!2$TY\%1^@BJ 9!%*
MT1QTBK:#@NVW%)5$)@3G/<,KR^?*W,X]:0V/S72==BM^/4LRY*NRDG:MQ*"/
M$F%+4B,Z5OJD0,3.GZT5E$F?Q7%%9STYVE;P/$&3&C!9&<:&BC)5L5A,TF("
M@=6PXQDRM'G4R;6J%#D07][ +S=IX5 *I&'W:O+KY"W=:/2K-#J.Y6YU>E.+
MVP%(-R'4Z6M+2X#UL0C>1F1J@] L0=0L<_4:N&7IS,L97 *D7R1Y7<+&,- T
MWJD?3@;!^\'I\<'1:3#8/Q44\YX5^F;Y9( @-1Y)EF<[!%E#0J2=&0U?Q#6U
M;\']"=G--JD%S<2#P(B*ADC,=F3=AY+NO"QUO27?19*2\%I'1%W"0RFC3#8W
M. )G181DWA-00F!VQ<KAI=$>4=J&$H\":^,@HJFIN&IPE-S!$%UC&/W>WI/'
MCY_B355?N2<ASR413Z7X:ZE7?0EGSR?2"]IM@3_.DU%"IZ"F3@L^HCMD5,C'
M\YP:RF''BE-A,L%1R6=TIIS4<R10#$[CHLCA!)J9NMBMY\^#UP@].H[/'@5/
M?][]Z>=@"\>XO?U"L/L2)M/S+LJ90RE/]H+]U\<ARB#[SB]#;/,SQ_33OSQ?
MBOZSR0+A'G_RK6>!GFRR0 _M]/S*'><F:SHV?^>:)#PM-[;2/?9^U];+:_Q)
M? V#'WH%/HYJZ*4L)@Y;$L>"\0_,CV-VG^8Y$E$SW'-"]\%^(8+TM*Z.Z]YJ
M(]W8!"J2GF)\58:.$@$GSL$D \/$-(\WG\N5A_!(GPQX6A?BH'BC(PANJ1Q&
M*AS#YE/MIP57/(Q QP:'Q_'ZS"8%R*-"$K14U=&W9@+'PEZCO#9C;<F\E G!
M$%51GB=SFR1UK3@\+ZL9(]^X./=ZVZXM9E68J,IQ++RYSJSO]SX2+RV!./TP
M)[M!!PV\/MV,4B*6%Z]HW!9SVNZF#3 L[ @,"TO(YPD^1)*>&&^82,),RE]8
MAHMX%D_(X3*MJOT6[_.ZP+TA>@,>,#"THB%"Z4T[=N1E3(@'%2ECQ2$@M"_I
M,F:)LW1"6-$=3\GVYA0,32*ID,VVN=?;Y@YZ5YZ R$_JU""]#S+&N'!/54[Z
M2SL%KX.[WCB6/0L1 Q=$=8OMW2N4*LGW<M&<!0V6\E"ORQ_O44_&?;P-W@OQ
M!?I$HT?A]:6KX2=QII,%Q9N&%$\Z'V^;G4_P@9)KB:@"?YJG:7Y96I8NV![,
M8 W7O!*4HNRHT'FY;N<:?*/#H1,7_\1,TL*F&3L&]F7VH9:TM;2T_GCPZO3-
M__Q V^4O[LBECN25F[![O^U>O==^^.WI(_,]&?_#P^'QX&VP?_2OX>'@\/3D
M$?L!^.W=][GW]_(WU7#\EIX>:+YH7?8"PNR&4SRS5=<<)%&GXYRT <(#.$>#
ML?FX&+,A[TH@^KT1WB;FVU :!*R#<@K:"Z8/+E69'@>4P3.W'&,A+46\E*'P
M$XZ$5 A\^ _Z@WZL-:&G$#92^'6D<+0F*?S 8+;WC(UKMV_R!=%@Z%0;R#)*
M'04UVFV,MC1,*JYPW)!/;L3GX<2PQNMBCK#E2 <N*]O5ME:L)U!C,9&WPPQ]
MBK5#0JRE: U1[EG:*'EN"A9-I>IO2EI/N9%E6<+ N6]F&:=(L,.89D(5N.;:
MOY#I9EJ?QEFPM;>['4RB!?Q@6DE!\S1)<0P6RG4RW ^IYG9N(6>#+*N)_922
M%:!>7\.[PZSL_#.D[_^W!FT?%Z"FCTU#*#!YS47_RP8E3,N^E.:XJ_A._]CY
MYPNV]62L5-BS]<P;:SU/\V@B;=4HYT,A&?JWM%SK+)]$>*RZ-4*'MO;HSG+C
M(B8P'+7+3&*;KT8GM31?EJJ9^(K0O%;3)P]UX!GI;(2;Q,[%MOD6%$X6<S+0
M+@\($N'YK"BADF((@VU"Y6(X[28ZZB6%I7TL]9B5=/.T4 _]HBB_9>NI(N-H
M<>NG,DLOU5A>Y,G$A-\F>3VJ0EDR=D,<7,5B7F&-"%L_RD$&+I(H&+[Z?7 <
MY&:A3/,<]U,O9,"),?OC2-,47&*=E>EP2@="OV?M#!R-<2-D, I(X\<AGI)&
M@6W_97S[OW@*?)U!K)1O>_JMY]N>?L_YMN_#>KF]\;NNU-I;!GDO,WHO\^)3
MHZ2$+)-Q+>BSE'^O OZ=60ORP;)(LA$.#8MPMG/L54;'88TL+'BJ_;O..<0K
MQ)2NA)[N)OTD^?[P8)V^X:+P"HE'<&S8BD:QUEH:(SZ]Z/25=,<V<P*76/1.
MM(3*@,HO,R\.[>RD4";*U*+8&S"_AXTL=P_61;SP5S1<*4V2>34617M:V?L
MZ:2S&_]++X('+,_X9_252]\Q\9>8PM5"P'*[=[?<E$H4&#A91!,9?D*P&WQG
ML"^YX19??RK7O*-*#>:%2!B#-Q>Z2MTWH-ECS^(2V00FLTX,4@?/TTP1'%PG
M>VJT(,@2&@88:VU3#QQD$]A"""5GC S6N UL ]$MURK@]<'A\4 W,**'&V)A
M$NVR44:X\?[N@?Z,U]4'TSKW0Z1#BBU-UDG77N(V=1+"4AN++5J]LZJ6*K9[
M#3>4BRG$YK$L>'0I!KK1N6/?CFB[34M#)#FR#E]S*W%W6=5O2G9V;%)743"+
MBS/F0\ D%QI(4L)94!C$Z*L;/-0"KBVD&7LP@J%]P>V^<#,AP0H2S]GNCK3!
M= =.LOM! <[BLO,A6A'@<TP3P(E3"[I'('.]@ :HI<T&67OD8F""GM+PF5CT
M>+M+TVN9? C,Q3L2!=2%\<0N&36U(E8;[R1(2G->P8OB^2=L)E:39CPUOM;<
MZ))[H$NFZZ.'0A[P,Q:2%\$1'6$'</*7"#M?9J-QK=VG6'3)E/$7O!^MMRXF
ME^E#&U"C3U_I;,M6\-F#.NA&BO@,:YUL[;9_&ZE(IH%@AP@<"=;5NUWG=ISZ
MU8 )/,>1B;/2#<2&:%S+Q8&)S)5AE7;&EOZIKKQJ1&!LOP0.R]JI4M0MII.B
M8O+T29X[:CC<$S>[\Q[LSK-U!7!=G<T^6ZC6(AT:)P:$>,73GPK>E]K5[=-_
MW'BD-7H[ D[^@%XT.2')W; N$9L>3(*4C-5]G1&]^K,V G\/!/Y\[6BN_?P"
M*^I,DG8%H-;8_ )LN:M064\9E47N^IV@LBSX!+0_O\]M0%I!"Z-E/>H'(/'W
M.(C[[%L/XC[;!'&_=4U]YRGH=<$,CV/7^Q&AAA1([$A!6^4MQO]Y(FEG5'BH
MC9&8.\CKBE#WMH6A%U84;BD.4Z)5;'K(Q!/QNB4KJIW@L-^C]&U%"[CU[#,C
M^+*::NW0F.^,H@KI%CUJ7L0[U" =;D/L#61-61=FU R33NLT#358GCQU$VSU
M@J?@FZ3C6BC_A2<\*I/2G7DV1CLO,+B,%# ,KA<ST,=L2A0;(QDR6S UPF1N
MX\))ACQ6I;3:T_E8=#=LJ<)E@57+V%Q\1G;;U!V/83M4C+A2_ZRU5: \9_:H
MMB>I,2+[/0*XA'YHB&:8RNP7P02C4EOXG8N2'HLTO(J1(\#0S7IATTX$*U>J
MVU,_SI#T7(D26!?=<76% F.)MDN#)BSBQ5Q;>+.^76;W-"G*2GY.RS@3JBPK
M3K;)$BP0,3C)BCBA;4B^>YTE8Y>9SHBT:B%!<-QSY-&Z76>%);_49@FO$+5P
MK#&#(Q".\P1K4+>>&!2'B$CWRAB0<:P($ZQ /8S,]0,Y/&YOYO^YMO8.H#0R
M[//E($E,L(A S(6!C&\Y(UG]:$$5SI%T*#6;N=]S**;$7,G%ZA0)BHH9E2)1
MF(?4#C\J(I^9?%RJBF+R79A\1;U@FH\("X/>7&?,>6Z;,W Y-46@.'+LTHB7
MY[GN:F=?UNZ6., NSQ)#,M[*WK..8)0$KLPUCW>['&/B5">_O3:MW73U=>6"
M8]WSC/T=6M/,BITA]]PK Q77JV@64=+ISSQAKL RON!FR *F0@8.;J*6.0Y"
MIG+#%7/M+EI/%YKV4L4/B,L"/"6<*AR/XT$$5475886'9R)$4%+ZE3RA]<ZP
M"2E7]% \+<LST&)3L"A,)2""N%PD!MM%(PQ,FRV42K;GEJAC7%ZS,&WA=>7O
MTM;P2X-]-]A_>=EG'O;_Y/UP_T!C_S?0_V\$^O\^.3M;4&NJ8YU-:#"W-:PQ
M)NV(C:6I\Q#$$?)CKF+_M@LGH@)TYTE"J5K^#_H<5171?XASE+E<BG\K"V#=
M&83=P QP84CC43943'8VFZXPNFV JS)M[=%W8.HXKWF&L?(\T]PB,!6C2+^G
MNH HA3DAEBCCHH'>QB>E"3QJ0H[-A$\/ZF;Q5+I9[.ZV0VPJAO>,A +#>)SY
M26;X-LS0-*EC9F\!2[8=N)/J9VMERLE+&AT&,([*<]/+["'$V;[YS;^NBHOC
MV#2?(PO&K[SX2.$&ZIZ'60?73(_=&C_P ,>U'XP6;L92A*=5JZ%K^A4,S<DW
M&FYOC_9U##EOAIACBZZ2L?5[< %8>VJ'QH&4.X=*X%F-D5=+QB#12PJDH\Q3
M[N10Q$9#F(2K?D$TJ=4&PVSD(JCG^/G>[G]1P,*PI?*KTWV,(RF@<S6S9(-?
MZU0^F%CW-[\'UU6/LM_H@4P=0O:>C1_O[.VUS]^*\ 5IZ@CV7&-J0CI:M(L+
M;[3I'QTU]=PU*!FY!B7R^$X':@L>PM&TA DI% G7<R3A>KRW'3+HTO3,9) 0
MAJ9&1?Z)2AJ01AT.9F3\JRJ*$TI[T9I8[VES./"I 0AXX1EL_\+^:+K0+4?3
M1<@5#2.P(_#06_  _-OQ/+'3XZ)\YFC465X](W#"/H3-=X\33<^_]433\TVB
MZ;9R^["Z97_]FH$!.$[5,A_-PE2C3+J@DJ''"*W@_?[@Z*4X;@P/BUR3MVF"
MD1RF<^444"/4ALA^9:L\!)7XS0O5NH#4-P@#H#_?<.<Y;HLAUD::PQK^?J?#
MD*K[U!/;+O[)SAZWHS4Y(AL.X.BM@3LW9'2+4C Z]:6>8CL1ZC NOV+W=?+&
M%$"USO/R:M#1(I0.$L1M8&LE72\+:@?";-B6"8$;O/NX&6&T'TO&\CHJ[^L*
M5/N]1K/(5K?.)>]OL&L\ ]0@@@+6M4\PVP[BA)VV)_'%=#V^E!#$.)I+%EB6
M\'T:9<Q Y^C]#2KHRJ$OXQ"@'L5Q"2:BHJS@+*(NV4:O[2*!_2_DZC0;-M^[
M9+8D?1'I#J&4^)T7"?=9K8A*0Q5N2^D!56XW<((\YC-*I;O[&=Q4I.-89.G*
M*$M^<^WQ1FF9(P5>AC9V S7;9BIWJ5F8JSB=>HE9B^@O->+8+ZMPQ=:2 3=O
M1M3P",:?Q2 O$V;U=NMJLB!*M-B0)T]>3K)17%V:#HT2QI(:=4EE4=:IF?8@
M&8NX^ME[Y)*BB%*A0:/25!R/U$HL3"J[75KNUR=833G'.("L&S6282F@N@Z_
MOMY.6+><A<+(?&Y#F!2<'.?<?BENU6KA*]S%P&$<-QNY=VP\"@:\Y6B+R$*X
M2;GB_=O;!!NM<R?E3[HG*!-45D4=JQ-F"Z,P:1J?483%_W);RFR,PL:FOM>H
M2/2,RWH^3^E/A13IOGZ;XL6SI*2@M1Z+^;!S# W]30.69L$)2;O7D1WK$5BS
ME*[WLEP<<LB9NM<+<L:K.."@D\U"8G.N@EL!A5SKD)1I'$V$Q\$T++:^=)8;
MLC%_9BDTYK^3GHB$8_XNQ+#$/.!D@HVCE=6.^PE%'DQ(WIU4KJ=41'E(BRI"
MK^LL1TNVXZR W\_F&&,@!>RTC:M<I?$2_F;+I3,XV0D+(4UI0;2W90!,Q( 7
M1/AD'"@===0HT(P59]C45S0)YP,7\A^1&.WM+DF(._6@CSQ'TH1+)CPBN;/G
M[%ET]>2*.EVV-W%M. 2DUX"$=,(/U&&6SE=JUN-ML.T/"S&YKHJL$U4*-)!2
MH(ZV4I1.:X5(K4*\)MOHGSJ1]$"+4E))^-?GA=,_%&.4FFTUNG[/#"]TU?'8
M?NHS<=%P 69^R?W1+;^O%&LJ.5]6&NFG1.A+26]06M,B :6;-/>LZI@\T]>2
MW\ 9 /^WSN+@R2[%<9^%C8:+-TU64AJRWVOD(8.UI"$5-F>9<!CO  %$)6L2
M6T8FVE)1[. Y^R>7E2\Q!75VYB(G@]+'.II6H(*H8=-3_I!P.PH1&$L55?#&
M7"P/<\#:E9K!7N=8MCS$9C9-5?@J@<(\]N>Q 7N9B#YLG6@>*A21UZ4TFN .
MY=-6#EJJR;,-UZ2]>E#"X529/T"I@\,KOI_ 6(W+SIVN4B2_,C@W0F29#JZZ
MDIBFD_8@Y<A$?F*&X98<\3=_-),#6CQL]@)>M246_)3J'!8)90&6AM)N"N,L
M%RA4=I11!T4B!_?DU_C&'>4OOFNB"IRM'2P>DN@E!& CXI7WI[$GFN+;<E8T
M;52'V>" ;W*#1A%SF_.)VS,QZ5/;)6WK/Z=@?%RO%5!OPJ@!SG\1MUI>V':
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M\/98:DO=T1L9:6F*"%</EB'CLI0OU%'[E4VX(3V%F0(/-T\^/#KY;"VJ">0
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MS1GBN43O$_'C;4WI^B#5#VZ7[/,RGU3Y^%,PA/,;+ C#-F&%@U4>KKJT0K(
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M 14I32O;]@QH>6;^3$8TF^7 [PG*A[@ "DI:4&#A&)?K^5_;+5GCILTQJWF
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MGN'F+Z-9W*AB\PT <B0IV$6N#GFY$@T7C/M' 7)K>LX:7<4\S_$:8T*SO,
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M_8^-]JZQ*Y&<U,R.&^OD,09:G "E?<SHR:H'@QXAS;S%VS6-I;/K19SDUL7
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MJ">N&H F?F2LZ/XG#*I0'A1&<$GGK$<M ^U/I)%8\A-P3C0;K-R;7KS*"H>
M6C-L_98O<V187P]:N-6Y@8TO$T0Q+_@=PF(DGG"TV[ZY_KWY!MB3F^(EPL1
MV'F6S4US*0J5TZB>+SUQHRYX$.$D6T!5"5J2)_TJ9?F)V%$<+$M*$9MV!$]B
M,_7&UB71(WFQ0NN,C=TT1@\[J&5[?M_![T^=)(STP2S)9YL5BGZ]>>'N<5E<
M;"ETRZ52 SR7+I -X3R2>2!#*4<Z B$UU]P,ROQS0O'PIT'J8* B#QQ>+Z,K
M AI 6<:MD]GGX -6NJCB#*E1P_-2F*]B=A%SQH!S[8>(A@)/"V9'-;/'+1T.
M35"(+O-+^!(<UQPQ[_G+E+K+-1DQ-5+E/]#=,R5Q(IE-< )0B!N$2=OEKR&=
MEQ$7:34Q\0%CM\01>AS!Z"O1Z9ECF&LC3UQX<(!U!P8!V>"(!F=><.\\G-X<
MGI\)UI_UIWPE$V,?'WK\:!\@D@#1XT?["-$/<JD\LTI4<GY^C4VEVZV1VS[#
MS5F>7#@]0KBS"S<1PT ["_QM_;XR1 SF=#N_'8?Q]H_[1Z'C3J\G>YH2'-)O
M.%KDI[GX56Y.T !]I5;A9I]HZ?9Z;PQCN!$/TI]JN, P9>1JN*L*TU=$1;<X
M_O@]KI5TG,T(K1%VT/$!SC-NRL91D,1M[UQ!#H5=(XV6;AE)D*0$A)IE!8OP
MEV>/'J'! Q=[3%F 7\F@H5XOQJ+9*VX[SICMB7B"K73;K5/I(.0!V<FJ2]2M
MT,P@.FL=@^ MYFHIWLS"29^E1[M2:(-N^\961Z;3D<'(OD6KHZ_:WLB)&8,:
MTV[M:FS4U*R'B*5 W6TZ$S4MK>F 1(;_)L<U<%NCCR6B':4[&P&%WA[QYG V
MH;6%%I0PG,YK&!KV/82SS)G#C.2*'3\:NEG!FT7A31G?$%/YW(AFR'VSI!6/
M]"6ZM T4M5HHI2)AMA'I#W F,@6!HQ"?@0DWM:9NT$OB^94>OI7<WOK25-58
M8_7AS.*TV.2Q$PJ3/: $?UF''.DA<91G*4QYR1C0QQ]Z1\)0_@WE]( OE"]9
M6JOURM:-"YCK^O(IN(;&>))3EC8Q#+QG97PV.ED8[A(N%\GJNR"L(I/AS77(
MQF9P>YQ@% *AEDAHL\'6T--^^WQ8U\<K[%HO,*Z@DVDV3-"YI=0?*<8$,, <
M:ZO%ZF!3T6QWK"EI=G <AKINI,0H9F5=FJTCH6K>R-M#:XQN U4F&IJO;YN&
M8/,6'"S->D"3HR\4V$/<:KDHNZ$TM$K2?VKA(IT@"=_8>UZ"IPK5;&Y3Y[2;
M(!"ED1.3DS*Q,)GX,1 !!VX6++.B$)>C;2DVS1CXT\LBOY;K6RV^?_=XT1T&
MC/J_]8>3<7#ZNMTZ[K_NO3^9W*N]^)/UG&6\*!G:SE;]D.KNG'[;D%=:&T6<
M_V1J:5,G[E'-?76[\I!JDV8V&4% [C4WV:3;;AAO/%Z7E/(F]QE?&62 S%_<
M^<K=6XWUJ1/[>\T&"F5/G,$]<69",;#F ^E%88W#6IYYH(%S&\,1> >RM/C[
MG/A!\:,X):LD\X+R"HD2B5!]%Y4L$X\I'4XAI9#CJ.8/U;^U@(>M38J =!C@
M1V<S4"2L ].8>7M#9@=;V(B+S9]AAZ?59G?QPLY,>]_X[)#W-@6;92:I>J)J
M<&,X]/&2JD5&JL3Q, 1X 3=K7E%ZC'7=K<"&573;6AUBDQ>U*>^'U+ F; <S
M<VO_Y*I3-BKXYB\=6JMNT*GHN^R?<+1^*G==H;$'IM1G-(VW( 1N5[?/*"@2
M_[3H+Q=:\D?N:%K8YIR:.3R V84-\Z=F%_Y:S>,E]NP$/6L=)3G'S1["WR^0
M__.F4;@D5"T&PMC).(T8_OUYZQG<<CFY -E;U';K:ZUJL&51,^=<<?=EQCRV
MRPLLV;B^\C3.7%=5E_G&U57C$D:@Y?1:X!I3DRA!&PE/QSP'JT2J@]:.K2ZF
MKKH73.X=7P]=]2A6]V 'K$D36S< X'R=': YVFP*3>Y2F;7B1FR>"Y1%F HM
MV^.6C$5&'"/IQ2$H:[+5^PBA,0HWW?JBZ^1#@DZE[D3) $7S,DFQ6#"=4:9,
M1Q:PD=J@B5CAF2:Q6CB).Q2+*F;(-W-'0'?;+<I_;&K$Z^0]>X8?Y6A*0R:,
M93=6(AP$ ZI(1A>7E?-9I=@-69!#Y &KIN0GK<X"+Z8:H],+G,Y]JJ!6M5/5
M3*N8/H&;GUW)["<X,#AP:-GR46-_U0*[0N;LP&6<^,AFA5PUP+]LH]Q@9WG=
M8%4F>;G"T9SBG(64K:5ST\.Z5C-7D014$3!G*L"\IQHY=]+: )I?,.?!'=AK
M$#V-,W*(DS[.6/1]_2 FY;[S[.]=X,:-X(C 0JZH=)XJ./>ASJ\4ZGR\#W5J
MJ//Q/M3Y@U@O-G_FD%QY#&*BZ&4-=HN)['$W&LZCL9XY5/BE :FX)IN3RK7]
MAO6'- <#47-5QZ7):)3VPB(7#6B-(7MOK^[8\6=-.SZ**5DO5:PDO#X^, 96
MHN9KC]1:]SG<1$'*NJ[I&12^LE5RLMD.6)ZG63D:;;N%;1Y3UZ0UZBCCYJF!
M8@//^'<)\>VNW&EFF&YHU9I%M,3 !"C)JZ18QH278:%K@;\30C1@Q9Q489SI
M=W"YWAW+2:QW!#S'=5(Y03).4+6+XWH6A5HTMM>6'\\UF:K4RPS#E?!&SIX0
M2V$:I_&"@UDS4"23,LLE^8W:-DK;#2DZ,:#O\&$&=H<F^45:UL4].IA:^BXG
M>7)4R6FJ3*GR&E\R(''PE.KX1 )K@$UCJR)H[;"I(:HQNK&7:LIB/QNI]K\V
M\W.+O]5N]<GCW=AX["_/.0T$8?>2E:3>@/9]&*?_C%9PYET$X$$Z._"K5RT"
MB19P!V!WQ]= %Y,0D@"C/=>6JFH4N/$\8^K0^R.L_RPJF:A;3\06M ^7^20H
MR,W:%A(CI\!^BBL@B?^AP&)Q#2J9AYOT,B+O3PC_Q  <D[D!ZM!.4UQ2V+R,
M&QQ?Q7@1=)YH[UVII[7L+ >.[VXV<ZP!)J7O4@AFG)=3M-1-<@(70B.2X/XX
M[#@.%O'I,$H_YIMU.;M^V6Z=V/[L+'4Q(\8^@3%EL$'@\IU=-[4'=MN[$R,3
M=+@/C*E_#)WL8KJNS:\A^S_R>)G$"P.[>PU6O=*A26>$X"CA>PIE\5<05#B>
MHDBWQRC1N!D=8/RN<XRVWBNFH9CSA'>JHOD*CY.CBO"O%BJ'8CD)X>]-X><Y
M7#RY)F' 4*0S;'+V39(7QS_E"8:W4<FUJ[6.R\0 EMM%>6FR=Z1]ITWY=O:%
MWG.5<(G09HUKU21$S(5E:ZO).6J<412W_!X (._NC%D<D>,8\<JHGJ3B?FTP
MH)AE%P0YZ!3,(-O)*(ZV4^M7.>R-CWO_$% I!@G;;]*.3?JE,6A[5,'4Z"OX
M>V_69//Z6X:U"P)HZ8X!IA$>)IN.PE7_MISQ&9<S&@,%3UO-H*4R)AP$G;TI
MU]J+>Q8$!PK6[DN-2#34BS(R"L=>*F#76^GC\+&[!+O>0/%$E&.<S(B"SJ*>
M4.XSU85(MI"-$1CO//5\1Y.3$@:?SYX\>/S8.&-=*K#-DZ0N8A0%3P(H<C&!
M\CWY.0R>/'KRN$NH%52:@VH*J=842ICFV4=IM,Y8:YC,C&EEBC%'Y!><K6QA
MV.2FJ4!X8((?QY T.*:_:3N_55+:@(,_'*^3"&?K/)?48I>+W!7I1-W]N=Z5
MC/'(2M_)D:CZS;6_)E\8KLXE-3^A5M;V!I>XBD;0+A-3<8Q9E ]?]\83C6C8
M0*F3VZ;WLAF<0UR%T]40: SZ, E$(3^0P>[/<M[#[;7)-D>8#VN*6$_7DJ#B
M.*5F^@2%,<T#9,DYND]-J:-@F35.K.JV2?5X^LI=I)6:_*N4G,XW<:AIU!B\
M@G=<<D!)4'XQ'QAX V.0%:NM 7HQ,/%)0A42_B$<)XI=SN(\56[T0HWH")DK
M;%,C-"FA=E0FQ#JJG<EW('3N=9#HR3Y(I$&B)_L@T0_!]R"-;8[;NX@2,TQW
MGQZYE:S.[ #9N?%K!Q? \:+C4$N\43>4DR@NJUS:4,!OZ/-9HB?"_;SBTC+8
MX7GL5T]@"&HC75J,7=O1M,DTT[HV2L;=H)'>51,9)/8Z*Q+U>U#\_MJM=393
M(!J,^JI3_@ZDZ!W>[3;F^#I!3DJP_&MLHD&CV$2&+%_EL1,N$CQA_;*-)!76
MA^M=?FXYI4F8XL8>N3HP,5L"3*&K++B.$11EBZNW7HF^@?MZZ6>RI SW@WJ'
M"_ CN-.V?8,T_K!3(T#/D J,N+0L*3A5$[^';E#.TVZ:>\AFF<T@QS0ARZ=S
MS$")_590S;F<KJ=<0B.5ZLW[$7&]?Y(R .9^AE6IHYA7>TPXZ0T>!=Z&#4%N
M8BB('R=8=0,OX5B@7N_>NS_#]U"FV'+24;P&;4D L6 M)YJAU3LW$F4W2!1=
M-63+46(H#=>04U;)X;7)_6P*A$:"L(/%>C*\_FNY)3=$(-@-&B#QIWA&)]@G
M'N@V^:'!25R6DGG-Y<<1.J:QX Y'L+F"'NQD\^EUG%+;DBQ,K1KEU^7 L=F,
MPC&"\;,#*AZ_7H$;[H(=!5MH)34L!=[<;MVJ2?^V=EL%MW1_R^XZ$3]OL:"E
M!<@6\[GD3S_3!1W:^N/&T4RC0+)L.?[C1@X7B=Q<R/;X[\[SKA(*M^[U/A"Q
M<ZMMM.\HSXKB@5,D]N7PGSYD@X,92 H*%=+/+7:#%L)BP\_T@45M""GC0Y%H
MJ_J9:'2?G4[FI(^=TO-&I!6A036N9/U6BI1CTR68%*:YUUNBCIE<?XV!^M+;
M9'O-;M!!Z>ITLK'5(5W*;*;D%(K -X 2^UJ:Q0"HU]ALI187GD/IFBA,LVVW
M>+0"LX\KWZ&XI=9_'S@EB=6QW9+$51Q1_Y>,K#LXT.@IIRIW2PK7VN-])J3%
MY54<IP@6M4*H3 Q^7K\(.H^['J\(<("DW_BY/B$EU+N)W%('$"TP>&*T=Y,1
M;?IBFY:U%%RFCK7M5FWU/'27S\DO$V<@)KFA$>Q)U8;KV.M VVXY+6C]<(<L
M677&YEAUG +2D],C/Z_3M@+R:).L/[]^1W4(DRGE#Z<=TYUA&M!RG EN(=R[
MW.EN6F91ZJ,#8%X(P6/,2-0)!RMD#M?@T[Y5OVI*RIU*><(D9)DX%Q\ >4:]
ML+F7?K^_B'9=1#8D/B"9BB$9$PZT&H=$XNK7@%33P&D%/BHTZ)8Y-6[F)-L*
M0CA\H;AH0O6UQP;ICAN"2]D7]C1#AY)UZ-!SCH/^RTA"$61,;KP !?'%"8H:
M)WZU%T#H,YJ^V6C&@E5(N8Z%9DLE4BSEX!=Q49/C?S-!!@X@L^0'P;=JM_[^
MX'_[("ZF?57P^CC0.$*!T"AHM.R37'<QOTTU>)]*3)R".IQ@+? XS6V.!3^X
MH;>95Y>4%$YH"L.9C*6.2:BHW&'?6Y'X\"8L.\2*= $[6I*Y*$(?-'"L#<*0
M$4PLQYQ%)\,.Z\#791W\RJ7%,!4'VM&!ODA 5^NPRD+.(U+JEW%$!:?X:3>L
MB7F+_+^CDFH1S7 E"5&D3L$-+3]B\<HA?C9! 3E&26[5JCI!?MN21J@CMZ,"
MJ$AK:K9 GF.O:PJ]>^?:8?'TIM&-=M?1KOON<[KK]=D9#7RZCP9J-/#I/AKX
M0_!]0S]K@VQ3Z]!H(-.":)I=4I,N0IG@NT4PD7$P<5>2-:]UV )C4ZF\I7Y*
MMHU64>U\>JPF+5=(>^T&S&6@EOF-:/;-K9(8O\6_&K$D=X,XG: ^%0N#]LV@
M=8U@:B'=O]Q^#2'&*+FP\XG)++&PJ!GN7[[B&?PP\?5R4W 7[^LNWB?Y1D#/
M-RE6%6..L0#+R ;RWV\86&:I+FN#U<]#:..7/&8D.G(.IUA.L4'W.4Y&E&0D
MRB&RW>K\BQ.93>^8JQKX1G.SL<(T3,+)P=^Q]]B">X\)BD[GMBN(OJ ;9NJN
M[.VF'/(.H&KPKZYQ?5I/"-K5B%F72OI-$_/6._;6>[P9/YX4V57<>0+J8TZ6
MC^M2/55D%.BQ%7"!#N8[@8%-WC9^2;?2=)Q\ <U]6?6P&0\<82-ZQ?>&F(O8
M?+G6A JS0(4(M/N7V55702@WA8T@J!M!,4+]43QUF_6V6G_CD+4XUL*U:8<(
M#*Z(\1IW"+1\;?-J[W8=8U*X%F/IS:.#1X_1!\Y:XMZQL)6>R84%+G'@,$P
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MQI#FEZB9&LQR_L#"6/!%+TW!R4Q$?+.[*:G^=6"$VN#575'PG__YGU1 1EU
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M#N1^\VIX_.N05G-T=GHZI'=4JPF>GYT.@A<GQT-X_/Q76?';4Z+B&5V!5V=
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MW[P0XY>Y[M$.3+U\]CI&#)T0W=&FOLCZ]O=^_O(\T2RBEQBE4_D]FACC6^2
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MJ"^#S20<[;/M[+(;)DDXA$_6C@Y/VRWG\9/!@\='C9\#V94)<%7]?+AU##+
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M7#SA(2*$&PJ:@JW2UMLH#*2KCN=GASD5$-'V+<T)^T)_%-\[I@ Q-BWQ]O%
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M?\U7KDNN&?"H0:YDZ+;%4+XA7V@,#?(1!"AJI'I#[BE/K41>,PZ*7,HXX6
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M0G@;9TC[,\<3%3T!DY%4=<0_1+="?2MI2/[W;N6?K3"EYNXD8K5Z?Q'?"@L
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M^A6T01<<E9D']*92AE@<ZT4AJDV.V,F#OC@J.6?8#_5 N1L,Y[?F87E@)#I
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M)]W0??GDJC*\T5X=EP5H6:;T_M@[2% W?Z^_2[:;'^;/TN@M_P=02P,$%
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ME6XQV:C[BB8L!)K&8!(J6D\-^PU9Q&G&U8.(LL=I:<8 O>NFO]6VV1=8Q4%
MT\<AV%M4@U 9Y8FC8TK7.+DA*\;;\*G+7%-C,VG"4M4$Q8C%&(B&UB(M]D3$
MO]:89X0G3YU0-)2NN0"LFF@8LJ#HL'L# 2GE?AFYY9BFL6S .B%I2IU?;@!F
M&Y<>ABXH3@!S\"5)J?=+RN2.)(E\;P73[@;%)G9-"VS8Y*6I#(H8T![(C(I
M>4@XV)P^R-&Y&";U+&Q%[Q.>ANTV?DIQL B9#GM2I,*0C/-$4N5]F0Z&&DK7
M] !636X,65#$V+V!K&@Y4GK_D)S262]$2IT?0 R;=CQR48!PU)UUH2'4/L$X
MB],()]K+F=AF/E[IT+H&!+1K0M(0!@4*Y Z$10<4S*@0K\#\AV#>#Y>*T@\L
M#:MV5$I9@*"8WKHPD7HOD)RL.:^YAGL<6.H*DRZS!2>0+@A0.LPU7M+2\AHH
MGGJ@4YK%V9.<]W&YMKQH99>X8@,R5S!A[@^"!<"4R8"6(:E#6NBEYHNG!#23
MLVW XI@RMP383=8IJ&L"(L%J#*!AJU63G[P0<2):)HZ3<SHCFS_($UBNALXM
M$X#-.A2&*" J[,X +'(Q4FHDY%[ N.;Q$O.G21QU=!5-H5LT(*-U-DQ50'
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M?1P"K\[(H.&]C$)%6'XGS M)GUFRIAGF:BXYM[5,@,XM.8#-.C&&*"!2[,X
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M;>@A/)4"%(<&JAGOA +SJ(C7FVY)H&WRP7Z[^<;]<'];P1[Y/U!+ 0(4 Q0
M   ( *> K%JED<SF:!P  $:F   8              "  0    !E83 R-#$W
M,C8M.&M?;W-R:&]L9"YH=&U02P$"% ,4    " "G@*Q:S$[Z6')L  #NE (
M'0              @ &>'   96$P,C0Q-S(V,#%E>#$P+3%?;W-R:&]L9"YH
M=&U02P$"% ,4    " "G@*Q:JY+(*MU@  "0!P( '0              @ %+
MB0  96$P,C0Q-S(V,#%E>#$P+3)?;W-R:&]L9"YH=&U02P$"% ,4    " "G
M@*Q:GPO0\F=1  "]O $ '0              @ %CZ@  96$P,C0Q-S(V,#%E
M>#$P+3-?;W-R:&]L9"YH=&U02P$"% ,4    " "G@*Q:_?5B/^ 1  "<@0
M'0              @ $%/ $ 96$P,C0Q-S(V,#%E>#$P+31?;W-R:&]L9"YH
M=&U02P$"% ,4    " "G@*Q: E>6C.4#   X#P  $0              @ $@
M3@$ ;W-R:"TR,#(U,#4P-BYX<V102P$"% ,4    " "G@*Q:PIZ)81<)   2
M:0  %0              @ $T4@$ ;W-R:"TR,#(U,#4P-E]D968N>&UL4$L!
M A0#%     @ IX"L6K:##"@D#   *)$  !4              ( !?EL! &]S
M<F@M,C R-3 U,#9?;&%B+GAM;%!+ 0(4 Q0    ( *> K%I& 9@,8 @  *QC
M   5              "  =5G 0!O<W)H+3(P,C4P-3 V7W!R92YX;6Q02P4&
2      D "0!Z @  :' !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>ea0241726-8k_osrhold_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:OSRH="http://bellevuespac.com/20250506"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="osrh-20250506.xsd" xlink:type="simple"/>
    <context id="AsOf2025-05-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840425</identifier>
        </entity>
        <period>
            <startDate>2025-05-06</startDate>
            <endDate>2025-05-06</endDate>
        </period>
    </context>
    <context id="From2025-05-062025-05-06_custom_CommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840425</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">OSRH:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-06</startDate>
            <endDate>2025-05-06</endDate>
        </period>
    </context>
    <context id="From2025-05-062025-05-06_custom_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840425</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">OSRH:RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-06</startDate>
            <endDate>2025-05-06</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-05-06" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-05-06" id="Fact000004">0001840425</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-05-06" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-05-06" id="Fact000010">2025-05-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-05-06" id="Fact000011">OSR HOLDINGS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-05-06" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-05-06" id="Fact000013">001-41390</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-05-06" id="Fact000014">84-5052822</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-05-06" id="Fact000015">10900 NE 4th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-05-06" id="Fact000016">Suite 2300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-05-06" id="Fact000017">Bellevue</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-05-06" id="Fact000018">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-05-06" id="Fact000019">98004</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-05-06" id="Fact000020">425</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-05-06" id="Fact000021">635-7700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-05-06" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-05-06" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-05-06" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-05-06" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-05-062025-05-06_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000026">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-05-062025-05-06_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000027">OSRH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-05-062025-05-06_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-05-062025-05-06_custom_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember"
      id="Fact000029">Redeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-05-062025-05-06_custom_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember"
      id="Fact000030">OSRHW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-05-062025-05-06_custom_RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember"
      id="Fact000031">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-05-06" id="Fact000032">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-05-06" id="Fact000033">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
